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ABSTRACT 
 
Magnocellular neurosecretory cells (MNCs) are neuroendocrine cells with 
somata located in the hypothalamus and nerve terminals in the posterior pituitary. 
They receive neuronal inputs from the brain and release vasopressin and oxytocin 
into the blood to regulate many important functions such as water balance, 
lactation, and parturition. The process of hormone release depends on Ca2+ influx 
mediated by voltage-gated Ca2+ channels (VGCCs) on the plasma membranes of 
neuroendocrine cells. To better understand the cellular and molecular 
components that are involved in regulating secretory vesicle exocytosis, this 
thesis work was conducted to investigate the expression and function of different 
subtypes of VGCCs in MNCs and pituicytes (the glial cells surrounding MNC 
nerve terminals). 
 
 Molecular biology, immunohistochemistry and cellular biology were used to 
detect expression and alternative splicing of different VGCC subtypes in MNCs, 
neurons, and pituicytes. First, the presence of CaV2.2 and CaV2.3 channels were 
detected on the pituicytes in situ. When the pituicytes were isolated and cultured 
for 14 days, more VGCC subtypes were expressed including CaV1.2 channels. 
Regulation of VGCC expression was measured in normal and dehydrated rats, 
and CaV1.2 channels were found to be selectively up-regulated in pituicytes after 
24 hours of dehydration.  
 
Second, two splice variants of CaV2.1 channels (CaV2.1Δ1 and Δ2) that lack a 
large portion of the synprint (synaptic protein interaction) site were detected in 
 
III 
 
the rat brain. To determine whether the splice variants were expressed in MNCs, 
we did immunocytochemistry using two antibodies (the selective and the 
inclusive antibody) that recognized the carboxyl-terminus of channels and the 
synprint site, respectively, in different cell types. We found that vasopressin 
MNCs, but not the oxytocin MNCs, and one type of endocrine cell (the 
melanotropes of the pituitary gland) expressed the synprint site deleted variants, 
whereas the hippocampal neurons mainly expressed the full-length isoform. The 
splice variants were properly distributed on the plasma membrane of the somata 
and nerve terminals of the MNCs, suggesting the synprint site is not essential for 
CaV2.1 channel targeting into the nerve terminals of neuroendocrine cells. 
 
Third, expression and distribution of CaV2.2 channels were studied in the 
MNCs. All CaV2.2 isoforms we detected contained the full-length synprint site. 
To test the importance of the CASK/Mint1 binding site for CaV2.2 channel 
targeting, we over-expressed a peptide that inhibits the interaction between 
CaV2.2 channels and CASK/Mint1 in differentiated PC12 cells (a neuroendocrine 
cell line). We found that the distribution of CaV2.2 channels in the growth cones 
of PC12 cells were significantly decreased, suggesting that the CASK/Mint1 
interaction is important for CaV2.2 channel targeting into the neuroendocrine 
terminals.  
 
In conclusion, these results provide insights of VGCC expression in 
neuroendocrine cells, and also give rise to a better understanding of the 
molecular components that are involved in forming the exocytotic machinery in 
these cells. 
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1 
INTRODUCTION 
 
Ca2+ ions are important intracellular messenger and impact nearly all aspects of 
cellular function. Exocytosis, which triggers neurotransmitter release from neurons 
and hormone secretion from neuroendocrine cells, is dependent on influx of Ca2+ 
through voltage-gated Ca2+ channels (VGCCs). The locations and the properties of 
VGCCs determine where Ca2+ influx occurs and therefore how the exocytotic 
machinery senses the Ca2+ signal. To better understand the differences between fast 
neurotransmission of neurons and slower neurosecretion of neuroendocrine cells, this 
thesis work is to investigate the molecular properties of VGCCs expressed in one type 
of neuroendocrine cell, the magnocellular neurosecretory cells (MNCs), that release 
oxytocin and vasopressin into the blood through their nerve terminals in the posterior 
pituitary gland (neurohypophysis). To better understand the importance of the 
synaptic proteins that are involved in the regulation of exocytosis in both neurons and 
neuroendocrine cells, this thesis work addresses whether the P/Q- and N-type Ca2+ 
channels of MNCs have the synaptic protein binding sites as these channels do in 
neurons, and how their molecular properties will affect channel targeting and 
distribution. The expression and regulation of VGCCs in the glial cells within the 
neurohypophysis were studied to better understand the interaction between pituicytes 
and MNC terminals and how these glial cells respond to the hyperosmolality that 
triggers the vasopressin release from the MNC terminals. 
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In this introductory part I will firstly describe calcium signaling and its 
physiological roles. Different ion channels and proteins that may be involved in 
mediating Ca2+ ions flow will be introduced. The SNARE hypothesis, which is 
important for Ca2+-dependent exocytosis, will be also described. Secondly, I will 
introduce the history of VGCC discovery and their classification system. In this 
section, more information will be given in terms distributions of VGCCs in neurons 
and neuroendocrine cells. I will describe how the neurosecretion of MNCs is related to 
functions of VGCCs in the hypothalamo-neurohypophysial system. Next, CaV2 
channel targeting and alternative splicing within the synaptic protein interaction site 
will be introduced, especially for the CaV2.1 and CaV2.2 channels in neurons and 
neuroendocrine cells. The introductory parts above lead to our first main hypothesis of 
the expression of splice variants of the CaV2.1 and CaV2.2 channels in the 
hypothalamo-neurohypophysial system. These variants are hypothesized to be 
involved with the alternatively splicing of synaptic protein interaction sites. Finally, I 
will describe the physiology of the pituitary gland and in particular the pituicytes, the 
glial cells of the neurohypophysis. A comparison between Ca2+ signaling of glial cells 
in the CNS and in pituicytes will also be introduced. This will lead to our second main 
hypothesis of the expression of VGCCs in the pituicytes. 
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1.1 Calcium signaling and physiology 
 
In 1883, physiologist Sydney Ringer accidentally discovered that the frog heart failed 
to contract normally if he prepared the saline solution with distilled water rather than 
regular tap water. Soon, he realized that the substance in London tap water that was 
responsible for the contraction was Ca2+ (Ringer 1883). The concept of Ca2+ signaling 
only started to gain much attention in the 1940s, when Heilbrunn and Baily published 
their landmark findings on muscles. Heilbrunn found the isolated frog muscle fibers 
only contracted when the Ca2+ was applied to their cut ends, but not to their surfaces 
(Carafoli 2003). Bailey showed that Ca2+ stimulated the ATPase (adenosine 
triphosphatase) activity of myosin, and suggested that the presence of Ca2+ in close 
proximity to the myosin filaments was important for muscle contraction (Bailey 1942). 
Later on, Fatt and Katz published their work on the electrical properties of crustacean 
muscle fibers, which suggested that Ca2+ could be responsible for transforming 
electrical signal to a chemical or mechanical response (Fatt & Katz 1953a). Later, 
numerous great discoveries proved that the Ca2+ ion functions as a carrier or 
messenger to fulfill diverse important biological processes (Neher 1992). It is now 
very clear that intracellular Ca2+ signaling regulates diverse neuronal functions such as 
neuronal survival, axonal pathfinding, neurotransmission, and synaptic plasticity 
(Bear & Malenka 1994; Bliss & Collingridge 1993; Burgoyne 2007; Franklin & 
Johnson 1992).  
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1.1.1 Calcium influx, storage, and release 
  
If Ca2+ is to deliver signals to the targets that control essential processes, its 
intracellular concentration must be precisely regulated. In response to certain 
extracellular stimuli, the concentration of intracellular Ca2+ rises and falls and the 
concentration achieved is determined by three aspects of Ca2+ ion flow: influx, storage, 
and release. In most of the mammalian cells, the extracellular Ca2+ concentration is at 
mM level, whereas the intracellular Ca2+ concentration is typically ~0.2 μM and, 
therefore, there is a large Ca2+ gradient that allows Ca2+ influx to occur and act as a 
signaling mechanism. 
 
1.1.2 Plasma membrane Ca2+ channels 
  
Cells increase their intracellular Ca2+ concentration in two ways: by allowing Ca2+ 
influx through the cell membrane, or by releasing Ca2+ from intracellular stores. The 
physical entities allowing ions to flow into the cell are proteins called ion channels. 
There are several types of ion channels found to be able to mediate Ca2+ flux into the 
plasma membrane, such as VGCCs, N-methyl D-aspartate receptors (NMDARs), Ca2+ 
release-activated Ca2+ channels (CRACs), arachidonate- regulated Ca2+ channels 
(ARC), and TRP (transient receptor potential) channels.  
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VGCCs are members of a gene superfamily of transmembrane proteins that 
includes voltage-gated potassium and sodium channels (Yu & Catterall 2004). They 
are highly selective for Ca2+, with permeability to Ca2+ being about 1000-fold greater 
than that of Na+ (Nestler et al 2008). VGCCs are found in the plasma membrane of 
many excitable cells (neurons, neuroendocrine cells, etc.) and are activated by 
membrane depolarization (Catterall 2000). One of the major functions of VGCCs is to 
contribute to the depolarization phase of action potentials in cells. VGCCs mediate 
Ca2+ influx in response to membrane depolarization of the cell, and regulate 
intracellular responses such as contraction in cardiac and skeletal muscle cells, 
secretion in endocrine cells, neurotransmission in neurons, and gene expression in 
many types of cells. 
 
Ligand-gated non-selective cation channels lead to membrane depolarization by 
providing relatively non-selective passage of the major cations such as Na+, K+ and 
Ca2+. Channels of this type may have significant permeability for Ca2+ and include 
neuronal acetylcholine receptors, ionotropic glutamate receptors (NMDA and AMPA, 
or alpha- amino-3-hydroxy- 5-methyl- 4-isoxazolepropionic acid receptors), cyclic 
nucleotide- gated channels, and P2X receptors. They have significant physiological 
effects, particularly in neural systems. NMDA and AMPA receptors contribute to 
long-term potentiation and depression in the central nervous system (CNS) and are 
believed to contribute to learning and memory (Collingridge et al 2004; Malenka & 
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Bear 2004). Ca2+ overload mediated by NMDARs had been found to be related to 
excitotoxic neuronal cell death (Choi et al 1988; Franklin & Johnson 1992; Ghosh & 
Greenberg 1995). Cyclic nucleotide-gated channels (CNGs) are important for the 
process of vision, in which cGMP-gated channels (cGMP, 3′5′ cyclic guanosine 
monophosphate) carry the light-sensitive currents (Kaupp & Seifert 2002). In the dark, 
the [cGMP]i is high within the photoreceptor cytoplasm and keeps CNGs open. Light 
stimulates the phosphodieasterase and thus decreases the [cGMP]i, then reduces the 
numbers of opened CNGs, which in turn hyperpolarizes the photoreceptor and passes 
a visual signal to the retinal neurons (Boron & Boulpaep 2005). P2X receptors are 
sensors for extracellular adenosine triphosphate (ATP) and are expressed in both CNS 
and peripheral systems (North 2002). In sensory neurons, they are involved in the 
initiation of afferent signals in sensing the inflammatory stimuli. In some endocrine 
organs, ATP signaling through P2X receptors acts in a paracrine fashion, a signal 
transduction process from one cell to adjacent cells often seen in the hormonal 
regulation of surrounding cells by hormone releasing cells (North 2002). 
 
  CRACs can be selectively activated by a fall of Ca2+ concentration within the 
endoplasmic reticulum (ER) (Parekh 2006), and their molecular identities were quite 
elusive. The Ca2+ entry process through CRACs is mysterious because the links 
between ER Ca2+ release and the subsequent initiation of a slower and sustained influx 
from the plasma membrane are not known. The decrease in luminal Ca2+ triggers 
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store-operated channels (SOCs) present in the plasma membrane, which mediate the 
Ca2+-selective Ca2+ release–activated Ca2+ current (I) CRAC observed in many cell types, 
particularly in B immune cells (Parekh & Putney 2005). Because of the small current 
amplitude, it is very difficult to characterize these Ca2+ currents. Recently, ER 
membrane proteins like Orai1 (Calcium release-activated calcium channel protein 1), 
STIM1 (Stromal interaction molecule 1), and IP3 (inositol 1,4,5- trisphosphate) 
receptors were found to be expressed or translocated into the plasma membrane where 
they mediate the CRAC currents (Dellis et al 2006; Feske et al 2006; Gill et al 2006; 
Roos et al 2005). The arachidonate-regulated Ca2+ channel (ARC) is closely related to 
CRAC, but plays different roles on the plasma membrane including the regulation of 
the frequency of Ca2+ oscillations. Activation of ARC channels is specifically 
dependent on arachidonic acid acting at the intracellular surface of the membrane and 
is totally independent of any depletion of internal Ca2+ stores (Shuttleworth 2009). 
TRP channels are important for sensory systems. They can be activated by light, 
temperature or pH stimuli and mediate Ca2+ influx into cells at hyperpolarized 
membrane potentials. Most TRP channels are relatively nonselective to cations and 
therefore depolarize cells from their resting membrane potential and raise [Ca2+]i 
(Clapham et al 2001; Ramsey et al 2006).  
 
In the following section, I will briefly introduce the intracellular Ca2+ storage and 
release, which helps to regulate and maintain Ca2+ homeostasis in all cells.  
  
8 
 1.1.3 Intracellular Ca2+ storage and release 
 
Intracellular Ca2+ ions are mainly stored by Ca2+ binding proteins that act in cytosol 
and ER. These proteins account for 90-95% of the total Ca2+ load in a cell (Clapham 
2007).  
 
  Mobile Ca2+ buffering proteins in the cytosol are acidic proteins that can store large 
amounts of Ca2+ with affinities that range from low to high. They belong to the 
EF-hand family, which contains characteristic helix-loop-helix binding motifs that are 
highly conserved in sequence, and includes parvalbumin (PV), calmodulin, and 
troponin C (Cates et al 1999). Parvalbumin has high affinity for Ca2+ and is found in 
high concentration in the sarcoplasm of fast contracting muscles (Celio & Heizmann 
1982). The process of muscle relaxation occurs when Ca2+ is bound with troponin C 
and transported into the sarcoplasmic reticulum (SR). The role of calmodulin in Ca2+ 
signalling has been intensively studied. Calmodulin changes its conformation when 
Ca2+ binds with it, which allows calmodulin to transmit Ca2+ information to its 
downstream target proteins (Hudmon et al 2005; Rosenberg et al 2005). Calmodulin 
can serve as a separate subunit for some enzymes such as Ca2+-dependent protein 
phosphatase, and calcineurin (Perrino et al 1995). Some enzymes can integrate 
“calmodulin” domains into their genomic sequence (Carafoli 2003). Another major 
source of intracellular Ca2+ storage is in the ER. The resting ER free Ca2+ 
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concentration is thought to be on the order of several hundreds of μM (Miyawaki et al 
1997). There are some low affinity Ca2+ binding proteins such as calreticulin, 
calsequestrin, calnexin etc., that act in the sarco (endo)-plasmic reticulum (Carafoli 
2003).  
 
In addition to the Ca2+ binding proteins, Ca2+ pumps or exchanger proteins on 
different cellular membranes maintain homeostasis of intracellular Ca2+ storage. Ca2+ 
can be extruded by a high-affinity/low capacity plasma membrane Ca2+ ATPase 
(PMCA) pump and a low-affinity/high capacity Na+/ Ca2+ exchanger (NCX) to the 
outside of the plasma membrane (Blaustein & Lederer 1999; Herchuelz 2007). Ca2+ 
pumps on the ER membrane are called SERCAs (sarcoplasmic-endoplamic type 
ATPase), which can balance the Ca2+ uptake and release through the ER to regulate 
the free-Ca2+ level within the ER (Carafoli & Brini 2000). The SERCAs play a 
dominant role of Ca2+ homeostasis in the insulin releasing β-cells of pancreas (Hughes 
et al., 2006). 
 
There is another Na+/Ca2+ exchanger on the plasma membrane of mitrochondria 
(MNCX, mitochodrial Na+/Ca2+ exchanger) that transports Ca2+ out from the 
mitochondrial matrix (Hernandez-SanMiguel et al 2006). Mitochondria also express 
Ca2+ transporters that are physically close to the ER Ca2+ releasing port and move Ca2+ 
into the mitochondria by a uniporter (Rizzuto et al 1998). The mitochondrion is the 
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dominant regulatory intracellular organelle that regulates intracellular Ca2+ and 
therefore maintains the proper hormone release from corticotropes, the cells release 
adrenocorticotropic hormone (ACTH) in the anterior pituitary gland (Lee et al., 2005).  
 
  The cytoplasm or sarcoplasm of cells is not a free space where Ca2+ ion can diffuse, 
but is instead filled with Ca2+ binding proteins. Therefore, to effectively reach 
intracellular targets, a local Ca2+ releasing mechanism for signal transduction is 
needed. The ER is not only an important Ca2+ storage organelle, but also a local Ca2+ 
releasing organelle (Blaustein & Golovina 2001). Ca2+ is released from the ER in 
either a stimulated or passive way. Stimulated release is dependent on two receptors: 
the IP3 receptors and the ryanodine receptors (RyR). These two receptors are among 
the largest ion channels with molecular weights around 1-2 million daltons (Fill & 
Copello 2002; Wu et al 2002). IP3 receptors trigger Ca2+ release when they bind with 
IP3, which is generated by phospholipase C enzymes upon activation of other 
receptors on the plasma membrane (Patterson et al 2004). The important functions of 
RyRs in muscular systems have been well reviewed (Fill & Copello 2002), where the 
VGCCs are distributed and coupled with the RyR channels throughout the T-tubule 
network. This spatial arrangement insures rapid and near simultaneous release of Ca2+ 
to bind adjacent troponin and enable myosin-actin contraction. Although multiple 
mechanisms related to intracellular storage and release may affect the exocytosis, in 
this thesis I will focus on Ca2+-dependent exocytosis mediated by VGCCs.  
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  As we introduced above, Ca2+ ions flowing through the cellular membrane is 
mediated by many different kinds of ion channels (Figure 1.1). The gradient of Ca2+ 
concentrations between outside and inside of the cell is so high ([Ca2+]o is 
approximately 1.2mM and [Ca2+]i is only about 10-7M), that the VGCCs, the fastest 
Ca2+ signaling proteins, are widely used and can initiate dramatic changes of Ca2+ 
level within cells. It is estimated that each VGCC channel conducts roughly a million 
Ca2+ ions per second down the 20,000-fold gradient, and only a few thousand channels 
per cell can drive >10-fold changes in intracellular levels within milliseconds 
(Clapham 2007). I will introduce more about the Ca2+-dependent exocytosis that is 
related to fundamental functions of neurons and neuroendocrine cells.  
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Figure 1.1 Calcium influx, storage, and release in a cell. Calcium influx can be 
mediated mainly by four types of ion channels on the plasma membrane: 
voltage-gated, ligand-gated, those activated by emptying of Ca2+ stores, and TRP 
channels. The intracellular Ca2+ pool is regulated by binding to Ca2+ sensors and by 
transport into organelles. Ca2+ can be stored in the sarco(endo)plasmic reticulum by 
SERCA (sarcoplasmic-endoplasmic type ATPase) pumps or released through IP3 
receptors or ryanodine receptors. Ca2+ can exit mitochondria through MNCX, the 
mitochodrial Na+/ Ca2+ exchanger. There might be nuclear Ca2+ transporter(s) 
responsible for the trafficking of Ca2+ in and out of the nuclear ports (not identified 
yet). Ca2+ is expelled from the cell through PMCA (plasma membrane Ca2+ ATPase) 
and NCX (Na+/ Ca2+ exchanger). This Figure is modified from the paper (Carafoli 
2003) and reproduced with permission from Copyright Clearance Center. 
 
1.2 Neuronal Ca2+ signaling and the SNAREs hypothesis 
1.2.1 Ca2+-dependent exocytosis mediated by VGCCs  
 
The process of Ca2+-dependent exocytosis is among the central events of neural 
function. The release of neurotransmitters from presynaptic terminals of neurons and 
of hormones from neuroendocrine cells are both controlled precisely by Ca2+ signals. 
In the following sections, I will discuss the vesicles that hold 
neurotransmitters/hormones, the soluble N-ethylmaleimide–sensitive factor 
attachment protein receptors (SNAREs) that regulate the membrane fusion of vesicles 
and the VGCCs that mediate the Ca2+ influx. 
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1.2.1.1 Vesicles holding eurotransmitters and hormones 
 
Neurons are highly asymmetric (polarized) cells that have three major structures: a 
cell body (soma), a single long process called axon, and a variety of branches known 
as dendrites. The axon is a fine tubular process that conducts electrical impulses from 
the soma to the axon terminals that form the presynaptic component of the synapse. A 
synapse is a specialized structure involved in transmission of information from one 
neuron to another. The functions of the dendrites include reception, processing, and 
integration of incoming synaptic communications. Neurotransmitters (glutamate, 
γ-aminobutyric acid (GABA), acetylcholine etc.) are packed into small membranous 
compartments called synaptic vesicles (SVs, A small secretory vesicle (~50 nm in 
diameter) containing neurotransmitters that are released during Ca2+-dependent 
exocytosis, Ludwig & Leng 2006, see Figure 1.2) within the synaptic specializations 
(Rizzoli & Betz 2005).  
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Figure 1.2 Molecular model of a typical synaptic vesicle. This figure shows 
important macromolecules such as syntaxin, SNAP25, and VAMP that are 
associated with a typical synaptic vesicle at near atomic resolution. CSP (cysteine 
string protein); SCAMP (Secretory carrier membrane proteins); VGLUT (vesicular 
glutamate transporter); VAMP4 (vesicle-associated membrane protein 4); CIC3 
(voltage-gated chloride channel 3); SNAP29 (soluble NSF attachment protein 29); 
V-ATPase (vacuolar ATP synthase subunit H) (Takamori et al 2006) (Reproduced 
with permission from Copyright Clearance Center). 
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Most synapses rely on three vesicle pools: the readily releasable pool, the recycling 
pool, and the reserve pool. The reserve pool makes up ~ 80-90% of the total pool, and 
the recycling pool is significantly smaller (~10-15%). Both of them are highly 
movable in the presynaptic terminals. The readily releasable pool (RRP) consists of a 
few vesicles (~1%) that seem to be docked and primed for release (Rizzoli & Betz 
2005). The RRP is important for fast neurotransmission because of its physical 
proximity to the releasing site. Vesicles in the RRP are docked to the presynaptic 
active zone, a region of membrane that faces the postsynaptic density where synaptic 
vesicles are clustered, docked and depleted. The RRP is depleted rapidly (Smith & 
Augustine 1988). This process is initiated by influx of Ca2+ through VGCCs and may 
occur in less than 1ms when the action potential arrives at the synaptic terminals 
(Catterall 1999; Zucker 1993). 
 
  Neuroendocrine cells are cells of neural origin that release hormones or 
neuropeptides into the circulatory system, such as the magnocellular neurosecretory 
cells of hypothalamus or the chromaffin cells of the adrenal gland. Hormones in 
neuroendocrine cells are packed into the large-dense core vesicles (LDCVs). LDCVs 
are large secretory vesicles (100–150 nm in diameter) that contain proteins or 
peptides, and can be released from all parts of a neuron (Kasai 1999; Robinson & 
Martin 1998)). A comparison of time courses needed for neurosecretion from 
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neuroendocrine cells and nerve terminals of neurons suggests the two types of vesicles 
may respond differently to action potential firing patterns (Neher 1998; Verhage et al 
1994). SVs, being tightly coupled to VGCCs, would respond to both single action 
potential and to bursts, whereas LDCVs, located further away from channels, would 
require bursts of action potentials, which cause Ca2+ concentrations to build up slowly 
to reach the threshold of exocytosis (Klingauf & Neher 1997).  
 
1.2.1.2 The SNARE proteins 
 
Neurosecretion is mediated by a specialized membrane trafficking cycle that includes 
the assembly and filling of secretory vesicles, their transport to the active zone, 
docking, fusion, and recycling (Bajjalieh 1999). I will now describe the SNARE 
hypothesis, which attempts to explain the process underlying the docking and fusion 
of SVs and LDCVs with the plasma membranes of secretory cells (Sudhof & 
Rothman 2009).  
 
SNARE proteins were identified as the receptors for N-ethylmaleimide–sensitive 
factor (NSF) and soluble NSF attachment protein (SNAP) which were purified on the 
basis of their functions in vesicular trafficking. Three proteins, syntaxin-1, SNAP25 
and VAMP (vesicle-associated membrane protein, also called synaptobrevin), form 
the core of the SNARE complex that is proposed to bridge the exocytotic vesicle to 
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the plasma membrane (Bennett et al 1992; Sollner et al 1993). The SNARE hypothesis 
postulates that SNAREs fall into two broad categories, v-SNAREs (in transport 
vesicles) and t-SNAREs (in target membranes), which pair specifically to add 
compartmental specificity to membrane fusion. The evidence of the importance of 
SNARE complex in synaptic exocytosis was revealed when the atomic structure of a 
core domain of the SNARE complex was determined (Sutton et al 1998). Individual 
SNARE proteins can spontaneously assemble into a stable bundle of four helices 
(trans-conformation) that forms between membranes. These bundles can generate an 
inward force to pull the membranes together, forcing them to fuse. When the fusion is 
completed, the SNARE complex returns to the low-energy cis-position (Hua & 
Scheller 2001; Li et al 2007). The SNARE proteins function as general fusion 
machinery responsible for nearly all intracellular membrane fusion. 
 
There are other important molecular elements that act as the Ca2+ sensor or as 
regulatory proteins in the processes of forming the SNARE complex and triggering 
exocytosis. Synaptotagmin is one of the most well investigated Ca2+ binding proteins 
and ensures that the exocytotic machinery is competent to undergo fusion upon an 
increase in Ca2+ concentration (Arac et al 2006; Fernandez-Chacon et al 2001; Voets 
et al 2001). Complexin acts as a grappling protein that elevates the zippered SNARE 
complex (Reim et al 2001; Tang et al 2006) and releases them when Ca2+ binds to 
synaptotagmin (Sudhof & Rothman 2009). Munc18 or Sec1 is a cytosolic protein that 
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binds to the N-terminal of syntaxin. Syntaxin must dissociate from Munc 18 before it 
can form the core complex with SNAP25 and VAMP (Dulubova et al 2003; Misura et 
al 2000). Therefore, the core SNARE complex (syntaxin, SNAP25, and VAMP) and 
synaptotagmin play important roles in Ca2+-dependent exocytosis. 
 
 
1.3 Voltage-gated Ca2+ channels (VGCCs)  
 
1.3.1 VGCCs and Ca2+ domains  
 
The Ca2+ influx mediated by VGCCs is essential for the exocytosis of neurons and 
neuroendocrine cells. Once Ca2+ ion enters the presynaptic terminals, the diffusion of 
Ca2+ will yield an immediate accumulation of Ca2+ ions within nanometers of the 
mouth of a VGCC (Augustine 2001; Augustine et al 2003). This area is called 
“nanodomain” (Kasai 1993). In a single nanodomain, Ca2+ concentration can go as 
high as 100µM. When VGCCs are clustered together in a membrane area of roughly 
1µm2, a “microdomain” will be formed from the spatial summation of Ca2+ entering 
from multiple channels (Augustine et al 2003; Llinas et al 1992). Free Ca2+ 
concentration within microdomains can range from tens of micromolar to hundreds of 
micromolar, depending on the the numbers of nanodomains that are summated. A 
third type of Ca2+ signal is from an even bigger spatial domain when VGCCs are 1μm 
or further from target Ca2+ binding proteins. The radial gradients of [Ca2+] occur when 
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Ca2+ diffuses into the interior of the cell (Marengo & Monck 2000). These three 
models of Ca2+ domains are all useful to explain some exocytotic events in certain 
neuronal terminals or neuroendocrine cells, but not all (Figure 1.3). It appears that the 
Ca2+ concentration needed for exocytosis varies; rapid exocytosis triggered by 
physiological Ca2+ concentrations can be as low as 5-10 μM (Heidelberger et al 1994) 
or as high as 100-200 μM (Mennerick & Matthews 1996) . Because the VGCCs are 
important for triggering neurotransmitters and hormone release, in the following 
sections, I will give more details of the classification of VGCCs and why I am 
interested in studing the CaV2 channels. 
 
 
Figure 1.3 Types of presynaptic Ca2+ signals. ‘Nanodomains’ arise from local 
diffusion from single open Ca2+ channels, ‘microdomains’ from multiple open Ca2+ 
channels, and ‘radial gradients’ from long-distance movements of Ca2+ away from the 
channels. CBP indicates a Ca2+-binding protein that translates Ca2+ entry into vesicle 
fusion (Augustine 2001) (Reproduced with permission from Copyright Clearance 
Center). 
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1.3.2 Classification of VGCCs  
 
The establishment of the concept of voltage-gated Ca2+ channels was due to the early 
work done by Sir Bernard Katz, Susumu Hagiwara, Harald Reuter and their 
colleagues (Fatt & Katz 1953b; Hagiwara & Nakajima 1966; Reuter 1967). These 
early discoveries opened a new era of searching for VGCCs by biochemists and 
electrophysiologists. Electrophysiological recordings from neurons, muscle and 
endocrine cells revealed voltage-activated Ca2+ currents with distinct characteristics. 
Based on their biophysical properties, VGCCs can be classified into two categories: 
high-voltage activated (HVA) and low-voltage activated channels (LVA) (Ertel et al 
2000). HVA currents generally have larger conductances (15-25 pS), are activated by 
stronger depolarization (about -10mV) and display variable inactivation kinetics. The 
HVA group includes L- , N-, P/Q- and R-type currents, whereas the LVA group only 
includes T-type currents which show a much lower voltage threshold of activation 
(about -60mV) and smaller channel conductance (8 pS).  
 
L-type (long-lasting) currents are the major Ca2+ currents found in cardiac, skeletal 
and smooth muscles and are characterized by high voltage activation, large single 
channel conductance, and slow, voltage-dependent inactivation (Catterall 2000). 
Selective blockers are useful tools for identifing different subtyes of Ca2+ currents. For 
example, the L-type currents can be selectively inhibited by antagonists including 
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dihydropyridines (DHP), phenylalkylamines, and benzothiazepines. Drugs from these 
families are clinically useful antihypertensive drugs (Nowycky et al 1985; Triggle 
1999).  
 
N-type (non-classical, neither L- nor T-) currents were first identified in chicken 
dorsal root ganglion neurons (Carbone & Lux 1984). These currents usually have 
faster voltage dependent inactivation than L-type, but slower than that of T-type Ca2+ 
currents (Nowycky et al 1985), and they are insensitive to selective L-type blockers. 
Pharmacologically, N-type currents are sensitive to inhibition by a class of peptide 
toxins called ω-conotoxins, which are a family of small (13-29 amino acid) peptides 
found in the venom of marine snails (Olivera et al 1994).  
 
Later, analysis of the effects of other peptide toxins revealed three additional Ca2+ 
current types: P-, Q-, and R- types. P-type currents were originally identified in 
Purkinje cells of cerebellum and distinguished by high sensitivity to spider toxin 
ω-agatoxin IVA (with a dissociation constant, or Kd of about 2nM) (Llinas et al 1989). 
Q-type currents were first described in cerebellar granule cells and differ in sensitivity 
to ω-agatoxin IVA (Kd> 100 nM). Their inactivation kinetics are also different; 
P-type currents show a non-inactivating waveform during prolonged membrane 
depolarization, whereas Q-type currents show a pronounced inactivation (Bourinet et 
al 1999). R-type (residual or resistant) currents comprise approximately 15% of the 
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HVA currents in cerebellar granule cells and were classified due to their lack of 
sensitivity to all Ca2+ subtype selective blockers mentioned above (Randall & Tsien 
1995). A selective R-type channel blocker was not found until the molecular identity 
of this subtype was clear. A toxin extracted from the venom of the tarantula 
Hysterocrates gigas called SNX-482 blocks heterologously expressed R-type currents, 
but is only partially effective on native cerebellar R-type currents (Newcomb et al 
1998; Tottene et al 2000). 
 
T-type (transient, or tiny) currents was among the earliest Ca2+ currents discovered 
in various excitable cells due to their dramatic differences from HVA currents (Bean 
1985; Hagiwara et al 1975). T-type currents can be reliably distinguished from other 
types of currents by relatively low threshold of activation and rapid inactivation at 
fairly negative voltages (Armstrong & Matteson 1985; Monteil et al 2000). The 
permeability of T-type channels for Ca2+ is equal to (Carbone & Lux 1984), or higher 
than Ba2+ (Friedman et al 1986). In contrast, other Ca2+ channels have significantly 
larger conductance for Ba2+ than Ca2+ (Fox et al 1987). T-type Ca2+ channels can be 
selectively blocked by a scorpion toxin called kurtoxin (Chuang et al 1998).   
 
  The development of techniques in molecular biology eventually led to a new 
nomenclature of all VGCCs subtypes based on their molecular entities (Figure 1.4). 
The genomic screening of primary and accessory subunits of VGCC had its 
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breakthrough by the sequencing of the first L-type gene from skeletal muscle (Tanabe 
et al 1987). The cDNA sequences of α1 subunits were carefully identified and the 
amino acid structures of different subtypes of channels were also predicted (Dubel et 
al 1992; Lee et al 1999; Mori et al 1991; Naylor et al 2000; Soong et al 1993; Starr et 
al 1991; Williams et al 1992). These cDNA sequences are very useful because 
researchers can construct heterologous expression vectors with mammalian promoters 
and other necessary protein translational information and then incorporate these 
vectors into experimental model cells to investigate specific properties of each 
subtype of Ca2+ channels. These tools provide platforms for studying the 
electrophysiology of VGCCs, systemically screening of new selective blockers, and 
imaging of channel distribution and targeting (Figure 1.4).  
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Figure 1.4 Sequence similarities of VGCCs α1 subunits and their major tissue 
distributions (Catterall et al 2005) (Reproduced with permission from Copyright 
Clearance Center). 
 
Historically, a variety of names have been given to the corresponding VGCC genes, 
resulting in confusing nomenclature. A new nomenclature system therefore was 
adopted using the chemical symbol of the principal permeating ion (Ca2+) with the 
principal physiological regulator (voltage) indicated as a subscript (CaV) (Catterall et 
al 2005). The numerical identifier corresponds to the CaV channel α1 subunit gene 
subfamily (1 to 3 at present) and the order of discovery of the α1 subunit within that 
subfamily (1 through n). According to this nomenclature, the CaV1 subfamily 
(CaV1.1–CaV1.4) includes channels containing α1S, α1C, α1D, and α1F, which 
mediate L-type Ca2+ currents (McRory et al 2004; Mori et al 1991; Tanabe et al 1987). 
The CaV2 subfamily (CaV2.1–CaV2.3) includes channels containing α1A, α1B, and 
α1E, which mediate P/Q-type, N-type, and R-type Ca2+ currents, respectively (Dubel 
et al 1992; Soong et al 1993; Starr et al 1991). The CaV3 subfamily (CaV3.1–CaV3.3) 
includes channels containing α1G, α1H, and α1I, which mediate T-type Ca2+ currents 
(Lee et al 1999; Naylor et al 2000; Soong et al 1993) (Table 1-1). 
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Table 1-1 The α1 subunits of VGCCs and corresponding Ca2+ currents 
 
Family α1 subunits Former name Ca2+ currents 
CaV1 CaV1.1 
CaV1.2 
CaV1.3 
CaV1.4 
α1S 
α1C 
α1D 
α1F 
L-type 
CaV2 CaV2.1 
CaV2.2 
CaV2.3 
α1A 
α1B 
α1E 
P/Q-type 
N-type 
R-type  
CaV3 CaV3.1 
CaV3.2 
CaV3.3 
α1G 
α1H 
α1I 
T-type 
 
1.3.3 The expression and function of subtypes of VGCCs in neural systems 
 
As we can see in Figure 1.4, at least eight types of VGCCs have been identified in 
neurons, including CaV1.2, CaV1.3, CaV2.1, CaV2.2, CaV2.3, CaV3.1, CaV3.2 and 
CaV3.3 channels (Fisher & Bourque 2001). Different subtypes of VGCCs may have 
different functions in different cells and in different subcellular locations.  
 
For example, the CaV1.2 and CaV1.3 channels are predominant forms of CaV1 Ca2+ 
channel family in the CNS. They are important for long-term adaptation of neuronal 
functions, such as dendritic development, synaptic plasticity, and neuronal survival 
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(Ahlijanian et al 1990; Bean 1989; Silver et al 1990). The CaV1.2 and CaV1.3 channels 
are mostly found in somatic and dendritic structures (Hell et al 1993; Westenbroek et 
al 1990; Westenbroek et al 1998b). Compared to CaV1.2 channels, which are activated 
at ~-10 mV, the biophysical properties of CaV1.3 channels are different because they 
are activated at relatively hyperpolarized potential (Koschak et al 2001; Xu & 
Lipscombe 2001).  
 
Morgan and Curran hypothesized that Ca2+ influx through L-type Ca2+ channels 
activates expression of c-fos, an immediate early gene (IEG) (Morgan & Curran 1986; 
West et al 2001; Zhang et al 2006). They suggested that a calmodulin (CaM)-sensitive 
kinase would phosphorylate a transcription factor, initially located in the cytoplasm, 
causing it move into the nucleus to activate gene expression (Deisseroth et al 2003). 
This CaM nuclear translocation pathway is widely utilized by neuronal and 
non-neuronal cells to transduct Ca2+ signals from the plasma membrane into the 
nucleus (Deisseroth et al 1998; Mermelstein et al 2001).  
 
Ca2+ signals mediated by L-type channels can preferentially activate the 
transcription factor cAMP-responsive element binding (CREB) protein (Deisseroth et 
al 1998; Dolmetsch et al 2001). CREB drives the expression of many genes, including 
IEGs, that are critical for neuronal survival and plasticity (Shaywitz & Greenberg 
1999). CREB is activated by phosphorylation of Ser133, which allows recruitment of 
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CREB binding protein (CBP) and initiation of transcription (Chrivia et al 1993). 
Phosphorylation of the CREB proteins can be activated by several pathways, 
including a Ca2+/calmodulin kinase IV (CaMKIV) pathway (Kang et al 2001), a 
mitogen-activated protein kinase (MAPK/Erk) pathway (Dolmetsch et al 2001), a 
nuclear factor of activated T-cells family of transcription factors (NFATc4) pathway 
(Graef et al 1999), and an inhibition of the calcineurin/PP1 (protein phosphatase 1) 
pathway (Malleret et al 2001; Rajadhyaksha & Kosofsky 2005).  
 
In addition, both CaV1.2 and CaV1.3 channels contain PDZ (postsynaptic density-95, 
PSD-95/Discs large/Zona occludens 1) (Sheng 1996) interaction sequences that bind 
with PDZ domain proteins (Craven & Bredt 1998). CaV1.2 contains the motif 
Val-Ser-Asn-Leu (VSNL), which is critical for binding to PDZ proteins and activating 
CREB phosphorylation (Weick et al 2003). CaV1.3 binds with the post-synaptic 
scaffold protein Shank (SH3 and ankyrin repeat-containing protein) via the motif Ile- 
Thr-Thr-Leu ITTL that is essential for CREB activation (Olson et al 2005; Zhang et al 
2005). Shank proteins are thought to be key scaffold elements in the synaptic 
signaling complex (Sheng & Kim 2000). 
 
The CaV3 family (CaV3.1-3.3) genes have been identified to encode the T-type 
currents (Mittman et al 1999a; Mittman et al 1999b; Monteil et al 2000). These 
channels are found mainly in the neuronal somata and dendrites. Because of their low 
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threshold and slow inactivation, they are often involved in regulating firing patterns of 
neurons. For example, in the thalamus, CaV3 channels are distributed in the somata 
and dendrites of neurons and contribute to thalamic oscillations (Perez-Reyes 2003). 
Mutations of the CaV3 channels cause altered channel activities and link to epilepsy in 
humans (Becker et al 2008; Khosravani et al 2004).  
 
Among the VGCCs expressed in neurons, the CaV2 channel subfamily is of special 
interest because of their roles in mediating neurotransmission of neurons and hormone 
release of neuroendocrine cells. 
 
The CaV2.1 and CaV2.2 channels are highly expressed in presynaptic terminals of 
neurons (Stea et al 1994; Westenbroek et al 1992). Mutations of CaV2.1 channels have 
been linked to multiple human genetic disorders, including familial hemiplegic 
migraine, ataxia and epilepsy (Fletcher et al 1996; Ophoff et al 1996; Zhuchenko et al 
1997). Although CaV2.2 channels have a function that is similar to that of CaV2.1 in 
presynaptic neurotransmission, there appear to be fundamental differences between 
CaV2.1 and CaV2.2 channels. The CaV2.1-/- knockout mice suffer fatal consequences 
shortly after birth whereas the CaV2.2-/- knockout mice show a normal lifespan (Ino et 
al 2001). The CaV2.2-/- knockout mice, however, exhibit significant higher thresholds 
of pain sensation (Beuckmann et al 2003; Saegusa et al 2001). They are particularly 
important in mediating rapid neurotransmission (Catterall 2000; Jarvis & Zamponi 
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2007). The CaV2.3 channels are expressed preferentially within the somata and 
dendrites of many neurons in the rat brain (Fisher & Bourque 1996; Yokoyama et al 
1995), and their roles in fast neurotransmission are obscure, but they do contribute to 
presynaptic long-term potentiation in the mossy fibers of hippocampal neurons 
(Dietrich et al 2003). 
 
Neurosecretion of neuroendocrine cells, such as MNCs, also depends primarily on 
Ca2+ influx through CaV2.1 and CaV2.2 channels (Cazalis et al 1987; Wang et al 1997). 
Ca2+-dependent increases in whole cell capacitance of patch clamped MNCs suggests 
that the rate of Ca2+ evoked release is slower from MNC terminals than from neurons 
(Giovannucci & Stuenkel 1997; Lim et al 1990). Why do the same subtypes of 
VGCCs result in significantly different exocytotic behaviors between neuronal and 
neuroendocrine terminals? The study of the main subunits of CaV2 channels may 
provide some hint to explain why the neuroendocrine cells have a much slower 
hormone release comparing to neurons.  
 
In the following sections, I will dissect the molecular structures of VGCCs and 
elaborate how channel regulation may be involved with different segments of those 
structures, especially the synaptic protein interaction (synprint) site.  
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1.4 VGCC molecular structure and regulation  
1.4.1 Molecular structure of VGCCs 
VGCCs are heterogenous complexes consisting of a channel forming α1 subunit as 
well as accessory α2-δ, β, and γ subunits (Catterall 2000). To form a fully functional 
VGCC, the α1 subunit is essential, and the other subunits are considered as auxiliary 
components (Liu et al 1996; McEnery et al 1991; Witcher et al 1993). The 
combinations of different subunits vary in different tissues. The α1 subunit is the 
largest component (molecular weight MW~190 kDa). The α1 subunit is the 
pore-forming subunit, determines most channel biophysical properties, and has 
structural similarity with the Na+ channel (Goldin 2001). Four different α2-δ subunits 
(α2-δ1, α2-δ2, α2-δ3, α2-δ4, MW~170kDa), four different β subunits (β1, β2, β3, and 
β4, MW~55kDa), and eight different γ subunits (γ1, γ2, γ3, γ4, γ5, γ6, γ7, and γ8, 
MW~33kDa) have been identified and characterized from a variety of tissues 
(Catterall et al 2005; Ertel et al 2000; Klugbauer et al 1999).  
 
The amino acid sequence of the α1 subunit is organized in four repeated domains (I 
to IV), each of which contains six transmembrane segments (S1 to S6) and a 
membrane associated loop between S5 and S6. The S4 segments of each homologous 
domain serve as the voltage sensors for activation, which move according to voltage 
change and initiate a conformational switch that opens the pore (Catterall 2000). 
There are five major intracellular parts of the α1 subunit molecular structure, 
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including the N-terminus, carboxyl C-terminus, and 3 loops (or linkers) that connect 
domains (I-II, II-III, and III-IV loop; see Figure 1.5B). These are important regulatory 
regions that provide protein binding sites or phosphorylation sites and allow other 
intracellular or membrane components to modulate VGCC functions or anchor the 
channels in specific locations (Jarvis & Zamponi 2007; Randall & Benham 1999; 
Spafford & Zamponi 2003).  
 
 
A               
 
B          
Figure 1.5 Primary and accessory subunits of VGCCs on the plasma membrane. 
A. Three dimensional demonstration of relationships between subunits of VGCCs. B. 
Major domains of the VGCC α1 subunit structure (Randall & Benham 1999; 
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Reproduced with permission from Copyright Clearance Center).  
 
The β subunits are cytoplasmic proteins that bind to the I-II loop of the α1 subunits 
(Pragnell et al 1994). The β subunits have important regulatory effects on the level of 
expression and biophysical properties of VGCCs in both neuronal and cardiac tissues 
(Birnbaumer et al 1998; Dolphin 2003). The α2-δ subunit is transcribed and translated 
from one gene but post-translationally cleaved into α2 (extracellular) and δ 
(transmembrane) units that are linked by disulfide bonds (Klugbauer et al 1999; 
Takahashi et al 1987). Loss of the α2-δ subunits in cerebellum, for example, which 
naturally occur in the ducky (α2-δ2 mutant) mice (Barclay et al 2001), results in 
reduction of Ca2+ currents in Purkinje neurons (Donato et al 2006). Nevertheless, it 
has been revealed recently that the α2-δ subunits may play important roles in channel 
targeting at the presynaptic terminals (Dickman et al 2008; Taylor & Garrido 2008). 
The γ subunits were first discovered in the VGCCs of skeletal muscle and later in 
neurons (Letts et al 1998; Tanabe et al 1987). Unlike the α2-δ and β subunits, the 
functions of the γ subunits are less clear (Arikkath & Campbell 2003). No auxiliary 
subunits are necessary for functional CaV3 channels (Cribbs et al 1998; Perez-Reyes et 
al 1998). The γ2 subunit seems to have broader effects on neuronal membrane protein 
trafficking, such as on AMPA receptors (Chen et al 2000).  
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As I introduced above, the α1 subunits of VGCCs are the main determinants for the 
channel activities and functions. I will further explain the importance of the synprint 
site within the II-III loop of the CaV2 channels. 
 
1.4.2 Neurotransmission and CaV2 channel activities regulated by SNARE 
proteins 
 
The term “synprint site” is designated to describe the synaptic protein interaction sites 
of the α1 subunits of CaV2.1 and CaV2.2 channels (Catterall 1999). This protein 
interaction site was first identified as a segment of amino acid sequence (residues 
718-963) within the II-III loop of the CaV2.2 channels. Immunochemical studies have 
indicated a tight association of the core SNARE proteins, such as syntaxin, SNAP25, 
and synaptotagmin, with the CaV2.2 channels in rat brains through the synprint site 
(Bennett et al 1992; Leveque et al 1992; Sheng et al 1996; Sheng et al 1994). A 
similar synprint site (residues 722-1036) has been identified in the II-III loop of the 
CaV2.1 channels (Rettig et al 1996). 
  
The interaction between the CaV2 channels and SNARE proteins has been shown to 
have functional effects on neurotransmitter release. The biological function of this 
direct coupling of the SNARE proteins and CaV2.2 channels has been tested by 
injecting competing peptides containing synprint site into the the superior cervical 
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ganglion neurons (SCGN). The peptides representing segment (LII-III 718-963) 
disrupted the coupling of CaV2.2 channels and syntaxin in vitro and reduced synaptic 
transmission in SCGN by 42% (Mochida et al 1996). The corresponding peptides 
from L-type Ca2+ channels had no effect. These results provide direct evidence that 
binding of presynaptic Ca2+ channels to the SNARE proteins is required for rapid 
neurotransmitter release. Further tests of the effects on Ca2+ dependence of 
neurotransmitter release revealed that the competing peptides shifted the Ca2+ 
dependence of neurotransmission to a higher values, suggesting the interaction 
between syntaxin and CaV2.2 channels is important for docking synaptic vesicles to 
the Ca2+ entry sites (Rettig et al 1997). In a mouse chromaffin cell line that lacks 
endogenous CaV2.2 channels, exogenously expressing a recombinant plasmid 
encoding channels lacking the synprint site showed a significantly decreased total 
amount and rate of neurosecretion detected by capacitance measurements (Harkins et 
al 2004) compared to cells transfected with the WT channels.  
 
The synprint site interaction might also modulate Ca2+ channel biophysical 
properties. Bezprozvanny and colleagues found that coexpression of syntaxin with 
CaV2.1 and CaV2.2 channels in Xenopus oocytes resulted in a change in the 
voltage-dependent inactivation of the channels (Bezprozvanny et al 1995; 
Bezprozvanny et al 2000). Another functional link between syntaxin and the CaV2 
channels was suggested by the observation that proteolytic cleavage of syntaxin by 
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botulinum, a specific SNARE protein toxin (Rossetto et al 1994), prevented the 
normal G protein modulation of presynaptic terminal CaV2 channels in the calyx-type 
chicken ciliary ganglion synapse (Stanley & Mirotznik 1997). This G protein 
modulation normally shifts the channels to the reluctant state, from which the gating 
of channel is slow, which is reversible upon strong depolarization (Wickman & 
Clapham 1995). The G protein interaction site on CaV2.2 channels is within the I-II 
loop, which was proved by site-directed mutagenesis and expression experiments 
(Page et al 1997; Zamponi et al 1997); see Figure 1.6). It appears that co-expression of 
individual SNARE proteins (e.g. syntaxin 1A) with CaV2.2 channels causes decreased 
current amplitude, enhanced G protein inhibition, and increased voltage-dependent 
inactivation (Jarvis et al 2002; Jarvis et al 2000).  
 
The synprint site may be involved in the CaV2 channel targeting. Mochida and 
colleagues showed that deletion of synprint site impaired the effective targeting of 
CaV2.1 channels into nerve terminals of the SCGNs (Mochida 2003). However, 
similar synprint site deletion isoforms of CaV2.2 did not affect the ability of channel 
targeting to the axonal compartments of cultured hippocampal neurons (Szabo 2006), 
and thus the role of the synprint site in CaV2 channel targeting is not clear. Because 
the channel targeting mechanism will determine the numbers of channels transported 
and anchored to the proper location(s) that will eventually affect the Ca2+-dependent 
  
36 
exocytosis (Dolphin 2009), I will expand my introduction to some identified 
mechanisms that are related to CaV2 channel targeting. 
 
1.4.3 Mechanisms of CaV2 channel targeting 
1.4.3.1 β subunits regulation of the CaV2 channel targeting  
 
The α1 subunits of VGCC contain endoplasmic reticulum retention motifs in the 
N-terminus and I-II loop, but when the α1 subunits are bound with by β subunit, the 
retention motifs are blocked, thus allowing for co-trafficking of the α1/β protein 
complex to the plasma membrane (Cornet et al 2002). It is believed that the α1 
subunit binds β subunit by its beta-interaction domain (BID), and β subunit has its 
alpha-interaction domain (AID). Only recently, it has been revealed that the Src 
homology 3 (SH3) domain and the guanylate kinase (GK) domain within the β 
subunit contribute to this high affinity binding between the two subunits (Chen et al 
2004).  
 
The β subunits may have differential effects on targeting of CaV2 channels. Using  
Madin-Darby canine kidney (MDCK) cells, Brice and Dolphin found that CaV2.2 
channels were expressed at the apical membrane with all accessory subunit 
combinations (β1, β2, β3 and β4). In contrast, CaV2.1 channels can only be targeted to 
the cell membrane with β1 or β4 but not with β2 or β3 (Brice & Dolphin 1999). 
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Although there has been no exclusive association between particular α1/β 
combinations in tissue, the β3 subunit has been found to associate mainly with CaV2.2 
channels in rabbit brain (Scott et al 1996). Expression of GFP-β4 subunits in the 
hippocampal neurons revealed a synaptic staining pattern of β4 (Wittemann et al 
2000), and endogenous expression of β4 subunits was detected in the presynaptic 
terminals of Purkinje and granule cells (Westenbroek et al 1995). However, there is no 
clear evidence showing which β subunits are mainly associated with presynaptic 
CaV2.1 channels. 
 
1.4.3.2 CASK/Mint1 regulation of the CaV2 channel targeting 
 
CASK (calcium, calmodulin associated serine kinase) is enriched in the brain at the 
synaptic membrane (Hata et al 1996), and it binds with neuronal junction proteins 
during neuronal development (Biederer & Sudhof 2001; Hsueh et al 1998). The ability 
to form macromolecular complexes beneath the synaptic membranes might involve a 
role for CASK in trafficking and anchoring ion channels on the plasma membrane 
(Schuh et al 2003). It has been reported that CASK is important for the targeting for 
ion channels such as potassium channels and NMDARs (Jeyifous et al 2009; 
Leonoudakis et al 2004). 
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More interestingly, CASK and Mint1 (Munc-18-interacting protein 1) are proposed 
to form macromolecular complex with VGCCs to anchor Ca2+ channels at presynaptic 
terminals (Maximov et al 1999). It has been observed that CASK binds to CaV2.2 at 
C-terminals between the amino acid 2020-2233 and Mint1 binds to CaV2.2 between 
the amino acids residues 2331-2336 (Maximov et al 1999). Blocking this interaction 
resulted in inhibited synaptic targeting of CaV2.2 channels in hippocampal neurons 
(Maximov & Bezprozvanny 2002). CASK can also be detected in peripheral tissues 
like adrenal gland and pituitary gland (Stevenson et al 2000), suggesting that it may 
interact with the exocytotic machinery in neuroendocrine cells, but whether 
CASK/Mint1 interaction is important for CaV2.2 channel targeting in neuroendocrine 
terminals is not known. 
 
1.4.3.3 G protein regulation of the CaV2 channel targeting 
 
Recently, a few studies have shown that G protein coupled receptors are involved in 
the distribution of CaV2.2 channels. The opioid receptor-like receptor 1 (ORL1) 
physically binds with CaV2.2 channels and triggers internalization and degradation of 
calcium channels upon prolonged agonist application. This may mediate inactivation 
of the involvement of the CaV2.2 channels in pain sensation (Altier et al 2006; Beedle 
et al 2004). GABAB receptor activation results in rapid internalization of CaV2.2 
channels from the plasma membrane but this process may not include CaV2.2 channel 
  
39 
degradation (Richman et al 2004; Tombler et al 2006). It has been found that in 
prefrontal cortex, the interaction of dopamine D1 receptor with CaV2.2 channels are 
critical for the distribution of channels (Kisilevsky et al 2008). These mechanisms are 
not fully understood and I will not elaborate upon them in this thesis. 
 
 
 
 
Figure 1.6 Possible regulatory regions that affect channel activity and targeting. 
(Modified from figure of the paper (Spafford & Zamponi 2003) and reproduced with 
permission from Copyright Clearance Center). The α1 subunit defines the channel 
subtype, and is comprised of four homologous transmembrane domains, which are 
connected by large cytoplasmic loops, and formed by six membrane-spanning helices. 
The domain I-II linker interacts with the calcium channel β subunit and G protein βγ 
subunits. In N-type (CaV2.2) and P/Q-type (CaV2.1) channels, the domain II-III linker 
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region contains a synaptic protein interaction site (synprint) which binds syntaxin1 
isoforms, SNAP25, cysteine string protein (CSP) and synaptotagmin 1. The 
carboxy-terminus of CaV2.2 calcium channels binds the scaffolding proteins CASK 
and Mint1, and contains a binding site for calcium channel β subunits. 
 
1.4.4 Alternative splicing of CaV2 α1 subunits  
 
As we introduced above, CaV2 channel function is largely determined by the 
molecular structure of CaV2 α1 subunits. Systematic screening of cDNA of VGCCs 
has revealed that several regions are consistently subjected to alternative splicing, 
including the domain IV, the II-III loop, and the C-terminus of the α1 subunits 
(Lipscombe 2005).  
 
Alternative splicing is a mechanism used extensively in the mammalian nervous 
system to increase the level of diversity of proteins (Lipscombe et al 2002). In humans, 
over 80% of genes are alternatively spliced (Matlin et al 2005). Genes are composed 
of multiple short (50-300 nucleotides in length) protein coding regions called exons, 
which are disrupted by larger non-coding introns (200- several thousands nucleotides). 
Messenger RNAs are transcribed as precursors (pre-mRNAs) containing products of 
both exons and introns. Exons need to be reshuffled into mature mRNA with a process 
to remove introns. This process is called alternative splicing. Some exons are always 
part of the mature mRNA (i.e. they are constitutively expressed), while others are 
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alternatively expressed in subset of mRNAs depending on cell-type, developmental 
stage, and activity (Black 2003; Cheung & Spielman 2009). 
 
Systematic screens of splice variants of human CaV2.1 channels have indicated at 
least 9 known exon loci that could be alternatively spliced (Hans et al 1999a; Soong et 
al 2002). These sites contain exon 10 in the I-II loop, exon 16 and 17 in the II-III loop, 
exon 31a in the IVS3-IVS4 linker, and exon 37a/37b, 43, 44 and 47 in the carboxyl 
terminus (Figure 1.7). 
 
Figure 1.7 Schematic representation of human CaV2.1 molecular structure 
showing the loci of exons (Soong et al 2002); reproduced with permission from 
Copyright Clearance Center). A, Diagram of CaV2.1 channel backbone structure, 
showing four homologous domains (I–IV), each with six transmembrane spanning 
regions (1–6). The C-terminal tail contains structures postulated to be important for 
Ca2+ regulation of the channel. EF, EF-hand; IQ, IQ-like CaM interaction domain; 
CBD, CaM binding domain. B, Locations of exon transcripts corresponding to the 
backbone diagram in A. 
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I am particularly interested in the II-III loop, which is relatively long in the CaV2 
channel subfamily in comparison to the CaV1 channel subfamily and also contains the 
synprint sites in CaV2.1 and CaV2.2 channels. Two isoforms of CaV2.1 in this loop 
were found to be present in presynaptic nerve terminals based on 
immunohistochemical studies (Rettig et al 1996; Sakurai et al 1995; Sakurai et al 1996; 
Wu et al 1999). Two other alternatively splicing sites have been identified as well that 
involve exons 16 and 17, although the functional significance is unclear (Soong et al 
2002). 
 
The C-terminus of CaV2.1 channels is another important region susceptive to 
alternative splicing and is related to CASK/Mint1 interaction with CaV2.1 channels. 
Exon 47 encodes >230 amino acids in the long isoform of channels, which has been 
found in human brain, spinal cord, and neuroblastoma cells (Hans et al 1999b; 
Krovetz et al 2000; Soong et al 2002). Notably, only isoforms that contain exon 47 
express the SCA6 polyglutamine expansion that underlies spinocerebellar ataxia type 
6 (Zhuchenko et al 1997). As I mentioned, this long C-terminus isoform is also 
involved in binding with modular adaptor proteins such as CASK and Mint1 
(Maximov & Bezprozvanny 2002; Maximov et al 1999). 
 
Lastly I would like to briefly mention another important exon of CaV2.1 channel, 
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exon 31, which can be alternatively spliced and alter the channel the sensitivity to 
selective blocker, ω-agatoxin IVA. Exon 31 has been identified in the S3-S4 
extracellular linker of the domain IV. Bourinet and colleagues found relatively small 
alterations in the domain S3-S4 region (a two amino acid insertion, N1605-P1606). The 
splice variant containing this insertion causes an approximately +6 mV shift in the 
current-voltage relationship compared to the wild type CaV2.1 channel (Bourinet et al 
1999; Hans et al 1999b). The second major change in channel properties associated 
with this splice variant is the altered affinity of ω-agatoxin IVA. The insertion of 
N1605-P1606 causes about 11-fold decrease in toxin affinity of CaV2.1 channels 
(Bourinet et al 1999).   
 
CaV2.2 channels have very similar molecular structure with CaV2.1 channels in 
terms of number of exons, cDNA size, and potential sites of alternative splicing 
(Fujita et al 1993; Lipscombe et al 2002); see Table 1-2 and 1-3). The II-III loop 
region of the CaV2.2 gene contains exons 18 to 21 and is dominated by exon 19, 
which encodes 266 amino acids. The majority of CaV2.2 mRNA in the adult 
sympathetic ganglia expresses exon 18a, which refers to an isoform with a 21 amino 
acid insertion in the exon 18 of wild type CaV2.2 gene. This splice variant is tissue 
specific, probably linked to monoaminergic neurons (Ghasemzadeh et al 1999; Pan & 
Lipscombe 2000), and its expression varies during development. During the first three 
weeks of postnatal life, for example, the expression of splice variant 18a continuously 
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increases in the rat superior cervical ganglia (Gray et al 2007; Thaler et al 2004). 
Surprisingly, isoforms that are missing all of exon 19 to 21 have been found in human 
brain tissue and cell lines (Kaneko et al 2002). These two splice variants lack 382 and 
263 amino acids within the II-III loop, causing an alteration of channel inactivation 
properties and the loss of binding with syntaxin (Kaneko et al 2002). These results 
suggest that the synprint site could be alternatively spliced in normal rat brains.  
 
Table 1-2 Comparison of the genome information between the human CaV2.1 
and CaV2.2 channels 
 Chromosome Genome 
size 
Number of 
exons 
cDNA size 
hCa2.1 19p13 400kb 49 ~7800bp 
hCav2.2 9q34 300kb 50 ~7300bp 
 
Table 1-3 Comparison of alternative splicing sites between the human CaV2.1  
and CaV2.2 channels 
 I-II loop II-III Loop IVS3-S4 C-terminus 
hCa2.1 E10 E16, 17 E31a E37a/37b, 43, 44, 47 
hCav2.2 E10 E18a,19,20, 21 E31a 37a/37b, 46 
 
However, whether the synprint site is essential for CaV2 channel targeting in 
neurons is not known, and there is even less knowledge available for the roles of the 
synprint site in the CaV2 channel functions in neuroendocrine cells. As the alternative 
splicing of channels is a common mechanism used for regulation of the channel 
  
45 
expression and targeting, it is possible that synprint site deletion isoforms of the CaV2 
channels are expressed in neuroendocrine cells.  
 
  In the next few sections, I will focus on introducing the model system I used in my 
research, and why I used them to test my hypotheses.  
 
1.5 VGCCs expression and function of neuroendocrine cells and pituicytes in the 
hypothalamo-neurohypophysial system (HNS) 
 
1.5.1 Magnocellular neurosecretory cells (MNCs) in the HNS  
Mammalian neurosecretion has been well investigated in the rat hypothalamo- 
neurohypophysial system (HNS) (Hatton 1988; 1997). The HNS is composed of 
hypothalamic magnocellular neurons and the neural lobe pituicytes that accommodate 
surround and regulate the nerve terminals. The magnocellular neurosecretory cells 
(MNCs) have their somata located in the paraventricular nucleus (PVN) and 
supraoptic nucleus (SON) of the hypothalamus and nerve terminals in the posterior 
ptuitary (Figure 1.8). Individual MNC axons frequently entwin around blood vessels 
and a short length of axon can form multiple “endings” (Tweedle 1989). In this thesis, 
nerve terminals of MNCs do not structurally resemble presynaptic terminals of 
neurons, but are described as “MNC terminals”. Oxytocin (OT) and vasopressin (VP) 
are synthesized and released from MNCs (Brownstein et al 1980). LDCVs filled with 
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OT or VP are assembled in the somata of MNCs and then transported to the terminals 
where they are exocytosed in response to the arrival of action potentials (Fisher & 
Bourque 2001).  
A              B  
      
Figure 1.8 MNC soma in the SON of hypothalamus and terminals in the 
posterior pituitary (permission from Dr. Thomas Fisher’s lab). A. MNC soma (red) 
labeled by neurophysin I and II antibodies in the SON of the rat brain. Scale bar =20 
µm. B. MNC nerve terminals in the (red) labeled by neurophysin I and II antibodies in 
the posterior pituitary of the rats Scale bar = 40 µm. 
 
MNCs synthesize and release oxytocin (OT) and vasopressin (VP; Brownstein et al 
1980). Both OT and VP are 9 amino acid peptides, and their genes are closely related 
which consist of three exons (and two introns) with little variability in structure 
among species from rodents to humans (Gainer & Wray 1992). OT and VP are 
synthesized as portions of large carrier proteins, neurophysin I and neurophysin II, 
respectively. Although these two precursors are encoded by a pair of genes that share 
many similarities in structure and sequence, they are separately associated with OT 
and VP (Marini et al 1993; Mason et al 1986; Rose et al 1996).  
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OT has been known for its function in lactation and the initiation of labour. During 
labour, sensory signals from the uterus and birth canal stimulate MNCs, and the OT 
released into the bloodstream binds to uterine OT receptors to facilitate parturition by 
contracting the smooth muscle (Gainer & Wray 1992). OT also has central effects 
where it may act as a key mediator of complex emotional and social behaviours (Insel 
et al 1999; Insel & Young 2001).  
 
VP is the main hormone involved in regulating water balance and the osmolality of 
body fluids. The physiologic regulation of VP synthesis and secretion involves the 
osmolality of body fluids and the pressure and volume of the plasma. VP acts in the 
collecting duct of the kidney to increase water permeability, thereby allowing osmotic 
equilibration by extracting water from the urine into the medullary interstitial blood 
vessels, resulting in increased urine concentration and decreased urine volume 
(antidiuresis). The epithelial principal cells of the collecting tubule in the kidney 
possess vasopressin V2 receptors that allow VP to produce antidiuretic effects (Park et 
al 1998; Petersen 2006; Spanakis et al 2008). There is some evidence showing the 
involvement of oxytocin in regulating salt appetite during hyperosmolality in some 
species (Blackburn et al 1993; 1995). 
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Biophysical and pharmacological experiments demonstrated the presence of T-type 
currents and several HVA currents (L-, N-, P/Q-, and R-) in isolated MNC somata 
(Fisher & Bourque 1995b; Foehring & Armstrong 1996; Joux et al 2001). These 
channels are involved with the regulation of firing patterns, gene expression, and 
somatodendritic release in MNCs. The somatodendritic regions of MNCs are 
responsible for regulation of the cell firing pattern and can release OT and VP. MNC 
somata can undergo plasticity following sustained dehydration involving gene 
expression and morphological changes. Oxytocin and vasopressin are released into the 
circulation from MNC terminals upon physiological stimulations such as dehydration 
and lactation (Bielefeldt et al 1993 (Fisher & Bourque 1996; Li & Hatton 1997; 
Renaud & Bourque 1991). Recording from isolated terminals from neurohypophysis 
demonstrated Ca2+ currents sensitive to channel blockers DHPs, ω-conotoxin GVIA, 
and ω-agatoxin IVA (Fisher & Bourque 1995b; Lemos & Nowycky 1989; Wang et al 
1997), which suggested the importance of L-, N- and P/Q- type VGCCs for the release 
of OT and VP.  
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Figure 1.9 Possible functions for VGCCs in the MNCs (Fisher & Bourque 1996) 
(Reproduced with permission from Copyright Clearance Center).  
 
MNCs can display different firing patterns upon osmotic changes. The intrinsic 
sensitivity to osmotic changes makes MNCs osmoreceptor cells that are able to detect 
differences between extracellular fluid osmolality and pre-established set-point (which 
represents normal or isotonic condition), and to encode this signal into persistent 
electrical information during acute and chronic perturbations (Bourque 2008). Plasma 
VP level is strongly correlated with the osmotic changes and feelings of “thirst” in 
animals (Baylis & Thompson 1988). Studies have revealed that VP-MNCs change 
their firing pattern when the external osmolality change (Bourque 1998); see Figure 
1.9). The rate and pattern of the action potentials generated by the somata are 
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controlled by Ca2+-dependent afterpotentials (activity dependent currents), 
endogenous membrane currents, and external synaptic inputs (Fisher & Bourque 1996; 
Li & Hatton 1997; Renaud & Bourque 1991). VP release increases when the 
osmolality increases within physiological range, accrodingly, the firing rate of 
VP-MNCs also increased (Figure 1.8 A and B). On the other hand, high frequencies of 
firing also results in neuronal fatigue and ultimately a decrease in VP release, thus, the 
VP release is therefore maximized by burst firing (Bicknell 1988). 
 
      
Figure 1.10 Effects of plasma osmolality on vasopressin secretion and firing rate 
in VP-MNCs (Bourque 1998) (Reproduced with permission from Copyright 
Clearance Center). 
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1.5.2 Pituicytes in the posterior lobe of the pituitary gland 
 
I have introduced the neurosecretion of MNCs and the VGCCs expressed on them. As 
an important component of the entire HNS, the Ca2+ signaling of the neurohypophysis 
is critical for the proper MNC terminal hormone release. In the next and last section, I 
will briefly dissect the physiology of each part of the pituitary gland including the 
neurohypophysis, especially the Ca2+ signaling in the the pituicytes of the 
neurohypophysis.  
 
The rat pituitary gland consists of three parts: the anterior lobe (adenohypophysis, 
AH), the intermediate lobe (IL), and the posterior lobe (neurohypophysis, NH). The 
AH has a special vascular connection with the brain through the portal hypophysial 
vessels. Five endocrine cell types have been identified by immunocytochemistry and 
electron microscopy: somatotrope, lactotrope, corticotrope, thyrotrope, and 
gonadotrope, which release growth hormone (GH), prolactin, adrenocorticotropic 
hormone (ACTH), thyroid- stimulating hormone (TSH), follicle-stimulating hormone 
(FSH) and luteinizing hormone (LH), respectively.  
 
  The NH is made up with neurosecretory axons, axonal swellings called Herring 
bodies, and axonal endings of the MNCs, all of which contain LDCVs (Hatton 1988; 
Hussy 2002). In addition to the tens of thousands of axonal structures, the NH 
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contains non-secretory axons, basal lamina, capillaries and pituicytes. The pituicytes 
are the only cell bodies of neural origin in the NH. They constitute a large percentage 
(30%) of the total volume of the NH (Tian et al 1991), and could contribute to the 
extracellular microenvironment of the NH. In rat tissues, they are relatively large. 
Under basal conditions, pituicytes processes often physically engulf the MNC axons 
and separate them from the basal lamina, occupying a high proportion of the vascular 
surface and therefore limiting the number of contacts between axons and vessels 
(Hussy 2002).  
 
Pituicytes are characterized as glial cells (Salm et al 1982). By definition, the term 
glia (from the Greek word meaning “glue”) reflects the nineteenth-century 
presumption that these cells play a supportive role in the CNS. There are three major 
types of glial cells located in the mature CNS, including astrocytes, microglia and 
oligodendrocytes. Astrocytes communicate with neurons in a variety of ways to 
maintain and regulate neuronal signaling. One of the many functions of astrocytes is 
to buffer extracellular ion gradients of neurons to maintain the microenvironment 
(Walz 1989). Microglia function in a manner similar to macrophages in the immune 
system (Hatten et al 1991) and oligodendrocytes surround the axons of neurons with 
myelin, which is important for transmission of electrical signals (Purves et al 2004).  
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In contrast, pituicytes are glial cells located outside of the brain. Both OT and VP 
terminals and non-secretory axons make contacts with pituicytes. Physiological 
stimulations (lactation, parturition, and dehydration etc.) lead to retraction of the 
pituicyte processes, allowing increased occupation of the perivascular contact zone by 
MNC terminals (Beagley & Hatton 1992; Tweedle & Hatton 1980). This retraction is 
reversible following return to basal conditions (Tweedle & Hatton 1987).  
 
Similar morphological changes are observed in astrocytes around MNC soma in the 
hypothalamus, where the withdrawal of the processes leads to the increased 
soma-somatic and dendro-dendritic membrane apposition (Hatton & Tweedle 1982; 
Theodosis et al 1981). This glial-neuron interaction is important for maintaining 
proper functions of MNCs in the hypothalamo-neurohypophsial system (Haydon 2001; 
Watkins et al 2001). For example, Gordon and colleauges found norepinephrine can 
trigger ATP release from astrocytes surrounding the MNCs in the PVN (Gordon et al 
2005), and their ATP acts at postsynaptic P2X7 receptors on the MNCs to promote the 
insertion of AMPA receptors through a mechanism requiring the calcium-dependent 
activation of PI3K (phosphoinositide 3-kinase) to increases postsynaptic efficacy 
(Gordon et al 2005).  
 
In addition, astrocytes surrounding MNC somata in the hypothalamus and 
pituicytes in the neurohypophysis can release an organic osmolyte, taurine. In the 
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hypothalamus, taurine is a potent opener of the strychnine-sensitive glycine receptors 
expressed on MNCs (Hussy et al 2001), and its release has been shown to contribute 
to the inhibitory effect of hypotonicity on the firing rate of MNCs in vivo (Deleuze et 
al 2005; Hussy et al 1997). Therefore, the tonic release of taurine under isotonic or 
hypotonic condition from glial cells is essential to keep MNC soma at a low excitatory 
level in SON. In the NH, the retraction of pituicytes from the basal lamina will not 
only increase the hormone secreted from MNC terminals to the blood circulation, the 
reduced presence of pituicytes should also diminish the influence of taurine by 
limiting its access to the glycine receptors (Hussy 2002; Rosso & Mienville 2009). 
 
1.5.3 Ca2+ signalings in the pituicytes and glial cells in the CNS 
 
For a long time, glial cells were regarded as electrically silent elements, lacking 
transmitter receptors and expressing a limited set of ion channels (Seifert et al 2006). 
The study of voltage-gated ion channels on the glial cells was ignored. Now we know 
that glial cells are not passive players in the CNS. They express many voltage-gated 
ion channels (Na+, K+ and Ca2+) and actively participate in many Ca2+ signaling 
related pathophysiological processes such as pain, ischemic injury, and epilepsy 
(Fellin & Carmignoto 2004; Mulligan & MacVicar 2004; Watkins et al 2001). 
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Some evidence supports the idea that glial cells release gliotransmitters through 
Ca2+ -dependent exocytosis. Glial cells can release a variety of gliotransmitters, such 
as ATP, glutamate, and D-serine, into the extracellular space to communicate with 
neurons. Although other mechanisms are important for gliotransmitter release such as 
cell volume changes (Pasantes Morales & Schousboe 1988), opening of 
hemi-channels (Cotrina et al 1998) or activation of transporters (Szatkowski et al 
1990), strong evidence suggests that gliotransmission may be linked to 
Ca2+-dependent vesicular release (Parpura et al 1994; Zhang et al 2004). 
 
First, the notion that increased [Ca2+]i is necessary for glutamate release was proved 
by the high performance liquid chromatography measurement of glutamate release 
from cultured astrocytes (Parpura et al 1994). Adding the Ca2+ ionophore, ionomycin, 
in the presence of normal external Ca2+ (2.4 mM), caused increased release of 
glutamate from astrocytes, whereas depleting the external free Ca2+ inhibited the 
release (Parpura et al 1994). This notion was further proved by photolysis of caged 
Ca2+ (Parpura & Haydon 2000; Zhang et al 2004), which suggested that elevated 
intracellular Ca2+ is sufficient and necessary to trigger transmitter release from glial 
cells. 
 
Second, the presence of SNARE proteins such as synaptobrevin II has been 
identified in glial cells (Maienschein et al 1999; Montana et al 2006). The glutamate 
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release from cultured astrocytes is inhibited by the neurotoxin Botulinum B that 
selectively cleaves synaptobrevin (Araque et al 2000). The use of tetanus toxin, which 
cleaves astrocytic synaptobrevin II and cellubrevin, leads to a reduction of exocytotic 
events recorded from astrocytes. The toxin abolished the increased plasma membrane 
capacitance or the number of amperometric spikes, which can be measured by 
amperometry and represent the release of single LDCVs (Chen et al 2005; Kreft et al 
2004). Other evidence supporting the vesicular release mechanism is that astrocytes in 
situ in the hippocampus have been found to contain small vesicles resembling those at 
synapses (Bezzi et al 2004). Proteins used for sequestering glutamate into vesicles 
have also been found in astrocytes (Wilhelm et al 2004).  
 
The identification of VGCCs expression in astrocytes further proved that Ca2+ 
signaling may serve multiple functions in glia. In 1984, MacVicar and colleagues 
found spontaneous Ca2+ action potentials possibly mediated by VGCCs in rat cortical 
astrocytes that were reminiscent of Ca2+ oscillation in some neurons (MacVicar 1984). 
This finding inspired a series of studies aiming to further identification of VGCCs in 
glial cells. The L- and T-type Ca2+ currents could be detected in cultured astrocytes, 
but only under certain circumstances (for instance, when co-cultured with neurons or 
exposed to increased intracellular cAMP levels (Barres et al 1989; MacVicar & Tse 
1988)). Later, multiple subtypes of VGCCs were detected in cultured astrocytes 
(Latour et al 2003). Despite of all the observations metioned above, evidence of 
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VGCC expression in glial cells in situ is ambiguous. Some reseachers showed that 
both L- and T-type Ca2+ currents could be detected in subpopulations of immature 
astrocytes or progenitor glial cells of mouse brain slices (Akopian et al 1996; Berger 
et al 1992), but other groups failed to detect Ca2+ currents in astrocytes from postnatal 
rat preparations (Carmignoto et al 1998; Walz & MacVicar 1988). Another example is 
the observation that depolarization-evoked Ca2+ influx can be blocked by the selective 
L-type Ca2+ blocker in cultured astrocytes (MacVicar et al 1991), but not in the 
hippocampal slices (Duffy & MacVicar 1994). These evidences may suggest a 
differential expression of VGCCs in glial cells in situ compared to that in culture.  
   
The expression of VGCCs has been reported in glial cells outside of the brain. For 
instance, the mRNAs of L-type and T-type Ca2+ channels have been detected in the 
Muller cells, the retinal glia (Bringmann et al 2000; Puro et al 1996). Whether there is 
any VGCC(s) expressed in the pituictyes in situ or in culture is however unknown. 
Ca2+ signaling has been reported in cultured pituicytes (Hatton et al 1992), which 
showed activation of VP receptors, but not OT receptors, caused a transient elevation 
of intracellular [Ca2+]. Ca2+ signals were observed when the pituicytes were stimulated 
by other transmitters or nucleotides such as ATP, which mediated Ca2+ signals 
propagation in cultured pituicytes (Guthrie et al 1999; Nakai et al 1999). The 
consequences of Ca2+ signaling in pituicytes are largely unknown as well (Hussy 
2002). The L-type Ca2+ channels has been found to be upregulated in reactive 
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astrocytes in many brain injury models (Westenbroek et al 1998a), and this increased 
expression level of VGCCs may allow enhanced uptake of extracellular Ca2+ to clear 
the excessive extracellular Ca2+ and initiate the release of cytokines and growth 
factors from glial cells that support neuronal survival (Rudge et al 1995; Vaca & 
Wendt 1992). Little is known about L-type Ca2+ channels regulation of pituicytes 
during dehydration in which situation the demand of hormone release is high.  
 
1.5.4 Melanotropes of the intermediate lobe of pituitary gland  
 
The melanotropes containing melanin granules in the IL are the main cell type in this 
area, and these cells have been used as a good model for neurosecretion research 
(Stanley & Russell 1988; Williams et al 1993). Melanotropes synthesize a large 
precursor protein, proopiomelanocortin (POMC), which is cleaved by proteolytic 
processing to generate melanocyte-stimulating hormone (MSH) in melanotropes and 
adrenocorticotropin (ACTH) in corticotropes (Mains & Eipper 1979). MSH regulates 
melatonin synthesis in the epidermis in some vertebrate species (Dasen & Rosenfeld 
2001). α-MSH can inhibit the electrical activity of oxytocin cells by acting on their 
somata so that secretion from nerve terminals is inhibited (Sabatier et al 2003).  
 
Rat melanotropes express a much broader repertoire of VGCCs than other anterior 
endocrine cells. Early studies only found T-type and L-type Ca2+ currents in the 
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melanotropes (Stanley & Russell 1988; Williams et al 1990; Williams et al 1991), but 
later using single electrode voltage clamp, Williams and colleagues found P-type 
currents using specific channel blockers (Williams et al 1993). A complete 
pharmacological identification was performed using whole cell patch-clamp 
demonstrating that melanotropes also express N- and Q-type currents (Mansvelder et 
al 1996). Surprisingly, the N- and P/Q-type currents in melanotropes are very sensitive 
to the L-type Ca2+ blocker, nimodipine (Mansvelder & Kits 2000; Mansvelder et al 
1996). The exocytotic properties of melanotropes are similar to those of some 
neuroendocrine cells (Neher & Zucker 1993; Thomas et al 1990; Thomas et al 1993). 
In this thesis, I will therefore study the CaV2 channel expression in melanotropes.  
  
2. RATIONALE, HYPOTHESES AND OBJECTIVES 
 
Because both the CaV2.1 and CaV2.2 channels are important for the neurosecretion 
at the nerve terminals in neurons and neuroendocrine cells, one of the main focuses of 
this thesis is to study the molecular properties and locations of these channels in 
MNCs.  
 
The locations and the molecular properties of VGCCs are the determinants for 
proper Ca2+ influx to trigger neurosecretion. The synprint site within the II-III loop of 
the CaV2.1 and CaV2.2 channels is important for the presynaptic regulation of 
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channels by SNARE proteins (An & Almers 2004; Bezprozvanny et al 1995; Chen & 
Scheller 2001). There has been some evidence showing that the synprint site of CaV2 
channels could be missing in the brain (Kaneko et al 2002; Mori et al 1991). Deletion 
variants of human CaV2.2 have been identified that lack the synprint site. The early 
study on splice variants of CaV2.1 in rabbit brain also revealed an isoform lacking 348 
amino acids in the II-III loop (Mori et al 1991). However, there have been no further 
characterizations of such deletion variants (Jurkat-Rott & Lehmann-Horn 2004; 
Lipscombe et al 2002), and whether they are expressed in neuroendocrine cells was 
unknown. Through this thesis work, I am trying to identify the locations of the splice 
variants of the CaV2.1 or/and CaV2.2 channels in the rat brain, especially in MNCs of 
the hypothalamo-neurohypophysial system.  
 
The rate of Ca2+-dependent hormone release from MNC terminals is slower than 
neurotransmitters release from the presynaptic terminals of neurons (Giovannucci & 
Stuenkel 1997; Lim et al 1990). Both pulsed laser Ca2+ imaging (Fisher & Fernandez 
1999) and immunocytochemical studies of VGCCs expressed on the MNC terminal 
membranes (Fisher et al 2000) suggest that the MNC terminals lack specialized 
release sites. These observations suggest that the Ca2+ channels responsible for 
activating exocytosis in MNC terminals are not physically associated with synaptic 
proteins. To understand the hormone secretion process it is therefore important to 
understand the molecular architecture of release sites, the mechanism(s) by which 
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Ca2+ channels are targeted to them, and the significance of this architecture to the 
kinetics of secretion. I hypothesize here that the splice variants affecting the presence 
of the synprint site in the CaV2.1 or CaV2.2 channels may be expressed in 
neuroendocrine cells and these variants will lead to the alterations of SNARE protein 
regulations and channel activities of the CaV2 channels in neuroendocrine cells.  
 
To study the terminal targeting of channels, I used differentiated PC12 cells as my 
cell model. PC12 cells are cell lines of a tumor of rat chromaffin cells, which are 
located in the adrenal medulla and originate from neural crest. They are 
neuroendocrine cells containing small synaptic vesicles and large dense core vesicles 
(LDCVs). Exocytotic release from PC12 cells depends on CaV2.1 and CaV2.2 
channels (Chen & Scheller 2001; Fox et al 2008). PC12 cells can be transfected and 
efficiently express recombinant plasmids encoding proteins of interest. PC12 cells can 
also be experimentally stimulated to differentiate and grow neurite-like processes 
called growth cones or varicones (Adler et al 2006; Mingorance-Le Meur et al 2009). 
I therefore used PC12 cells as my model to study the CaV2 channel targeting in this 
neuroendocrine cells (Burgoyne 1997; Westerink & Ewing 2008).  
 
The pituicytes are important glial cells regulating MNC terminal functions. 
Whether they express VGCCs or not is unclear. The Ca2+ oscillations and uptake have 
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been observed in pituicytes, I therefore hypothesize that pituicytes express VGCCs 
and these channels may have function(s) related to MNC hormone release.  
 
In summary, our hypotheses are: 1) The neuroendocrine cells (MNCs) primarily 
express one or more CaV2 channels that lack the synprint site of the II-III loop; 2) 
Pituicytes express one or more VGCCs and the expression levels of channels can be 
regulated by dehydration. 
 
I propose to perform experiments to test: 1. Expression and locations of alternative 
splicing of CaV2.1 and CaV2.2 channels in the rat brain and neuroendocrine cells. 
Further identification of the possible cell-type specific expression of those variants. 
Targeting mechanism(s) of channels will also be studied. 2. The expression of 
voltage-gated Ca2+ channels in the pituicytes both in situ and in culture. Identifying 
the colocalization of VGCCs and pituicytes and quantifying the expression level of 
certain subtypes of Ca2+ channels before and after dehydration. 
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3. MATERIALS AND METHODS 
3.1 Animal and cell preparations 
 
MNC cultures 
Male Long-Evans rats (200-300g, 3-4 weeks old) were anesthetized with halothane 
and killed with a rodent guillotine following a protocol approved by the University of 
Saskatchewan Animal Care Committee. The supraoptic nucleus of the hypothalamus 
was dissected and MNCs were isolated. Coronal brain slices (~1 mm thick) were cut 
and blocks of tissue (~1 mm3) containing part of the supraoptic nucleus were dissected 
and incubated for 90 min at 34 °C in 10 ml of an oxygenated (100% O2) Pipes saline 
(mM: NaCl, 120; KCl, 5; MgCl2, 1; CaCl2, 1; Pipes, 20; D-glucose, 25; pH 7.1) 
containing trypsin (0.7 mg ml-1: Sigma). Tissue blocks were then placed in 
trypsin-free oxygenated Pipes saline and kept (up to 8 h) until use. Tissue blocks were 
triturated with fire-polished pipettes (0.2-0.5 mm i.d.) and plated onto Petri dishes 
(Fisher & Bourque 1995b; Oliet & Bourque 1992; Zhang et al 2007). For isolation of 
axon terminals, the anterior lobe was separated from the pituitary gland; the 
intermediate lobe was cut off as much as possible to expose the posterior pituitary. 
The isolated posterior pituitary was incubated in trypsin solution and rinsed as above. 
Trituration was performed in a Pipes saline just before plating (Fisher & Bourque 
1995a; Fisher et al 2000).  
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Pituicyte cultures 
The pituicyte culture was performed using a slightly modified version of a method 
from previous studies (Beagley & Hatton 1992; Bicknell 1988). Briefly, adult male 
Long-Evans rats were anesthetized with halothane and killed by decapitation and the 
pituitary glands were immediately removed. The neurohypophysis was dissected free 
from the anterior and intermediate pituitaries in sterile culture medium (Dulbecco’s 
modified Eagle Medium, Sigma, Oakville, ON) under a dissecting microscope. The 
neurohypophysis was then cut into four pieces and each piece was placed on a glass 
coverslip coated with collagen (BD, CA) in a 35-mm-diameter plastic Petri dish. The 
pieces of neurohypophysis were secured in place by covering them with a small piece 
of a glass cover slip. Cultures were maintained in culture medium for 10-14 days with 
10% fetal calf serum (Invitrogen, San Jose, CA), penicillin (100 U/ml, Invitrogen) and 
streptomycin (100 mg/ml, Invitrogen) in a humidified atmosphere (37°C) containing 
95% air and 5% CO2. After 10-14 days in culture, the pituicytes will grow into a 
single cell layer with the purity >95% and all the MNC terminals die off and can be 
washed away. 
 
Hippocampal neuron cultures 
Hippocampi were isolated from embryonic day 18 (E18) rat embryos and dissociated 
by digestion with trypsin (Invitrogen) and DNase I (Sigma). Neurons were plated on 
glass coverslips coated with poly-L-lysine (Sigma) and cultured in Neurobasal-A 
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Media (Gibco) supplemented with B-27 (Gibco). Neurons were plated at a density of 
50-60 neurons/mm2. Immunocytochemistry was performed on day 4-7 after plating. 
For transfection experiments, a glial feeder layer was prepared one week before the 
hippocampal neurons were plated (Kaech & Banker 2006). Primary cultures of glia 
were prepared from the cortices of newborn rat pups (postnatal 2 days), and the glial 
cells were isolated and plated at density of 7.5 x 106 per 75 cm2 flask. Gilal cells were 
maintained in the glial medium (Kaech & Banker 2006) for 7 days before they formed 
a thin glial layer. Neurons were co-cultured with ready-to use glial layer and 
transfected with expression constructs by the Lipofectamine 2000 methods following 
a commercial protocol from Invitrogen. Hippocampal neurons were fixed and 
observed 48h after transfection (Kaech & Banker 2006).  
 
PC12 cell cultures 
PC12 cells were obtained from American Type Culture Collection (ATCC) and 
cultured in Ham's F12K medium with 2 mM L-glutamine adjusted to contain 1.5 g/L 
sodium bicarbonate, 82.5%; horse serum, 15%; fetal bovine serum, 2.5% in a 5% CO2 
air humidified atmosphere. For channel targeting research, PC12 cells were treated 
with NGF 7S (neural growth factor 7S, Invitrogen) at final concentration of 10 ng/ml 
for two days. When the cells differentiated and had growth cones, DNA transfection 
was performed. 
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3.2 RT-PCR and Molecular Cloning  
 
Rats were sacrificed as described above. The brains were immediately removed and 
various parts dissected for total RNA extraction. RNA from these parts was isolated 
immediately or stored at –70°C after being frozen in liquid nitrogen. RNA was 
extracted using Trizole reagent (Invitrogen, Life Technologies). RNA was reversely 
transcribed using SuperScript First-Strand Synthesis System for RT-PCR 
(Invitrogen, Life Technologies).  
 
1) CaV2.1 
Variants with differences in the II-III loop were sought using nested RT-PCR. The 
sequence of the rat CaV2.1 II-III loop (accession number NM_012918) was used to 
design two sets of primers (P1 forward, 5’GGC ATG GTG TTC TCC ATC TA, 
corresponding to bases numbers 2065-2084 and P2 reverse, 5’ GAG CCC TGG CTC 
TCT TTT CT, corresponding to base numbers 2959-2978) that were then synthesized 
by the University Core DNA Services, University of Calgary. Initial amplification was 
carried out by 20 cycles of 95°C for 35 seconds, 60°C for 45 seconds and 72°C for 3 
minutes after initial denaturation of 95°C for 3 minutes and then the final elongation 
of 72°C for 10 minutes using primers P1 and P2 in 25 µl. A two microliter sample of 
these products was re-amplified with nested primers (P3 forward, 5’ACC CTC TTC 
GGG AAC TAC AC, corresponding to base numbers 2098-2117 and P4 reverse, 
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5’CTC CCC ATC ATC GCC TTC, corresponding to base numbers 2878-2895) using 
23 cycles of 95°C for 35 seconds, 60°C for 45 seconds and 72°C for 3 minutes after 
initial denaturation of 3 minutes at 95°C and then a final elongation at 72°C for 10 
minutes in 25 µl volume. Reactions were carried out in a solution containing 1.5 mM 
MgCl2, Taq DNA polymerase 2 Units, 2 pmol each primers 10 µmol dNTP and 1× 
PCR buffer (Invitrogen, Life Technologies). A negative control without cDNA was 
run with each reaction. The PCR products were analyzed on 1.5 % agarose gel stained 
with ethidium bromide. Gels were visualized under UV light and documented with 
Polaroid film.  Primers designed for the housekeeping gene GAPDH (P5 forward, 
5’CAT GAC AAC TTT GGC ATC GT, corresponding to base numbers 1336-1355 
and P6 reverse 5’ATG TAG GCC ATG AGG TCC AC corresponding to base 
numbers 1816-1835) were used as a positive control (31 cycle of 95°C for 30 sec, 
60°C for 40 sec and 72°C for 1.5 minutes).  
 
2) CaV2.2  
For the first round primers (DFc01-DRc01, 2016-3427 base pair NM92905 rat 
CaV2.2 , D is the alphabet used for laboratory storage purpose, F means forward, and 
R means reverse) were used to get template covering the II-III loop. For the second 
round, primers (DFc02-DRc02, 2072-2433 bp) were used to amplify a small region 
within II-III loop that cover the portion of synprint site (Dubel et al 1992; 
Ghasemzadeh et al 1999) 
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All PCR reagents were purchased from Invitrogen, Life Technologies, unless 
otherwise stated. 
 
Gel bands were cut and DNA was eluted using Quantum Prep Freeze ‘N Squeeze 
DNA gel extraction spin columns (BIO-RAD) and then DNA was precipitated with 
sodium acetate (pH 5.2) and ethanol. PCR products were cloned into pGEM-T easy 
vector and sequenced using an automated sequencer (Plant Biotechnology Institute, 
National Research Council, Saskatoon).  For the study of expression of these splice 
variants in individual MNCs, single-cell RT-PCR was carried out. Healthy cells were 
picked up by glass micropipettes using a micromanipulator and transferred to lysis 
buffer (5 µl) containing RNAse inhibitors, random hexamers, RNA guard, MgCl2, 
dNTP and reverse transcriptase buffer. Reverse transcription was carried out by 
addition 50 units of SuperScript First-Strand Synthesis System for RT-PCR 
(Invitrogen, Life Technologies) and incubated at 37°C for one hour (Glasgow et al 
1999). The product (1µl) was amplified by 40 cycles. 
 
3.3 Plasmid preparation  
 
1. Plasmids for CaV2.2 channel targeting experiments. Green fluorescent protein (GFP) 
fusion constructs were generated on the basis of pEGFPC3 (Clontech, Palo Alto, CA) 
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vector, GFP-NC3 (2021–2339) of rat CaV2.2 gene (Gene bank Access Number: 
M92905). GFP and GFP-NC3 encoding plasmids were gifts from Dr. I. Bezprozvanny 
at the University of Texas Southwestern Medical Center, Dallas.  
 
2. Plasmids for electrophysiology and imaging experiments of splice variants of 
CaV2.1 channels. Full length CaV2.1 was first subcloned into vector pMT2sx, and 
fragments covering II-III loop of the two deleted splice variants Δ1 and Δ2 were 
amplified by PCR and then sub- cloned back to full-length CaV2.1 constructs at 
restriction endonuclease sites BmgBI and SgrAI. Plasmids pMT2sx-CaV2.1, 
pMT2sx-CaV2.1Δ1, pMT2sx-CaV2.1Δ2, pEYFP-C-CaV2.1, pEYFP-C-CaV2.1Δ1 and 
pEYFP-C-CaV2.1Δ2 are all constructed in the laboratory of Dr. G. Zamponi at the 
Hotchkiss Brain Institute, University of Calgary and confirmed and sequenced by 
University Core DNA Services, University of Calgary. Plasmids pEGFP- CaV2.1, 
pEGFP -CaV2.1Δ1, pDsRed-CaV2.1, pDsRed-CaV2.1Δ1 and pDsRed-CaV2.1Δ2 were 
constructed at AgeI, XhoI, and SalI restriction endonuclease sites based on pEYFP-C 
encoding plasmids and sequenced at the Plant Biotechnology Institute Sequencing 
Center, National Research Council, Saskatoon, SK.  
 
Maximum preparation of plasmid 
Methods were modified from the protocol (Preparation of plasmid DNA by alkaline 
lysis with SDS: maxipreparation, see appendix I (Sambrook et al 2001). 
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3.4 Western-blot  
 
All procedures were performed on ice to prevent proteolysis of the Ca2+ channel 
subunits. Whole brains were removed from decapitated adult male Long-Evans rats 
and 1/2 of the brain was transferred into 4.5 ml of homogenization buffer that 
contained 50 mM Tris pH 7.4 (Sigma), 0.3 M sucrose, 0.1 M NaCl, 1 tablet of 
complete mini (Roche), 100 μg/ml benzamidine (Sigma), 1 μg/ml  pepstatin (Sigma), 
10 μg/ml calpain inhibitor I (Sigma), and 10 μg/ml calpain inhibitor (Sigma), the 
tissues were homogenized three for 30 second each, centrifuged for 15 min at 17,000 
rpm, and the supernatant was collected for Western-blot analysis. For cultured 
pituicytes, the cells were harvested on day 10-14 of culturing, rinsed by ice-cold PBS 
briefly, and collected with a plastic cell scraper in 1 ml of lysis buffer 
(homogenization buffer with 1% Triton X-100 and 0.5M NaCl). The solution was 
centrifuged at 10,000 g for 10 min at 4°C. The supernatant was removed and kept on 
ice or frozen until loading on the gel. After separation by sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE), proteins were transferred 
from the gels to nitrocellulose membranes (Amersham Biosciences). The membranes 
were then blocked by 5% nonfat milk in PBST for 1 h, followed by overnight 
incubation of different antibodies against α1 subunits of Ca2+ channels as described 
previously at 4°C in the blocking solution (dilutions were made according to the 
recommendations of the manufacturer). Horseradish peroxidase-coupled secondary 
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antibodies and ECLTM Western blotting reagents (Amersham Biosciences) were used 
according to the manufacturer’s protocol. 
 
3.5 Immunohistochemistry and Immunocytochemistry 
 
Immunohistochemistry 
All procedures used in these experiments were in accordance with the guidelines of 
the University of Saskatchewan Animal Care Committee. Adult male Long-Evans rats 
were anesthetized with a ketamine (125 mg/kg) and xylazine (7 mg/kg) mixture and 
intra- cardially perfused with ice-cold PBS, followed by cold, freshly prepared 4% 
paraformaldehyde (PFA) in PBS (pH 7.4). The rats were decapitated and the brains 
removed. Brains and pituitary glands were taken out immediately and transferred into 
4% PFA for postfixation overnight, then moved into 30% sucrose solution for 
cryoprotection. Samples were stored at 4°C until sectioning. The tissues were frozen 
on dry ice, and sectioned at 30 μm on a sliding microtome. The sections were 
incubated with 4% donkey serum and 0.3% Triton X-100 in 0.1M PBS, and then 
incubated with primary antibody overnight at 4 °C with constant rotation.  The 
following antibodies were used: mouse anti-S100β (1:1,000, Sigma, Oakville, ON), 
rabbit anti-CaV2.1 (1:1,000, Alomone Labs, Israel), CaV2.2 (1:1,000, Alomone Labs), 
CaV1.2 (1:1,000, Alomone Labs), CaV1.3 (1:1,000, Alomone Labs), CaV2.3 (1:1,500 
Alomone Labs), CaV3.1 (1:1,500 Alomone Labs), rabbit anti-synapsin I (1:1,500, 
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Millipore), goat anti-neurophysin I (1:1500, Santa Cruz, CA), and goat 
anti-neurophysin II (1:1500 Santa Cruz, CA); rabbit anti-oxytocin (1:500 Genway, 
CA), rabbit anti-neurophysin II (1:1000 Novus Biologicals); mouse 
anti-synaptophysin (1:1000 Sigma), rabbit anti-α-MSH (Melanocyte Stimulating 
Hormone, 1:500 Sigma). After incubation of primary antibodies, sections were 
washed 3 times with PBS and incubated with secondary antibody for 2h. The 
secondary antibodies used were: Alexa Fluor 555 donkey anti-rabbit IgG (1:500 
Invitrogen), Alexa Fluor 488 donkey anti-mouse IgG (1:500; Invitrogen), and Alexa 
Fluor 555 donkey anti-goat IgG (1:500; Invitrogen). After washing sections by PBS 3 
times, the samples were then air dried for 1 h at 37°C, dipped in xylene, and mounted 
on a microscope slide with Citifluor (Marivac, Lakefield QC) before confocal 
microscopy. Two types of negative control experiments were carried out for each of 
the Ca2+ channel antibodies. When the primary antibody was not added, or when the 
primary antibody was pre-incubated with the peptide antigen (supplied by the 
manufacturer). 
 
Immunocytochemistry 
General immunocytochemical methods were used for different types of cultured or 
acutely isolated cells except specifically described otherwise.  
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For isolated MNCs and hippocampal neurons, a goat polyclonal antibody directed 
against the carboxy-terminus of human CaV2.1 (Santa Cruz) and a rabbit polyclonal 
antibody directed against peptide residues 865-881 in rat CaV2.1 II-III loop (Alomone 
Labs) were used for immunofluorescence experiments on cultured cells. Cells were 
fixed in 4% paraformaldehyde (PFA, Sigma) and permeabilized and blocked for 1h 
with digitonin 100μg/mL, bovine serum albumin 4%, normal donkey serum 4%, and 
sodium azide 0.02% in PBS. Primary antibodies (range from 1:50 to 1:400) were 
incubated overnight at 4°C, followed by incubation for 1h with secondary antibodies 
Alexa Fluor 488 donkey anti-goat (1:400, Molecular Probes) or Alexa Fluor 555 
donkey anti-rabbit goat (1:200, Molecular Probes). Immunofluorescence was 
visualized using a Zeiss Axiovert 200 microscope with a 40× objective and 
appropriate filter sets and images were captured using a cooled CCD camera. 
 
Pituicytes were fixed in 4% PFA for 15 min at 4°C. The coverslips were then 
washed 5 times with cold PBS for 5 min and incubated for 30 min at room 
temperature in a fresh solution of PBS containing 10% normal donkey serum (Jackson 
ImmunoResearch). Cultures were incubated overnight at 4°C in antibodies diluted in a 
solution containing 1% BSA (Sigma), 0.05% sodium azide (Sigma) and 0.04% 
sodium EDTA (Sigma) in PBS. Pituicytes were co-labeled with an antibody directed 
against S100β (1:1,000, Sigma), and one of the following Ca2+ channel antibodies (all 
of which are from Alomone Labs, Israel): anti-CaV2.1 (1:400), CaV2.2 (1:400), CaV1.2 
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(1:400), CaV1.3 (1:400), CaV2.3 (1:400), and CaV3.1 (1:1000). The next day, cultured 
pituicytes were rinsed three times in cold PBS for 5 min and transferred in fresh PBS 
containing Alexa Fluor 555 donkey anti-rabbit IgG (1:200, Invitrogen) and Alexa 
Fluor 488 donkey anti-mouse IgG (1:200, Invitrogen) and incubated for 1h at room 
temperature. Cells were washed again 3 times with cold PBS for 5 min each time and 
mounted with mounting solution. Samples were observed under fluorescent 
microscopy with appropriate filters.  
 
3.6 Epifluorescent and Confocal Microscopy 
 
Acutely isolated cells and cultured cells were examined with an epifluorescent 
microscope after immunostaining. Immunofluorescence was visualized using a Zeiss 
Axiovert 200 microscope with a 40× objective and appropriate filter sets and images 
were captured using a cooled CCD camera. Immunofluorescence of fixed brain slices 
were observed with a Zeiss LSM 700 confocal microscope using a 20x objective and 
appropriate filters (in Dr. F. Cayabyab’s lab). The confocal imaging results presented 
here are the representative of three independent experiments performed on twenty 
different rats. The quantitative measurements of samples between treatment and 
control groups in one specific experiment were performed using the same fluorescent 
or confocal settings. 
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3.7 Statistics 
 
     Intensity analysis for immunohistochemistry 
For the study of VGCCs expression in MNC somata, brain slices containing most of 
the SON area were chosen from 10-12 rats. For the study of VGCC expression in 
pituicytes, the pituitary slices containing most of the neurohypophysial area were 
chosen. The intensity of immunoreactivity to the indicated calcium channel antibodies 
and S100β were measured as follows: images stained with S100β (usually green) 
showing the location of pituicytes were converted to binary images in which each 
pixel valued either “0” or “1” representing background or pituicyte respectively. 
Images showing indicated calcium channels (red) were obtained at same standardized 
confocal settings that distinguished control slices from positive staining. Red images 
were converted into 8-bit monochromatic images and overlaid with binary ones as 
described previously. New overlaid images will only show immunoreactivity of 
indicated calcium channels on pituicytes after each pixel multiplied from 
corresponding images. Fluorescent intensity was quantified in matched ROIs (region 
of interest) for each overlaid image. Three measurements from each slice were 
averaged and analyzed using imageJ (NIH). Values were presented as mean ± SEM 
and were compared using the Student’s t test, with p<0.05 being deemed as indicating 
a significant difference.  
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Intensity analysis for immunocytochemistry  
For the fluorescence of channels in PC12 growth cones, fluorescent intensity was 
quantified in regions of interest (ROIs) within the terminals of the growth cones. A 
ROI with about 1 μm2 was used to measure the intensity within this area. Three 
measurements from each growth cone were averaged and analyzed. Values were 
presented as mean ± SEM and were compared using the Student’s t test, with p<0.05 
being deemed as indication of a significant difference.  
       
      DNA gel analysis 
      PCR products were semi-quantified by using the ratio of CaV2.1 channel product: 
GAPDH. Two sets of independent RT-PCR were performed to amplify housekeeping 
gene GAPDH and a portion of the II-III loop of CaV2.1 channels in different brain and 
peripheral tissues. The DNA gel was imaged using a KODAK GEL LOGIC 200 
imaging system and the intensities of DNA bands were measured by Image J software 
(NIH).  
       
     Colocalization analysis 
The standard test for the colocalization of two proteins by immunocytochemistry 
generally involve tagging the first, protein A, one colour (usually green), and the 
second, protein B, a different and contrasting colour (usually red). Each colour is 
imaged separately, and proteins are deemed to be colocalized in areas stained with the 
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combined colour when the two images are overlaid (in this case, red plus green = 
yellow). Image J software was used to analyze the percentage of yellow colour within 
matched ROIs. If the ratio >50% then the colocalization analysis was considered as 
positive, in other words, the two proteins I am interested in are colocalized. For 
distribution analysis, if the yellow area is under 10% of the ROI, then the result will 
be considered as not colocalized. 
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4. RESULTS  
 
4.1 Expression and distribution of VGCCs on pituicytes  
4.1.1 CaV2.2 and CaV2.3 channels are expressed on pituicytes of the NH 
4.1.1.1 Identification of pituicytes 
 
I labeled pituicytes in slices of the pituitary gland using antibodies directed against the 
astrocytic marker S100 β, which has been shown to label these cells (Cocchia & Miani 
1980; Fujiwara et al 2002). Figure 4.1A shows immunoreactivity to S100 β in a 
pituitary slice. There is much stronger fluorescence in the neurohypophysis (NH) than 
that in the adenohypophysis (AH) or the intermediate lobe (IL). There was however a 
clear band of immunoreactivity between the intermediate lobe and the anterior 
pituitary (Figure 4.1A S100β) that corresponds to the S100 β-positive cells in the 
marginal cell layer of the hypophysial cleft (Cocchia & Miani 1980; Fujiwara et al 
2002). To ensure that the antibody to S100β was not labeling neuronal elements I also 
stained with an antibody directed towards the synaptic vesicle associated protein 
synapsin I (Navone et al 1984). There was intense immunoreactivity to synapsin I in 
the neurohypophysis (Figure 4.1A Synapsin I), which is consistent with the high 
density of synaptic terminals, and less so in the adenohypophysis and the intermediate 
lobe. Control experiments were performed without adding the primary antibodies for 
S100β and synapsin I, and there was no immunostaining detected at the same 
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microscope settings (Figure 4.1B). Table 4-1 describes the antibody labeling I used for 
identifying different components within NH. The immunostaining for GFAP in 
pituicytes was not observed in pituitary slices, but immunostaining of GFAP in 
cultured pituicytes was positive. The immunofluorescence of S100β was consistently 
stronger than that of GFAP for cultured pituicytes, which suggests that S100β is a 
better glial marker for labeling the pituicytes.  
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Table 4-1 Immunohistochemistry in the neurohypophysis (single labeling of 
MNC nerve terminals, synaptic inputs and S100β positive pituicytes). 
 
(This table is shown to demonstrate how I identified different components within 
the neurohypophysis using different markers) 
 
 
+++ strong immunofluorescence (>10 marker positive spots/400 μm2) ; ++ moderate 
immunofuorescence (range from 3-10 marker positive spots/400 μm2); + weak 
Target  Marker Fluorescence Staining 
OT-MNCs Neurophysin I  
 
Alexa Fluor 
488 
Posterior ++,  Intermediary -, 
Anterior lobe - 
OT- and 
VP-MNCs 
Neurophysin I 
&II 
 
Alexa Fluor 
488 
 
Posterior ++,  Intermediary-, 
Anterior lobe -  
Glia-like 
cells 
S100β Alexa Fluor 
488 
Posterior ++,  Intermediary ++, 
Anterior lobe++ 
Glia-like 
cells 
GFAP (Glial 
fibrillary 
acidic protein) 
Alexa Fluor 
488 
Posterior –,  
Intermediary + 
 
Synaptic 
inputs 
Synapsin I Alexa Fluor 
555 
Posterior +++,  Intermediary + 
Anterior lobe -  
Synaptic 
inputs 
Synaptophysin Alexa Fluor 
488 
Posterior +++ , Intermediary + 
Anterior lobe - 
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immunofluorescence (range from 1-3 marker positive spots/400 μm2); - no 
immunofluorescence (0 marker positive spots/in any area of 400 μm2).  
 
     
Figure 4.1 Distribution of immunoreactivity to S100 β and synapsin I in the 
pituitary gland. The panels show confocal fluorescent images of slices of rat pituitary 
glands. The labels show the location of the neurohypophysis (NH), the 
adenohypophysis (AH), and the intermediate lobe (IL). A. The image on the left 
shows immunoreactivity to S100β, the image in the center shows immunoreactivity to 
synapsin I, and the image on the right shows the overlay of the two images. B. These 
images show the negative controls for the images in part A, in which slices were 
incubated with the secondary but not the primary antibodies. Scale bars =40 μm. 
 
4.1.1.2 Identification of different subcellular components in the NH 
 
To better define the cellular elements of the neurohypophysis, I compared the 
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immunoreactivity to S100 β and synapsin I to that of the neurophysins, which are 
carrier proteins for VP and OT that are expressed only in the MNCs. Neurophysin I is 
selectively expressed in oxytocin-releasing MNCs and neurophysin II is selectively 
expressed in vasopressin-releasing MNCs. The combination of antibodies to the two 
neurophysins should therefore stain all of the MNC terminals, but not the pituicytes or 
synaptic terminals. The double staining studies illustrated in Figure 4.2 show that 
there is no colocalization between S100 β immunoreactivity and that of either 
neurophysins (Figure 4.2A) or synapsin I (Figure 4.2B). A comparison of 
immunoreactivity to synapsin I and the neurophysins shows some overlap (Figure 
4.2C), which is consistent with the observation that some MNC terminals do express 
small vesicles containing synapsin I (Navone et al 1986). There are also many small 
objects that appear to be positive for synapsin I but not the neurophysins, which likely 
correspond to synaptic terminals abutting onto either MNC terminals or pituicytes. 
Table 4-2 describes the colocalization analysis results for combinations of antibodies 
that recognized different components within the NH. These studies confirm that I can 
use immunoreactivity to S100 β to selectively label pituicytes in the neurohypophysis. 
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Table 4-2 Immunohistochemistry in the neurohypophysis (double staining of the 
combinations among MNC terminals, synaptic inputs and pituicytes). 
 
Target  Marker Fluorescence Colocalization 
MNC 
terminals and 
synaptic 
inputs 
Neurophysin I & 
II and Synapsin I 
 
Alexa Fluor 488 
Alexa Fluor 555 
<50%  
 
MNC 
terminals and 
synaptic 
inputs 
Neurophysin I & 
II and 
Synaptophysin 
 
Alexa Fluor 555 
Alexa Fluor 488 
 
<50%  
 
MNC 
terminals and 
pituicytes 
Neurophysin I & 
II 
and S100β 
Alexa Fluor 555 
Alexa Fluor 488 
 
<10% 
Synaptic 
inputs and 
pituicytes 
S100β and 
Synapsin I 
 
Alexa Fluor 488 
Alexa Fluor 555 
<10% 
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Figure 4.2 Distribution of immunoreactivity to S100 β, the neurophysins, and 
synapsin I in the neurohypophysis. The panels show confocal fluorescent images of 
slices of rat pituitary glands. A. The image on the left shows immunoreactivity to 
S100 β, the image in the center shows immunoreactivity to the neurophysins (i.e. a 
combination of neurophysin I and neurophysin II), and the image on the right shows 
the overlay of the two images. B. The image on the left shows immunoreactivity to 
S100 β, the image in the center shows immunoreactivity to synapsin I, and the image 
on the right shows the overlay of the two images. C. The image on the left shows 
immunoreactivity to the synapsin I, the image in the center shows immunoreactivity to 
neurophysin I and II, and the image on the right shows the overlay of the two images. 
Scale bars =20 μm. 
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4.1.1.3 Identifying VGCCs on the pituicytes 
 
I therefore undertook studies to co-label neurohypophysial slices with S100β and 
antibodies directed against a variety of Ca2+ channel α1 subunits. Figure 4.3 shows the 
immunostaining results obtained from a set of rabbit polyclonal antibodies directed 
against the α1 subunits of different VGCCs (Alomone Labs). Immunoreactivity in 
neurohypophysial slices was detected for CaV2.1 (Figure 4.3A), CaV2.2 (Figure 4.3B), 
CaV1.2 (Figure 4.3C), CaV2.3 (Figure 4.3E), and CaV3.1 (Figure 4.3F), but not for 
CaV1.3 (Figure 4.3D, despite the identification of staining for CaV1.3 in the AH). The 
double staining experiments show clear colocalization with S100β immunoreactivity 
for two types of Ca2+ channel α1 subunits, CaV2.2 and CaV2.3. Table 4-3 describes the 
details of each double staining for detecting the colocalization of pituicytes marker 
and VGCC marker. To further comfirm the colocalization results, I used another set of 
goat polyclonal antibodies directed against each VGCC subtype I am interested in. 
The Table 4-4 demonstrates colocalization results showing both the CaV2.2 and 
CaV2.3 markers are overlaid with pituicytes, whereas CaV1.3 and CaV2.1 are not (the 
immunostaining obtained from the goat polyclonal antibodies are similar to that from 
the rabbit polyconal antibodies, images are thus not shown here). These two groups of 
results confirm that only the CaV2.2 and CaV2.3 antibodies are colocalized with S100β, 
respectively. These results support the hypothesis that pituicytes in the NH express the 
CaV2.2 and CaV2.3 Ca2+ channels.  
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Figure 4.3 Distribution of immunoreactivity to Ca2+ channels in the NH. The 
panels show confocal fluorescent images of slices of rat pituitary glands. A-F show 
the results of double staining of the pituitary marker, S100β, and different Ca2+ 
channels antibodies in the rat NH. The images on the left show immunoreactivity to 
S100β, the images in the center show immunoreactivity to the indicated Ca2+ channel 
type, and the images on the right show the overlay of the two images. Double staining 
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of S100β and CaV2.1 (A), Double staining of S100β and CaV2.2 (B), Double staining 
of S100β and CaV1.2 (C), Double staining of S100β and CaV1.3 (D), Double staining 
of S100β and CaV2.3 (E), and Double staining of S100β and CaV3.1 (F). Scale bars 
=20 μm. 
 
Table 4-3 Immunohistochemistry in the neurohypophysis. Double staining of 
VGCC α1 subunits and pituicytes by rabbit polyclonal α1 subunit antibodies      
(Alomones laboratories) and S100β. 
 
Target  Marker Fluorescence Colocalization 
pituicytes and      
CaV2.1 α1 
subunit   
S100β and 
CaV2.1 
antibodies 
Alexa Fluor 488 
Alexa Fluor 555 
<10% (the staining pattern of 
CaV2.1 is dot-like) 
pituicytes and      
CaV2.2 α1 
subunit   
S100β and 
CaV2.2 
antibodies 
Alexa Fluor 488 
Alexa Fluor 555 
>90% (CaV2.2 antibody 
strongly stains in the NH and 
colocalized with pituicytes in 
the NH) 
pituicytes and      
CaV1.2 α1 
subunit   
S100β and 
CaV1.2 
antibodies 
Alexa Fluor 488 
Alexa Fluor 555 
<50% (the staining pattern of 
CaV1.2 antibody is along the 
periphery of pituicytes, 
which may represents the 
L-type channels expressed in 
basal lamina) 
pituicytes and      
CaV1.3 α1 
subunit   
S100β and 
CaV1.3 
antibodies 
Alexa Fluor 488 
Alexa Fluor 555 
No significant positive 
staining has been found for 
CaV1.3  
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pituicytes and      
CaV2.3 α1 
subunit   
 
S100β and 
CaV2.3 
antibodies 
Alexa Fluor 488 
Alexa Fluor 555 
>90% (Clear colocalization 
has been found between α 1E 
and pituicytes) 
pituicytes and      
CaV3.1 α1 
subunit   
 
S100β and 
CaV3.1 
antibodies 
Alexa Fluor 488 
Alexa Fluor 555 
<10% (Not colocalized) 
 
 
Table 4-4 Immunohistochemistry in the neurohypophysis 
Double staining of VGCC α1 subunits and pituicytes by goat polyclonal α1 
subunit antibodies (Santa Cruz Biotechnology) and S100β. 
 
Target  Marker Fluorescence Colocalization 
pituicytes and 
CaV2.1 
S100β and 
CaV2.1 antibodies  
(Santa Cruz) 
Alexa Fluor 488 
Alexa Fluor 555 
<10% 
pituicytes and      
CaV2.2 
S100β and 
CaV2.2 antibodies  
(Santa Cruz) 
Alexa Fluor 488 
Alexa Fluor 555 
>90% (CaV2.2 
subunits is 
colocalized with 
pituicytes 
pituicytes  
and      
CaV1.3 
S100β and  
CaV1.3 antibodies  
(Santa Cruz) 
Alexa Fluor 488 
Alexa Fluor 555 
<10% (no 
immunofluorescence) 
pituicytes and      
CaV2.3 
 
S100β and  
CaV2.3 antibodies 
(Santa Cruz) 
Alexa Fluor 488 
Alexa Fluor 555 
>90% (α 1E subunit 
is colocalized with 
pituicytes)   
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4.1.2 The CaV1.2 channels can be selectively up-regulated in the pituicytes after 
dehydration. 
 
Glia-neuron interactions in the hypothalamo-neurohypophsial system play an 
important role during dehydration. The interactions constitute a physiologically 
controlled system that intervenes in the regulation of several vital neuroendocrine 
processes such as hormone release during dehydration or lactation (Burbach et al 2001; 
Theodosis et al 2008). The regulation of L-type Ca2+ channels are involved in 
adaptation of both neurons and astrocytes (Deisseroth et al 2003; Westenbroek et al 
1998a), I therefore tested whether L-type Ca2+ channel expression changes in the NH 
during dehydration. Neurohypophysial slices from rats that had been deprived of 
water for 24 hours were compared with those obtained from normally hydrated rats. 
There was a significantly increase in the immunoreactivity to CaV1.2 on the pituicytes 
of dehydrated rats comparing to that of control rats, indicating a specific up-regulation 
of CaV1.2 L-type Ca2+ channels. Figure 4.4A-C show immunostaining of CaV1.2 
channels in the NH of normal rats, and the CaV1.2 fluorescence was along the 
periphery of the pituicytes. Figure 4.4D-F show the results of staining in 
representative slices obtained from dehydrated rats. The CaV1.2 expression was found 
relatively low on pituicytes from control rats as indicated by the staining of S100β 
(see overlaid images in Figure 4.4G-I), whereas the CaV1.2 expression on the S100β 
positive components was increased in the NH of the dehydrated rats (Figure 4.4 J-L). 
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Quantification of the staining in the slices is shown in the bar graph in Figure 4.5. 
There was a significant increase in the mean immunofluorescence for CaV1.2 in the 
pituicytes from water deprived rats (>50% increase when the immunofluorescence 
was normalized, 12.17 ±1.79 normal vs 16.8 ± 1.2 dehydrated, n=15). Negative 
control experiments were performed using a pre-absorption approach (primary 
antibodies were pre-incubated with specific antigens provided by manufacturer; 
Figure 4.6D and 4.6H) and using omission of antibodies (Figure 4.6C and 4.6G). 
There was no significant immunostaining found in the negative control slices. Figure 
4.6A, B, E, and F show the location of pituicytes on the same slices with Figure 4.6C, 
D, G, and H, respectively.  
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Figure 4.4 Increased expression of CaV1.2 in the pituicytes after 24h dehydration. 
A-C) Representative images show immunofluorescence of CaV1.2 in slices of the 
normal rats; D-F) Representative images show immunofluorescence of CaV1.2 in 
slices of the dehydrated rats; G-I) Representative overlaid images show double 
staining of CaV1.2 and S100β in the slices from normal rats; J-L) Representative 
overlaid images show double staining of CaV1.2 and S100β in the slices from 
dehydrated rats. Scale bar =40 μm. 
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Figure 4.5 Quantitative measurement of immunofluorescence of the CaV1.2 
channels in the pituicytes of control and dehydrated rats. 
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Figure 4.6 Negative control of immunostaining of the CaV1.2 antibody. A) and B) 
Representative FITC images of S100β immunostaining in the slices from normal rats. 
C) Representative CY3 image of control 1 showing immunostaining in the slices from 
normal rats without adding primary anti-CaV1.2 antibody. D) Representative CY3 
image of control 2 showing immunostaining in the slices from normal rats with the 
pre-absorption approach. E) and F) Representative FITC images of S100β 
immunostaining in the slices from dehydrated rats. G) Representative CY3 image of 
control 1 showing immunostaining in the slices from dehydrated rats without adding 
primary anti-CaV1.2 antibody. H) Representative CY3 image of control 2 showing 
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immunostaining in the slices from dehydrated rats with the pre-absorption approach. 
Scale bar =40μm. 
 
I also compared immunofluorescence of several different subtypes of Ca2+ channels 
on pituicytes from both normal and dehydrated rats including CaV1.3, CaV2.2 and 
CaV2.3 using the similar methods, and I found that there was no significant increase of 
CaV1.3 channels during dehydration (Figure 4.7 and Figure 4.8). For CaV2.3 channels, 
although the basal expression level of channels was very strong (Figure 4.3), there 
were no significant changes that could be observed during dehydration (Figure 4.9 and 
Figure 4.10 42.12 ±1.68 normal vs 47.72 ± 5.18 dehydrated, n=15). The expression of 
CaV2.2 channels, which had strong basal expression in the pituicytes of normal rats, 
was unchanged after 24 hours dehydration (Figure 4.11 and 4.12, 100 ± 12.43 vs 
97.83 ± 11.43, n=15). 
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Figure 4.7 Expression level of the CaV1.3 channels in the pituicytes was 
unchanged during dehydration in comparison with normal condition. A-C) 
Representative images show immunofluorescence of CaV1.3 in slices of the normal 
rats. D-F) Representative images show immunofluorescence of CaV1.3 in slices of the 
dehydrated rats. G-I) Representative overlaid images show double staining of CaV1.3 
and S100β in the slices from normal rats. J-L) representative overlaid images show 
double staining of CaV1.3 and S100β in the slices from dehydrated rats. Scale bar =40 
μm. 
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Figure 4.8 Normalized immunofluorescence of CaV1.3 channels in the pituicytes 
of control and dehydrated rats. 
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Figure 4.9 Expression level of CaV2.3 in the pituicytes was unchanged during 
dehydration in comparison with normal condition. A-C) Representative images 
show immunofluorescence of CaV2.3 in slices of the normal rats. D-F) Representative 
images show immunofluorescence of CaV2.3 in slices of the dehydrated rats. G-I) 
Representative overlaid images show double staining of CaV2.3 and S100β in the 
slices from normal rats. J-L) Representative overlaid images show double staining of 
CaV2.3 and S100β in the slices from dehydrated rats. Scale bar =40 μm. 
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Figure 4.10 Normalized immunofluorescence of the CaV2.3 channels in the 
pituicytes of control and dehydrated rats. 
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Figure 4.11 Expression levels of the CaV2.2 channels in the pituicytes was not 
changed during dehydration in comparison with normal condition. A-C) 
Representative images show immunofluorescence of CaV2.2 in slices of the normal 
rats; D-F) Representative images show immunofluorescence of CaV2.2 in slices of the 
dehydrated rats; G-I) Representative overlaid images show double staining of CaV2.2 
and S100β in the slices from normal rats; J-L) Representative overlaid images show 
double staining of CaV2.2 and S100β in the slices from dehydrated rats. Scale bar =40 
μm. 
 
       
Figure 4.12 Quantitative measurement of immunofluorescence of the CaV2.2 
channels in the pituicytes of control and dehydrated rats. 
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4.1.3 Multiple subtypes of VGCCs expressed on cultured pituicytes. 
 
It has been reported that in primary cultured cortical astrocytes, multiple VGCCs are 
expressed including CaV1.2, CaV1.3, CaV2.2, CaV2.3, and CaV3.1 (Latour et al 2003). I 
therefore tested whether there are more subtypes of VGCCs expressed in primary 
cultures of pituicytes. The pituicytes can be made to grow and expand from 
neurohypophysial explant using glial favoured cell culture medium, and after 14 
days, >95% of total cellular population is S100β positive cells (i.e. pituicytes). I have 
tested and counted cell numbers after performing immunocytochemistry to identify 
the percentage of pituicytes in the primary culture .The purity of our cultures was also 
tested by using RT-PCR for the neuronal marker SNAP25. The purity of the cultures 
was assured when the PCR results of SNAP25 was negative, which meant the 
neuronal inputs or MNC terminals were elminated after culturing. I then performed 
immunocytochemistry and Western blot analysis on the cultures to test the expression 
of VGCCs. I confirmed expression of these types of Ca2+ channels by Western-blot 
using homogenates of whole brain and pituicyte cultures. Whole brain membrane 
protein extracts were used as positive controls, and in some cases, cultured cortical 
astrocytes were used as specific positive controls. Generally, in the protein 
homogenates multiple VGCCs can be detected using Western-blot as we can see in 
Figures 4.13-4.18. Namely, CaV1.2 (Figure 4.13A), CaV2.1 (Figure 4.13C), CaV2.2 
(Figure 4.13D), CaV2.3 (Figure 4.13E), and CaV3.1 (Figure 4.13F), but not CaV1.3 
  
101 
(Figure 4.13B). Normally, in the whole brain, more than three bands can be detected 
in each independent immunoblot of Ca2+ channels except for CaV2.2 (Figure 4.1D), 
which may indicate differences in mRNA splicing or post-translational modification. 
The band for each subtype of VGCCs in the whole brain was determined by 
comparing to the standard molecular weight provided from the antibody manufacturer. 
Most detectable VGCC proteins labeled by specific antibodies were similar in size 
with the corresponding bands detected from the whole brain except for CaV2.3, which 
were slightly larger. A larger size for CaV2.3 was also noted in cultures of 
hippocampal astrocytes (Latour et al 2003). The expression of VGCCs was confirmed 
by immunocytochemistry which showed immunoreactivity of S100β positive 
pituicytes in culture to antibodies directed against the types of Ca2+ channels 
mentioned above (Figure 4.14A-F).  
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Figure 4.13 Western-blot of VGCC expression in cultured pituicytes. Whole brain 
cortical astrocytes preparation was used as control in some cases. A) CaV1.2 channles 
are detected using anti-CaV1.2α1 subunit antibody in the protein homogenates 
extracted from cultured pituicytes (~ 204 KDa), the same band is shown in the whole 
brain preparation. B) CaV1.3 channels are not expressed in cultured pituicytes. No 
band was detected at the position representing CaV1.3α1 subunit in cultured pituicytes, 
whereas a band (black arrow) with molecular weight ~ 204 kDa was detected using 
anti-CaV1.3α1 subunit antibody in the cultured cortical astrocytes and the whole brain. 
C) CaV2.1 channels are expressed in cultured pituicytes. A band (black arrow) with 
molecular weight ~ 175 kDa was detected which is at the same position which 
demonstrated the expression of CaV2.1 channels in the whole brain. D) CaV2.2 
channels are expressed in cultured pituicytes. A band (black arrow) with molecular 
weight ~ 204 kDa was detected using anti-CaV2.2 α1 subunit antibody in cultured 
pituicytes which is at the same position with the CaV2.2 channels in the SON and 
whole brain. E) CaV2.3 channels are expressed in cultured pituicytes. High level of 
CaV2.3 expression was observed and a band lower than 204 kDa (black arrow) 
showed the presence of one isoform of CaV2.3 α1 subunits in the pituicytes. Multiple 
bands were detected in the whole brain which may suggest a diverse expression of 
isoforms of CaV2.3 in the rat brain. F) CaV3.1 channels are expressed in cultured 
pituicytes. Similar bands were detected at the same position in the cultured cortical 
astrocytes and the whole brain. 
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Figure 4.14 Expression of multiple VGCCs in cultured pituicytes. Images show 
pituicytes double-labelled with antibodies directed against S100β and α1 subunits in 
immunocytochemistry. FITC images showing green colour were obtained using the 
pituicytes marker, S100β; CY3 images showing red colour were obtained using 
antibodies directed against α1 subunits of VGCCs; and overlaid images demonstrate 
the expression of VGCCs on pituicytes. A) CaV2.1; B) CaV2.2; C) CaV1.2; D) CaV1.3; 
E) CaV2.3; and F) CaV3.1. Scale bar = 20 μm. 
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Summary and brief discussion for Section 4.1  
 
The immunohistochemical evidence shows that the glial cells (pituicytes) in the 
neurohypophysis express at least two subtypes of VGCCs (CaV2.2 and CaV2.3) in 
tissue, and during dehydration, the expression level of CaV1.2 channels is selectively 
up-regulated. More subtypes of VGCCs expression could be detected when the 
pituicytes are cultured, including CaV1.2, CaV2.1 and CaV3.1 which suggests the 
expression of these channels is driven buy cultured condition. The 
immunocytochemical results showed that some of the VGCCs were expressed in the 
perinuclear regions of the cultured pituicytes, such as CaV1.2, CaV2.2, CaV2.3, and 
CaV3.1, which may demonstrate an upregulated protein synthesis for VGCCs in 
cultured pituicytes. It is however unknown whether these VGCCs are expressed on the 
plasma membranes or in the cytoskeletal networks of the pituicytes. The 
immunofluorescence of CaV2.2 and CaV2.3 channels showed clear staining on 
processes of the pituicytes. 
 
Under physiological condition, cortical astrocytes express an array of mRNA of 
VGCCs, including CaV1.2, CaV1.3, CaV2.2, CaV2.3, and CaV3.1 (Latour et al 2003), 
and only L-, N- and R- type currents could be detected electrophysiologically 
(D'Ascenzo et al 2004). In our results, pituicytes express substantial level of CaV2.2 
and CaV2.3 Ca2+ channels which may suggest the similarity of pituicytes with 
  
106 
astrocytes. The CaV2.2 channels interact with proteins in the core of SNARE complex; 
it is thus possible that the CaV2.2 channels in glial cells are involved with the process 
of docking vesicles filled with gliotransmitters at release site.  
 
In our results, only the expression of CaV1.2 channels was up-regulated, but not that 
of CaV1.3 channels, which is consistent with the earlier observation of L-type 
channels of the astrocytes in several brain injury models (Westenbroek 1998). It has 
been reported that acutely isolated astrocytes from hippocampus do not express L-type 
channels. The high [K+]-induced Ca2+ influx is not sensitive to L-type channel 
blockers (dihydropyridines, BAYK8644, or nifedipine) suggested that astrocytes 
might not express L-type channels in normal condition (Duffy & MacVicar 1994). 
However, L-type channels are needed when the demand of new protein synthesis is 
high, and to specifically activate CREB signal pathway (Ghosh and Greenberg 1995), 
or when the glial cells are under stress. Therefore, Ca2+ influx through voltage-gated 
Ca2+ channels may play a role in pituicytes function during periods of high hormone 
demand such as dehydration.  
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4.2 Targeting properties of the CaV2.1 and CaV2.2 channels in neuroendocrine 
cells 
 
The role of the synprint site in the II-III loop in CaV2 channel targeting is 
controversial. The CaV2.1 and CaV2.2 channels have physical associations with 
synaptic proteins that may be essential for fast neurotransmission and axonal targeting 
in neurons (Bezprozvanny et al 1995; Mochida et al 2003). Our objectives are to 
determine whether these variants are expressed in neuroendocrine cells, and to 
determine their targeting properties. 
 
4.2.1 RT-PCR results revealed the presence of CaV2.1 channel splice variants in 
rats 
 
Firstly, I dissected different brain areas and several peripheral tissues from 
Long-Evans rats (including whole brain, spinal cord, pons/medulla, midbrain, 
thalamus, amygdala, hypothalamus, hippocampus, cerebellum, cortex and adrenal 
gland). Total RNAs were extracted from tissues separately and further reversely 
transcribed into cDNA for PCR amplification. One of the housekeeping genes 
(typically constitutive genes that is required for the maintenance of basic cellular 
function, and are found in all cells, and their expression are kept at relatively constant 
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level), glyceraldehyde 3-phosphate dehydrogenase (GAPDH), was used to test the 
cDNA preparation.  
 
Secondly, several pairs of primers were designed to specifically amplify the II-III 
loop region of CaV2.1 (as shown Figure 1.8). Previously, Dr. Rajapaksha in our lab 
had performed wide range screening for splice variants of CaV2.1 gene within 
different regions including synprint site. He found it would be more effective if nested 
PCR was used to encompass the cDNA sequence coding for much of the CaV2.1 
subunit II-III loop. Nested RT-PCR is a two step PCR strategy by using multiple pairs 
of primers covering interested regions. It normally contains two or multiple PCR 
aiming at amplifying genes that have low copies of initial template(s). Having 
designed primers that should generate a PCR product with the size of about 797bp, he 
identified three bands of smaller size in multiple brain tissues (such as the whole brain, 
cortex, thalamus etc). These three bands were isolated and the DNA was sequenced. 
These sequences, which correspond to lengths of 330, 260, and 221 base pairs, were 
used to predict the amino acid sequences that would result from the deletions. 
Although the intermediate band would result in an mRNA containing a stop codon, 
and would thus be unlikely to be physiologically relevant, the smallest and largest 
bands would result in unchanged reading frames with expected deletions of 194 and 
155 amino acids.  
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I will refer to these two deletion mutants as CaV2.1Δ1 and CaV2.1Δ2. The predicted 
structures and sequences of the two variants are shown in Figure 4.15. The diagram in 
Figure 4.15A shows the structure of the CaV2.1Δ1 subunit. The II-III loop is the 
intracellular loop between domains II and III. The synprint site is shown by the thicker 
line and the sites of the deletions in the identified mutants are shown by the arrows. 
The sequence coded for by CaV2.1Δ1 would correspond to a deletion beginning at 
amino acid 754 and ending at amino acid 948 (Pro754-Arg948, 194 aa deletion), 
whereas CaV2.1Δ2 would predict a deletion between amino acids 793 and 948 
(Ser793-Arg948, 155 aa deletion). The amino acid sequences of the two deletion 
variants are compared to the sequence of the WT CaV2.1 in Figure 4.15B. The upper 
sequence is that of the full length protein with the synprint site underlined, the second 
sequence is that of Δ1, and the bottom sequence is that of Δ2. Neither variant was 
seen in tissues from peripheral tissues (such as spleen and adrenal gland). To analyze 
the relative abundance of these two isoforms of CaV2.1 channels in different brain 
tissues, I quantified the intensity of DNA bands for each isoform using GAPDH as 
internal control. Most of the brain regions express relatively high level of Δ1 isoform 
in comparison with that of Δ2 isoform. For example, in hypothalamus and cortex, the 
abundance of Δ1 is more than twice as much as that of Δ2 (Figure 4.16).  
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A. 
 
B 
 
FL QGGVQGGMVFSIYFIVLTLFGNYTLLNVFLAIAVDNLANAQELTKDEQEEEEAANQKL    741                           
Δ 1 QGGVQGGMVFSIYFIVLTLFGNYTLLNVFLAIAVDNLANAQELTKDEQEEEEAANQKL 
Δ 2 QGGVQGGMVFSIYFIVLTLFGNYTLLNVFLAIAVDNLANAQELTKDEQEEEEAANQKL 
                                                               
FL ALQKAKEVAEVSPLSAANMSIAVKEQQKNQKPAKSVWEQRTSEMRKQNLLASREALYG  799     
Δ 1 ALQKAKEVAEVSP-------------------------------------------------------------------------------------------- 
Δ 2 ALQKAKEVAEVSPLSAANMSIAVKEQQKNQKPAKSVWEQRTSEMRKQNLLAS------------ 
                         
FL DAAERWPTTYARPLRPDVKTHLDRPLVVDPQENRNNNTNKSRAPEALRQTARPRESAR    857     
Δ 1 -------------------------------------------------------------------------------------------------------------------- 
Δ 2 -------------------------------------------------------------------------------------------------------------------- 
                        
FL   DPDARRAWPSSPERAPGREGPYGRESEPQQREHAPPREHVPWDADPERAKAGDAPRRH  915     
Δ 1   -------------------------------------------------------------------------------------------------------------------- 
Δ 2   -------------------------------------------------------------------------------------------------------------------- 
                     
FL   THRPVAEGEPRRHRARRRPGDEPDDRPERRPRPRDATRPARAADGEGDDGERKRRHRH  973     
Δ 1   ------------------------------------------------------------------RDATRPARAADGEGDDGERKRRHRH 
Δ 2   ------------------------------------------------------------------RDATRPARAADGEGDDGERKRRHRH 
                     
FL   GPPAHDDRERRHRRRKESQGSGVPMSGPNLSTTRPIQQDLGRQDLPLAEDLDNMKNNK  1031     
Δ 1   GPPAHDDRERRHRRRKESQGSGVPMSGPNLSTTRPIQQDLGRQDLPLAEDLDNMKNNK 
Δ 2   GPPAHDDRERRHRRRKESQGSGVPMSGPNLSTTRPIQQDLGRQDLPLAEDLDNMKNNK 
                     
FL   LATGEPASPHDSLGHSGLPPSPAKIGNSTNPGPALATNPQNAASRRTPNNPGNPSNPG     1089     
Δ 1   LATGEPASPHDSLGHSGLPPSPAKIGNSTNPGPALATNPQNAASRRTPNNPGNPSNPG 
Δ 2   LATGEPASPHDSLGHSGLPPSPAKIGNSTNPGPALATNPQNAASRRTPNNPGNPSNPG 
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Figure 4.15 Amino acid sequences of the splice variants of CaV2.1 channels. The 
diagram in part A shows the structure of the CaV2.1Δ1 subunit. The synprint region of 
the II-III linker is shown in bold and the location of the amino acids that mark the 
barriers of the sequences deleted in the alternatively spliced variants are shown. Part B 
shows the sequences of the variants. The upper sequence is that of the full-length 
version of rat CaV2.1 with the synprint region underlined. The second and third 
sequences are those of CaV2.1 Δ1 and Δ2, respectively. Numbers on the right refer to 
the number of the amino acid at the end of row in the full length sequence of CaV2.1. 
 
 
 
 
Figure 4.16. Splice variants of CaV2.1 observed in RNA isolated from rat brains 
tissues. The graph below shows the relative expression of CaV2.1 Δ1 and Δ2 
(compared to that of GAPDH), in the indicated brain areas. The bars indicate the mean 
results obtained from the quantification of two sets of gels, those shown above and 
those from a similar experiment. The unit for relative expression is the ratio of the 
intensities representing DNA bands for isoform and GAPDH. 
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Thirdly, further tests were conducted to detect the presence of these splice variants 
in a variety of cells, especially neuroendocrine cells. I therefore probed for expression 
of the variants in PC12 cells. Previously, single cell RT-PCR experiments 
demonstrated that MNCs express CaV2.1, as well as CaV1.2, CaV1.3 and CaV2.2 
(Glasgow et al 1999), and currents mediated by CaV2.1 have been characterized in 
both MNC somata (Fisher & Bourque 1995b; Foehring & Armstrong 1996) and axon 
terminals (Fisher & Bourque 1995b). Studies of evoked secretion from isolated MNC 
terminals suggested that currents mediated by CaV2.1 are important in mediating VP 
release (Wang et al 1997). Dr. K. Rajapaksha and I used single cell PCR to look at the 
expression of the variants in acutely isolated MNCs and PC12 cells. The result of one 
such experiment is illustrated in Figure 4.17. The cDNA corresponding to CaV2.1 Δ1 
and Δ2 were observed in each of the three cells tested. These data demonstrate that 
individual MNCs can express splice variants of CaV2.1 lacking the synprint site. The 
splice variants were also detected in the PC12 cells where CaV2.1 Δ1 is the 
predominant form of channels.  
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Figure 4.17. A representative RT-PCR image demonstrating that the CaV2.1 
splice variants are found in isolated neuroendocrine cells. CaV2.1 Δ1 and Δ2 were 
detected in the isolated MNCs and PC12 cells. M. molecular marker, Lane 1 the splice 
variants in the whole brain; Lane 2. the splice variants in single MNCs; Lane 3, the 
splice variants in single PC12 cells.   
 
4.2.2 Immunohistochemical and immunocytochemical evidence showing the 
expression of the CaV2.1 splice variants. 
 
I used immunocytochemistry to test whether the splice variants are expressed as 
proteins. An antibody directed against a sequence in the II-III loop, which binds only 
to channels contain the full synprint site, is therefore referred to as the “selective 
antibody” (see the illustration in Figure 4.18A). An antibody directed against the 
C-terminus, which binds with any isoforms possessing the C-terminus of wild type 
CaV2.1 channels, is therefore referred to as the “inclusive antibody” (see the 
illustration in Figure 4.18B). Both the selective and inclusive antibodies were used to 
probe cultured neonatal hippocampal neurons, PC12 cells, and acutely isolated MNCs. 
I reasoned that immunoreactivity to the inclusive antibody, in the absence of 
immunoreactivity to the selective antibody, would suggest the presence of II-III loop 
deletion variants of CaV2.1, whereas overlapping immunoreactivity would suggest the 
presence of channels with or without the synprint site. 
 
Immunoreactivity to the two antibodies in hippocampal neurons is compared. The 
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two antibodies clearly stain both the somatic membrane and the axon terminals of 
hippocampal neurons, suggesting that CaV2.1 channels in both areas include the 
synprint site (Figure 4.19A-D). Our data do not, therefore, provide evidence for 
expression of CaV2.1 II-III loop deletion variants in hippocampal neurons. The 
patterns of staining for the two antibodies were clearly different, however, in PC12 
cells. Although there was robust membrane staining for the inclusive antibody, there 
was little or no staining observed on the membrane for the selective antibody (Figure 
4.19 E-H). This suggests that a variant lacking a portion of the II-III loop is the 
predominant form in PC12 cells. Similar results were obtained for isolated MNCs. I 
compared the staining of the two antibodies both in the MNC somata isolated from the 
hypothalamus and the large MNC axon terminals isolated from the neurohypophysis 
(Fisher & Bourque 1995b; Fisher et al 2000). The inclusive antibody showed clear 
staining in both locations, while the selective antibody showed little membrane 
staining (Figure 4.19 I-L). The lack of clear immunoreactivity on the MNC terminal 
membrane using the selective antibody is consistent with a previous report (Fisher et 
al 2000) and while punctuate staining near the plasma membrane of MNC somata has 
been observed in a tissue slice preparation, the authors of the report noted that they 
could not distinguish between membrane staining and staining of synaptic inputs onto 
the MNC somata (Joux et al 2001). Our data support the conclusion that the dominant 
form of CaV2.1 in both neuroendocrine cell types is not immunoreactive to the 
selective antibody and therefore may lack a portion of the II-III loop. Furthermore, 
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these data suggest that an intact II-III loop is not necessary for the targeting of CaV2.1 
to MNC axon terminals.  
A 
          
B 
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Figure 4.18. Working mechanism of the inclusive and selective antibodies 
directed against different parts of the CaV2.1 channels. A) The selective antibody 
is a rabbit polyclonal antibody directed against peptide residues 865-881 in rat CaV2.1 
II-III loop (Alomone Labs). It only binds with full-length CaV2.1 with intact synprint 
site. B) The inclusive antibody is a goat polyclonal antibody directed against the 
carboxy-terminus of human CaV2.1 (Santa Cruz). It binds with both the full-length 
and the splice variants of CaV2.1 channels. If the predominant form(s) of channels are 
splice variants, then this antibody could be used to label deleted forms of CaV2.1 
channels.  
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Figure 4.19 Immunofluorescence in three different cell types using two antibodies 
directed against different portions of the CaV2.1 α1 subunit. Images in the left 
column show results for an antibody (the selective antibody) that recognizes a 
sequence within the CaV2.1 synprint site. Images in the right column show 
immunoreactivity for an antibody (the inclusive antibody) that recognizes a sequence 
in the CaV2.1 carboxyl terminus. A-D) Results for cultured hippocampal neurons. 
Note that both antibodies clearly label the somatic membrane as well as the processes. 
E-G) Results for cultured PC12 cells. I-L) Results for acutely isolated MNCs. The 
insets show immunoreactivity for the two antibodies on MNC terminals isolated from 
the neurohypophysis. The colour images on the left are epifluorescence images, and 
the ones on the right are differential interference contrast (DIC) images. Note that for 
PC12 cells, MNC somata, and MNC terminals, the inclusive antibody displayed clear 
plasma membrane staining, while the selective antibody did not. The scale bar in each 
case represents 20 μm. 
 
4.2.2.1 Differential distribution of the CaV2.1 splice variants in OT-MNCs and  
      VP-MNCs. 
 
To test whether these synprint site deletion forms of CaV2.1 are also expressed in SON, 
I performed a series of immunohistochemistry using high resolution confocal 
microscopy. I was expecting to identify the location of immunostaining of different 
isoforms of channels at single cell level in situ. 
 
Firstly, I performed immunostaining with two MNC markers (neurophysin I and 
neurophysin II) and each of the CaV2.1 channel antibodies. The patterns of staining for 
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the selective and inclusive antibodies are very different in SON. Immunostaining of 
neurophysin I and II with the selective CaV2.1 antibody showed no colocalization of 
MNC somata and full-length CaV2.1 channels (Figure 4.20A-F). Immunostaining of 
the selective antibody showed a punctate pattern suggesting synaptic input staining 
(Figure 4.20A and 4.20D). The neuophysin I and II labeled all the OT and VP-MNCs 
(Figure 4.20 B and 4.20E). In addition, most of the dot-like staining is outside of 
somata of MNCs. In contrast, the inclusive antibody showed immunoreactivity that 
labeled at least some of the somata of the MNCs (Figure 4.20G and 4.20J). These 
results are consistent with the interpretation that full-length CaV2.1 channels are not 
the predominant form in MNCs. Interestingly, I noticed that the immunofluorescence 
of the inclusive antibody only colocalized with a portion of neurophysin I and II 
positive cells (Figure 4.20I and L), which suggested there might be a selectivity of 
distribution for splice variants on different subtypes of MNCs (Figure 4.20H and 
4.20K showing the somata of all the OT and VP-MNCs).  
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Figure 4.20 Expression patterns of different isoforms of CaV2.1 channels in the 
rat SON. Images (A) and (D, enlarged) reveal the distribution pattern of full-length 
CaV2.1 subunits (immunostained by CaV2.1 selective) are punctuate. (B) and (E, 
enlarged) show soma and projections of MNCs in SON using goat anti-neurophysin I 
and II antibodies. (C) and (F, enlarged) show that the full-length CaV2.1 α1 subunit 
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does not colocalize with MNCs. (G) and (J, enlarged) reveal the somatic distribution 
of splice variants of CaV2.1 subunits (immunostained by inclusive antibody) in MNCs. 
(H) and (K, enlarged) show soma and projections of MNCs in SON using rabbit 
anti-neurophysin I and II antibodies. (I) and (L, enlarged) reveal colocalization 
between variants of CaV2.1 subunits and soma of MNCs (original images are from 
20x confocal objective lens and the enlarged images are all 3x digitally zoomed). 
Scale bar = 40 μm. 
 
I then performed double staining with either only neurophysin I or neurophysin II 
with the inclusive CaV2.1 antibody to test whether splice variants are differentially 
expressed on OT and VP-MNCs. Double staining of neurophysin I and inclusive 
CaV2.1 antibody showed that neurophysin I positive cells were not colocalized with 
CaV2.1 channel positive cells (Figure 4.21C and 4.21F). Figure 4.21A and 4.21D 
show components that express CaV2.1 channels in the SON. Figure 4.21B and 4.21E 
show the locations of OT-MNCs in the SON. The lack of staining for inclusive CaV2.1 
antibody suggests that the OT-MNCs do not express any CaV2.1 channels that can be 
stained by the inclusive antibody. Figure 4.21 G and 4.22J show the location of 
components that express either splice variants or full-length CaV2.1 channels. Double 
staining of neurophysin II and the inclusive CaV2.1 antibody demonstrate that the 
neurophysin II positive cells are largely colocalized with CaV2.1 channels, suggesting 
the splice variants of CaV2.1 are mainly distributed on VP-MNCs (Figure 4.21I and 
4.21L).  
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Figure 4.21 Distribution of the splice variants of CaV2.1 channels in OT-MNCs 
and VP-MNCs. Images (A, D, G, and J) show distribution of the CaV2.1 splice 
variants in soma of MNCs; (B) and (E, enlarged) show neurophysin I expressed on 
oxytocin-releasing MNCs; (C) and (F, enlarged) reveal splice variants of CaV2.1 are 
not colocalized with OT-MNCs; (H) and (K) show neurophysin II expressed on 
  
123 
vasopressin-releasing MNCs; (I) and (L) demonstrate the colocalization between 
splice variants of CaV2.1 channels and vasopressin-releasing MNCs. Scale bar = 40 
μm. 
 
To test the distribution of full-length and splice variants of CaV2.1 channels on the 
nerve terminals of MNCs in hypothalamic slices, I performed colocalization analysis 
of the inclusive CaV2.1 antibody with neurophysin I and II to determine whether MNC 
terminals express CaV2.1 channels. The green spots shown in Figure 4.22A are all 
elements expressing CaV2.1 channels in the NH; the red spots shown in Figure 4.22B 
are all MNC terminals in the NH. Figure 4.22C is the overlaid image of Figure 4.22A 
and 4.22B, which shows that only a portion of MNC terminals are colocalized with 
the inclusive CaV2.1 antibody. The yellow regions show the MNC terminals that 
express CaV2.1 channels, and the red regions in the Figure 4.22C represent the MNC 
terminals that do not express CaV2.1 channels. Using double staining of the selective 
CaV2.1 antibody and neurophysin I and II, I found that the selective CaV2.1 antibody 
only labeled the non-MNC terminal components of the NH. Figure 4.22D shows the 
location of components labeled by the selective CaV2.1 antibody (red), which has the 
same punctate staining pattern as is seen in SON (Figure 4.20D). Figure 4.22E shows 
the all the MNC terminals (green). Figure 4.22F is the overlaid image of Figure 4.22D 
and Figure 4.22E. As the red spots are not colocalized with green spots, these data 
suggest that MNC terminals do not express full-length CaV2.1 channels. Double 
staining of the inclusive CaV2.1 antibody (Figure 4.22G) and neurophysin II (Figure 
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4.22H) shows the colocalization of these two components (Figure 4.22I), suggesting 
that VP-MNC-terminals express CaV2.1 channels, which is consistent with the 
previous observation that VP-MNC somata may express the splice variants of CaV2.1 
channels (Figure 4.21G-L). To further confirm the selective CaV2.1 antibody positive 
components in the NH are neuronal inputs, I used synaptic vesicle marker, 
synaptophysin, to test whether the red spots seen in Figure 4.22D are colocalized with 
synaptophysin. As we can see in Figure 4.22J-L, the immunoreactivity to the selective 
CaV2.1 antibody is colocalized with that of the synaptophysin antibody, suggesting 
these full-length CaV2.1 channels are located in the synaptic inputs (Figure 4.22L, the 
yellow regions show that most of the selective CaV2.1 antibody positive spots label 
the same components that are synaptophysin positive). Figure 4.22M-O demonstrate 
the locations of synaptophysin and MNC-terminals. The red regions are synaptic 
terminals with synaptic-like vesicles (Figure 4.22M), the green regions are MNC 
terminals (Figure 4.22N), and the yellow regions are probably due to the presence of a 
small portion of the synaptic-like vesicles in the MNC terminals. Figure 4.22O shows 
that most of the immunoreactivity to synaptophysin is located outside of the MNC 
terminals, which confirms the synaptophysin positive components are mostly synaptic 
inputs.  
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Figure 4.22 Localizations of the full-length and splice variants of CaV2.1 channels 
on MNC terminals. Slices from isolated rat pituitary glands were stained with 
inclusive CaV2.1 antibody and anti-neurophysin I and II. Image (A) All CaV2.1 
channels in the NH. (B) All the MNC terminals labeled by neurophysin I and II (C) 
Colocalization between CaV2.1 channels and the MNC terminals. (D) The selective 
CaV2.1 antibody positive components in the NH. (E) All the MNC terminals. (F) The 
full-length CaV2.1 channels are not colocalized with any MNC terminals. Pituitary 
slices were double stained with synaptophysin (synaptic marker) and the inclusive 
CaV2.1 antibody. (G) The inclusive antibody positive components in the NH. (H) The 
location of VP-MNC terminals. (I) Overlaid image showing the colocalization of the 
inclusive CaV2.1 antibody and the VP-MNC terminals. Double staining of the 
selective CaV2.1 antibody and synaptophysin were performed. (J) The selective 
CaV2.1 antibody positive components in the NH. (K) Locations of the synaptophysin 
positive components in the NH labeled with Alexa Fluor 488 (green). (L) 
Colocalization between the selective CaV2.1 and synaptophysin antibodies in the NH, 
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showing the selective CaV2.1 antibody labels synaptic inputs. (M) Synaptophysin 
positive components in the NH labeled with Alexa Fluor 555 (red). (N) MNC 
terminals labeled by neurophysins. (O) Synaptophysin is not mainly colocalized with 
MNC terminals. Scale bar = 40 μm.   
 
4.2.2.2 Expression of the CaV2.1 splice variants in the melanotropes of the IL    
 
The melanotropes in the intermediate lobe (IL) of the pituitary gland also showed 
evidence for expression of CaV2.1 splice variants that lack the synprint site. However, 
the neuroendocrine cells in the AH showed no similarity. Double staining of 
melanotrope marker, α-MSH, and the CaV2.1 inclusive antibody was performed using 
pituitary slices.The CaV2.1 inclusive antibody positive cells in the IL (Figure 4.23A 
and 4.23D) is colocalized with α-MSH positive cells in the IL (Figure 4.23B and 
4.23E), and in the same set of experiments, the selective CaV2.1 antibody showed no 
immunoreactivity to components within IL region (Figure 4.23G). These data suggest 
that the melanotropes may also express synprint site deletion splice variants of CaV2.1 
channels (Figure 4.23C and 4.23F). Because the α-MSH antibody is from the same 
species as the selective CaV2.1 antibody, and most of the cells in the IL region are 
melanotropes (Figure 4.23E), in the Figure 4.23H and 4.23K, I used nuclear marker 
Hoechst 33342 to show the location of melanotropes. As Figure 4.23I and 4.23L show, 
the overlaid images demonstrate that there is no immunostaining of the selective 
CaV2.1 antibody in the melanotropes. Using the synaptic marker, synapsin I, I showed 
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that in the IL there are few or no neuronal inputs (Figure 4.1). The positive staining of 
the selective CaV2.1 antibody in the IL (part of the NH Figure 4.23G) likely represents 
neuronal inputs expressing full-length CaV2.1 channels.  
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Figure 4.23 Localization of the splice variants of CaV2.1 channels on 
melanotropes in IL. Double staining of anti- α-MSH and inclusive CaV2.1 antibodies 
reveals the localization of splice variants of CaV2.1 channels in melanotropes. (A) 
demonstrates localization of splice variants of CaV2.1 channels in the IL of pituitary 
gland; (B) shows immunostaining of melanotropes in the IL; (C) colocalization 
between splice variants of CaV2.1 channels and melanotropes. (D, E and F) 
Representative region of interest showing enlarged images for image A, B and C, 
respectively. (G) Immunostaining of the selective CaV2.1 antibody in the IL and NH. 
(H) Nuclear staining of melanotropes in the IL. (I) Overlaid images of (G) and (H) 
showing that there is no positive staining of the selective CaV2.1 antibody in the IL. (J, 
K, and L) Enlarged image of (G), (H), and (I) in the IL area, respectively. Scale bar = 
40 μm. 
 
 
 
 
 
 
 
 
 
 
- 
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4.2.3 Expression of the CaV2.2 splice variants in the SON and NH  
 
Splice variants of the CaV2.2 (N-type) Ca2+ channel lacking portions of the II-III loop 
have not been identified in rat, and I therefore used the nested RT-PCR strategy 
described above (Rajapaksha et al 2008) to determine whether such variants are 
expressed in rat tissues. In addition, antibodies directed against the synprint site and 
the C-terminus of the CaV2.2 channel are commercially available, which enables us to 
employ the immunological strategy described above for the CaV2.1 channel variants to 
test for the expression of splice variants of CaV2.2 channels.  
 
As Figure 4.24A shows, the synprint site is a fragment covering 2319-2577bp 
(773-859 amino acid) of cDNA of the CaV2.2 channels (Rettig et al 1996; Sheng et al 
1994). I firstly ran PCR to confirm the validity of cDNA template by testing GAPDH, 
and all the cDNA samples used in the following experiments were housekeeping gene 
positive. Then, nested PCR was performed using primers DFc02 and DRc02. Two 
amplified fragments of 362 and 425 bp were detected and separated by gel 
electrophoresis (Figure 4.24B). The PCR products were isolated, purified, and 
sequenced. This 362 bp PCR product is the fragment of the wild type CaV2.2 channels 
within the synprint site, and the 425 bp fragment represents an isoform containing a 
21-amino acid cassette (e[18a+]) insertion in the synprint site between domains IIS6 
and IIIS1 (e[18a+]), which is consistent with the CaV2.2 channel isoforms expressed 
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in the monoaminergic neurons of the rat brain (Ghasemzadeh et al 1999). In our case, 
I tested different brain areas, and this splice variant is observed in the SON and 
pituitary gland (Figure 4.24B).  
 
Then, I used another pair of primers (DFc02-DRc03, 2072-2836) that were 
designed for amplifying the whole synprint site. Two bands of 765bp and 828 bp were 
detected, suggesting an isoform containing the entire synprint site might be the 
predominant form of the CaV2.2 channels present in the rat brain (Figure 4.24C). The 
full-length CaV2.2 channels were also detected in SON, pituitary glands and PC12 cell 
lines. Although it is still possible that other splice variants within II-III loop exist, for 
example, if the alternative splicing starts beyond the sequence of the II-III loop, then 
the primers I chose could not identify the deletion. I only focused on a very narrow 
segment that is closely related to the synprint site, and did not find any evidence for 
the II-III loop deletion vatiants of CaV2.2 channels.  
A. Illustration of RT-PCR primer locations for amplification of the synprint site of 
CaV2.2 channels.  
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B. PCR results for a fragment of the synprint site of CaV2.2 channel. 
        
C. PCR results for full sequence of synprint site of CaV2.2 channel. 
        
Figure 4.24 RT-PCR results of screening synprint site deletion isoform(s) of 
CaV2.2 channels. A) Illustration of primer design for amplifying regions contain 
synprint site within II-III loop of CaV2.2 channels. B) Representative PCR results for 
segment of synprint site of CaV2.2 channels) representative DNA gel image showing 
that PCR product of CaV2.2 channels contain full-length synprint site. Lane 1, whole 
brain; lane 2, pituitary gland; lane 3, PC12 cells; Lane 4, SON. 
  
  
133 
Further, I also performed immunocytochemistry using the selective and inclusive 
CaV2.2 antibodies to study channel expression at the protein level. Acutely isolated 
MNCs showed clear plasma membrane staining by both selective and inclusive 
antibodies of CaV2.2 channels. This is different from what we saw in CaV2.1 channels, 
suggesting the antibodies directed against different portion of the channels recognized 
an isoform that contains synprint site (Figure 4.25 A-D). I also did 
immunocytochemistry for hippocampal neurons, here as positive control because this 
model has been investigated intensively and reported that hippocampal neurons 
express CaV2.2 channels that contain the full-length synprint site. As we can see in 
Figure 4.25 E-H, two antibodies for CaV2.2 had same pattern of immunostaining on 
the plasma membrane of these cells. PC12 cells were used as a neuroendocrine cell 
model to test whether deletion variants of CaV2.2 channels are expressed. Not 
surprisingly, the similar pattern of staining observed in the Figure 4.25I-L further 
proved that the CaV2.2 channels in neuroendocrine cells contain full-length CaV2.2 
channels. 
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Figure 4.25 Localization of CaV2.2 channels in soma and nerve terminals of 
acutely isolated MNCs, and cultured hippocampal neurons and PC12 cell lines. 
Three sets of immunocytochemistry were done using both selective and inclusive 
CaV2.2 antibodies to test the localization of CaV2.2 channels in soma and terminals of 
isolated MNCs, hippocampal neurons and PC12 cells. (A) Plasma membrane 
distribution of CaV2.2 channels stained by inclusive CaV2.2 antibody in isolated 
MNCs (isolated nerve ending of MNCs from the NH were also stained with the same 
antibody, shown at the upper right corner) (B) DIC images showing an isolated MNC 
and one of the nerve endings. (C) Similar plasma membrane distribution CaV2.2 
channels stained by selective antibody. (D) DIC images of single MNC. (E) CaV2.2 
channels recognized by inclusive CaV2.2 antibody expressed on the plasma membrane 
of hippocampal neurons. (F) DIC images for hippocampal neurons labeled by the 
inclusive CaV2.2 antibody. (G) Membrane staining of the CaV2.2 selective antibody 
showed similar pattern as that of the inclusive antibody. H) DIC image for 
hippocampal neurons labeled by the selective antibody. (I) CaV2.2 channels stained in 
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PC12 cells by the inclusive antibody. (J) A DIC image of PC12 cells labeled in (I); (K) 
Similar membrane staining was observed in PC12 cells by the inclusive CaV2.2 
antibody. (L) A DIC image of PC12 cells labeled in (K); Scale bar =20 μm. 
 
Immunohistochemistry was also performed on rat brain and pituitary slices to test 
the expression of splice variants distribution of CaV2.2 channels in situ. 
Immunostaining of the inclusive CaV2.2 antibody and neurophysin I and II antibodies 
were perfomed using brain slices containing SON. Figure 4.26A and 4.26D show the 
locations of CaV2.2 channels labeled by the inclusive antibody, and Figure 4.26B and 
4.26E show the location of MNCs in the SON. I found that the inclusive CaV2.2 
antibody is colocalized with neurophysin I and II antibodies. Alternatively, I did 
another immunostaining using the selective CaV2.2 antibody and the neurophysin I 
and II antibodies. As the Figure 4.26G and 4.26J show, the selective antibody labels 
the cellular components within the SON. Figure 4.26H and 4.26K show the MNCs 
that are labeled by neurophysin I and II. I found that the immunostaining of selective 
CaV2.2 antibody is colocalized with those of neurophysin I and II antibodies, 
suggesting that the two types of MNCs express the same isoform of CaV2.2 channels. 
These data also supports the hypothesis that CaV2.2 channels on MNCs have the 
full-length synprint site. 
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Figure 4.26 Distribution of CaV2.2 channels in the SON. Immunostaining of 
inclusive CaV2.2 antibody and neurophysin I and II was performed using brain slices. 
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(A and D) CaV2.2 channels revealed by inclusive antibody have somatic staining and 
synaptic staining in the SON. (B and E) MNCs stained by neurophysin I and II in the 
SON. (C and F) coloalization of CaV2.2 channels and MNCs. Immunostaining of 
selective CaV2.2 antibody with neurophysin I and II was performed using brain slices. 
(G and J) Expression of CaV2.2 channels revealed by the selective antibody shows a 
similar pattern of immunofluorescence in the SON. (H and K) MNCs stained by 
neurophysin I and II. (I and J) colocalization between CaV2.2 channels and MNCs, 
and some CaV2.2 positive cells other than MNCs. Scale bar = 40 μm 
 
Finally, a comparison of immunofluorescence between the selective and inclusive 
CaV2.2 antibodies was conducted using pituitary slices containing the IL. As Figure 
4.27A and D show, the two antibodies both label the periphery of melanotropes 
residing in the IL. Figure 4.27B and 4.27E show the nuclear staining of IL slices. 
Selective and inclusive antibodies have similar patterns of immunostaining on the 
melanotropes (Figure 4.27C and 4.27F), which suggests that melanotropes express 
CaV2.2 channels with the synprint site. 
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Figure 4.27 α-MSH releasing melanotrophs in the IL of the pituitary express the 
full-length CaV2.2 channel. (A) CaV2.2 channels revealed by the inclusive antibody 
have somatic staining in the IL. (B) Nuclear staining of cells in the IL, which 
demonstrates the location of melanotropes. (C) An overlaid image from image (A) and 
(B), showing the melanotropes can be stained by the inclusive CaV2.2 antibody. (D) 
Expression of CaV2.2 channels revealed by the selective antibody shows a similar 
pattern of immunofluorescence in the IL. (E) Nuclear staining of melanotropes by 
Hoechst 33342. (F) Overlaid images of (D) and (E), showing that the selective CaV2.2 
antibody labels the same membrane structures of the melanotropes as the inclusive 
antibody does; Scale bar = 40 μm. 
 
 
In brief summary, the systemic screening of the synprint site could not find an 
evidence for the existence of deletion variants of CaV2.2 channels in MNCs and 
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melanotropes, as we have detected for CaV2.1 channels. These data suggests that the 
alternative splicing of the II-III loop that occurs in CaV2.1 may not occur in CaV2.2.  
 
4.2.4 Terminal targeting of the CaV2.2 channels in differentiated PC12 cells. 
 
To test possible targeting mechanism of CaV2.2 channels in neuroendocrine cells, I 
chose a molecular event that is important for forming the exocytotic machinery and 
terminal structure, and then try to interrupt or inhibit this process to see if the channel 
targeting or distribution could be altered. Adaptor modular proteins CASK and Mint1 
have been found to bind with CaV2.2 channels in vitro (Maximov et al 1999). I 
therefore aimed to test the role of CASK in CaV2.2 targeting in PC12 cells. Previously, 
Xiaoyu Xu in our lab tested the expression of CASK in primary cell culture of bovine 
chromaffin cells. Co-immunoprecipitation also proved the interaction between CASK 
and CaV2.2 using endogenous membrane protein extracts from chromaffin cells. I then 
used green fluorescent protein (GFP) tagged constructs encoding partial sequences of 
carboxy-terminus of CaV2.2, namely, GFP-NC3 to competitively interrupt this 
interaction. To develop a model that can make possible the observation of 
neuroendocrine terminal targeting using DNA transfection, I used differentiated PC12 
cell lines that can effectively express these constructs to test our hypothesis. As Figure 
4.28A and 4.28B show, I hypothesize that by blocking the interaction between CASK 
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and CaV2.2 channels, the targeting of channels to the growth cones of PC12 cells will 
be inhibited.  
 
 
A 
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 B 
 
Figure 4.28 Illustration of interaction between CASK and the CaV2.2 channel. A)  
CaV2.2 channels can be successfully targeted to the plasma membrane of PC12 
cells when CASK/Mint1 is bound with CaV2.2 channels. B) When the NC3 
peptide is overexpressed, the NC3 peptide binds with CASK/Mint1 and prevents 
the binding of CASK/Mint1 to the CaV2.2 channels, and prevents channel 
targeting to the plasma membrane.  
 
Previously, Xiaoyu Xu and I performed transfection of GFP-NC3 into 
undifferentiated bovine chromaffin cells (BCCs), the plasma membrane clustering of 
CaV2.2 channels was altered, and channels formed a dispersed pattern of distribution 
(some data have been shown in Xiaoyu Xu’s thesis). This data suggested the function 
of CASK as a protein to anchor CaV2.2 channels. However, the BCCs are difficult to 
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transfect with exogenous expression plasmids, they tend to not display long processes, 
and have relatively short lifespans in culture. PC12 cell lines have several advantages 
to improve those conditions for terminal targeting research. Figure 4.29A shows a 
GFP-NC3 expression PC12 cell, and CaV2.2 expression in the growth cones of this 
cell can be quantified (Figure 4.29B-D). Consistently, the distribution of CaV2.2 
channels was significantly decreased (>40% in comparison with controlled cells, 
p<0.01) in the growth cones of PC12 cells after transfection of GFP-NC3 (Figure 
4.29B). In contrast, transfection of the GFP plasmid without the NC3 coding segment 
did not change the CaV2.2 channel distribution (<10% decrease for the GFP-NC3 
positive group, and not statistically significant, p>0.05; Figure 4.29C).  
A 
                   
B 
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C 
           
D 
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Figure 4.29 GFP-NC3 inhibitory peptides significantly decreased the terminal 
targeting of CaV2.2 channels in differentiated PC12 cells. A) Representative 
images showing the immunofluorescence of CaV2.2 channels on the growth cones of 
GFP-NC3 positive and GFP-NC3 negative PC12 cells. B) CaV2.2 targeting in the 
neurite-like terminal was significantly decreased by expressing GFP-NC3 (black bar 
n=20 for NC3 negative control; grey bar n=27 for NC3 positive PC12 cells, >40% 
decrease p<0.01). C) GFP control plasmid has no effect on CaV2.2 targeting (black bar 
GFP negative control n=18; grey bar GFP positive PC12 cells n=12, p>0.05). D) 
GFP-NC3 does not affect granule biosynthesis in the terminals (black bar NC3 
negative n=15; grey bar n=12 NC3 positive PC12 cells, p>0.05). Scale bar = 20 μm. 
 
To test whether this decreased distribution of channel was due to the inhibited 
secretory vesicle biosynthesis, I used the synaptophysin antibodies to label the 
secretory vesicle (Takamori et al 2006). Neither plasma membrane nor terminals of 
growth cones showed significant changes of synaptophysin immunostaining in the 
GFP-NC3 positively transfected cells in comparison with control cells (Figure 4.29D). 
These results suggested that overall protein expression level of the granules was not 
changed by overexpressing blocking peptide, and the inhibitory effects of NC3 
peptide is selective to CaV2.2 channels. These results suggest CASK may not only 
anchor CaV2.2 channel at hormone releasing sites (Maximov et al 1999), but exert a 
regulatory role in sorting the channel into nerve terminals of neuroendocrine cells.  
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Summary and brief discussion for Section 4.2  
 
In this study, I tested the expression and distribution of CaV2.1 and CaV2.2 channels in 
neuroendocrine cellular models, and studied the alternative splicing of these channels 
within the II-III loop that have important roles in channel targeting and function.  
 
First, two splice variants that lack large portion of II-III loop of CaV2.1 channels 
have been detected by RT-PCR (CaV2.1-Δ1 and CaV2.1-Δ2 that have 155 and 194 
amino acid deletions, respectively) in different brain tissues of the rat. Single cell 
RT-PCR also detected the presence of these two splice variants in the MNCs. 
Immunocytochemistry was performed to study the distribution of channels in isolated 
MNCs. I found the splice variants expressed on the plasma membrane of the MNCs 
and PC12 cells, whereas the isolated hippocampal neurons appear to express only the 
wild type channels. The observation of nerve terminal distribution of the splice 
variants in MNCs suggested that the synprint site may not be necessary for the axonal 
targeting of CaV2.1 channels in these neuroendocrine cells.  
 
Second, I performed immunohistochemistry to test the tissue distribution of splice 
variants within the hypothalamus and neurohypophysis of rats. In the SON of 
hypothalamus, I found the immunostaining of CaV2.1 channels in the somata of 
MNCs showed cell-type specificity. The OT-MNCs express few or no CaV2.1 
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channels whereas VP-MNCs do express CaV2.1 channels. The immunostaining of the 
CaV2.1 inclusive antibody shows the splice variants of CaV2.1 lacking the synprint site 
may be expressed solely on the VP-MNCs.  
 
In the neurohypophysis, the immunostaining of wild type CaV2.1 channels was 
largely colocalized with the synaptic vesicle marker, synaptophysin, which suggested 
that the CaV2.1 channels may be predominantly expressed in synaptic terminals 
(Hatton 1988; Hussy 2002). Colocalization of OT and VP markers and inclusive 
antibody of CaV2.1 for splice variants suggested the main forms of CaV2.1 expressed 
on the nerve terminals of MNCs were the synprint site deleted form. The expression 
of the splice variants of CaV2.1 channels in melanotropes of the intermediate lobe was 
also detected, suggesting that this type of CaV2.1 alternative splicing may be present 
in other endocrine cells (Mansvelder et al 1996; Williams et al 1993).  
 
Third, I tested whether the synprint site deletion variants of CaV2.2 channels are 
expressed on MNCs using the same RT-PCR and immunohistochemical methods. 
RT-PCR results showed that all the detectable isoforms (CaV2.2 e[18a+] and CaV2.2 
e[Δ18a]) of CaV2.2 channels expressed full-length synprint site in the rat brain tissues. 
I also found that both the selective and inclusive antibodies for CaV2.2 channels had 
similar staining in the somata of MNCs and melanotropes, suggesting the deleted 
splice variants are not expressed in these neuroendocrine cells. These data also 
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suggest that alternative splicing of the synprint site in CaV2 channels is specific for 
only CaV2.1 channels in these neuroendocrine cells.  
 
Fourth, I studied targeting properties of full length Cav2.2 channels in an in vitro 
chromaffin cell model. I found that the terminal targeting of CaV2.2 channels are 
regulated by the interaction of CASK and the C-terminus of CaV2.2 channels.  
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5. GENERAL DISCUSSION 
5.1 VGCCs expressed in the glial cells of the neurohypophysis 
5.1.1 Ca2+ signaling in pituicytes and cortical astrocytes  
 
It is clear that the elevation of intracellular [Ca2+]i of glial cells is important for 
glial–neuronal interactions. Early studies showed that glutamate could trigger 
elevation of [Ca2+]i in cultured astrocytes, which could propagate through individual 
and even between glial cells (Cornell-Bell et al 1990). Further evidence demonstrated 
that the increased [Ca2+]i could evoke a [Ca2+]i rise in surrounding neurons (Attwell 
1994; Parpura et al 1994). These findings suggest a new model of functional synapse 
consisting of glial cells, presynaptic and postsynaptic neuronal elements (Hamilton & 
Attwell 2010; Perea et al 2009).  
 
Elevations of intracellular Ca2+ could result from release from intracellular stores or 
from influx through Ca2+ channels of the plasma membrane. It was thought that the 
Ca2+ release from intracellular stores was the only mechanism. Thapsigargin, which 
depletes the internal Ca2+ store of ER, potently reduces Ca2+ dependent glutamate 
release (Hua et al 2004). Diphenylboric acid 2-aminoethyl ester (2-APB), a 
cell-permeant IP3 receptor antagonist, greatly reduced exocytotic glutamate release 
from astrocytes, suggesting the importance of internal Ca2+ stores in gliotransmission 
(Hua et al 2004).  
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Elevation of the [Ca2+]i in pituicytes has been observed when pituicytes are 
stimulated by VP (Hatton et al 1992). Hatton and colleagues found that VP (10-20 nM) 
could cause a reliable [Ca2+]i oscillation in cultured pituicytes, whereas isotonic 
addition of K+ (25-50 mM) was not able to activate [Ca2+]i oscillations. Their results 
suggested that VP but not OT receptor activation in pituicytes can trigger an 
intracellular [Ca2+] release from intracellular Ca2+ stores. This phenomenon has been 
observed in other cell types that express V1 receptors such as hepatocytes and 
fibroblasts (Harootunian et al 1991; Kawanishi et al 1989). The sensitivity of VP 
concentrations for [Ca2+]i were quite different though (0.1 nM in hepatocytes and 50 
nM in fibroblasts, respectively). Although cultured pituicytes express V1 receptors, the 
expression of V1 receptors in pituicytes in vivo is controversial. It has been reported 
that [3H] VP binding in the NL is not specific (Freund-Mercier et al 1991; Tribollet et 
al 1988; Phillips et al 1990; van Leeuwen et al 1987), which may rule out a role for 
VP in triggering the [Ca2+]i oscillations in pituicytes in vivo.  
 
Some recent observations from astrocytes contradicted the notion that intracellular 
stores are the sole sources responsible for intracellular [Ca2+] increase. If the 
intracellular release of Ca2+ plays a major role in the process of gliotransmitter release, 
inhibiting the IP3 or RyR receptors should affect synaptic function. A recent study 
using IP3 receptor knockout mice, however, failed to see an impaired synaptic 
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plasticity of hippocampal neurons (Agulhon et al 2010). The researchers used IP3R2 
knockout mice to specifically inhibit Gq G-protein coupled receptor (GPCR) Ca2+ 
signaling of astrocytes (Fiacco et al 2007). MrgA1+ transgenic mice were also used, 
which express the MrgA1 gene only in astrocytes to enable an astrocytic-specific 
activation of Gq GPCR Ca2+ signals. Both activation and inactivation of intracellular 
Ca2+ signaling pathways showed no significant effects on synaptic function, thus 
challenging the role of Ca2+ elevation induced by IP3 receptors for gliotransmission 
(Kirchhoff 2010). Additionally, there is also a lack of evidence showing the 
functionality of RyR receptors mediating intracellular Ca2+ release in astrocytic 
activity in vivo (Beck et al 2004). These observations suggest that other channels such 
as VGCCs or transient receptor protential (TRP) channels may be responsible for 
Ca2+-dependent gliotransmission (Kirchhoff 2010). 
 
Some evidence suggests that elevations of the [Ca2+]i in glial cells can be mediated 
by VGCCs. MacVicar and colleagues found that a 3-4 fold increase of [Ca2+]i was 
evoked by extracellularly adding 50mM of K+ in cultured cortical astrocytes, and this 
increase could be blocked by a selective L-type Ca2+ channel blocker (MacVicar et al 
1991). Electrophysiological evidence of L-, N- and R-type Ca2+ currents has been 
recorded in cultured cortical astrocytes using whole-cell patch-clamp and single 
channel recording (D'Ascenzo et al 2004). In these experiments, the L-type Ca2+ 
channel blocker nifedipine (5 μM) reduced HVA Ba2+ current amplitude by 28%, the 
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N-type selective blocker ω-conotoxin-GVIA (3μM) produced a further 32% decrease 
and the R-type blocker SNX-482 (100 nM) contributed to 34% reduction (D'Ascenzo 
et al 2004). These results indicate that cultured cortical astrocytes may express 
VGCCs with properties resembling those in neurons.  
 
My data demonstrate that VGCCs are expressed in pituicytes in culture. Many 
subtypes of VGCCs were detected using immunocytochemistry, namely CaV2.1 
(P/Q-type), CaV2.2 (N-type), CaV1.2 (L-type), CaV2.3 (R-type) and CaV3.1 (T-type), 
but not CaV1.3 (L-type). Differential expression of the two types of L-type Ca2+ 
channels may reflect a functional difference between CaV1.2 and CaV1.3 channels. 
The expression of Ca2+ channel α1 subunits in cultured pituicytes was different than 
that seen in cultured cortical astrocytes (Latour et al 2003), which were reported to 
express CaV2.2, CaV1.2, CaV1.3, CaV2.3 and CaV3.1, but not CaV2.1.This difference 
may reflect a difference between glial cells obtained from neonatal and adult rats, or a 
difference between cortical astrocytes and pituicytes.  
 
My observation that pituicytes express the CaV2.2 and CaV2.3 Ca2+ channels in situ 
provide evidence of VGCC expression in glial cells in the pituitary gland (Wang et al 
2009). Immunoreactivity for CaV2.2 Ca2+ channels has been observed in astrocytes in 
the SON (Joux et al 2001). The CaV2.2 channels in astrocytes in the SON are 
predominantly located in astrocytic processes (Joux et al 2001). The immunostaining 
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of CaV2.2 channels in pituicytes show no preference for either the processes or somata 
(Figure 4.3B), whereas the CaV2.3 channels are mainly expressed in the somata of the 
pituicytes (Figure 4.3E). The relatively high expression level of CaV2.3 channels may 
represent the unique properties of pituicytes, for example, the CaV2.3 channels may be 
important to maintain a low basal release probability of gliotransmitters from glial 
cells. It is not known whether the CaV2.2 and CaV2.3 channels play a role in the 
osmotically-evoked morphological changes of pituicytes or whether they are involved 
in the osmotically regulated taurine release from pituicytes.  
 
5.1.2 L-type Ca2+ channels are up-regulated in the pituicytes during dehydration 
 
To test the hypothesis that the L-type Ca2+ channels are related to MNC functions, I 
measured the changes of expression levels of different VGCCs (including the CaV1.2 
and CaV1.3 channels) in pituicytes after dehydration. Our data showed that the 
expression of the CaV1.2 Ca2+ channels was selectively increased in the pituicytes in 
vivo after 24 hour dehydration in rats.  
  The CaV1.2 channel regulation could be important in initiating [Ca2+] oscillations 
in glial cells (Fiacco & McCarthy 2006). If Ca2+ influx is involved in the activation of 
exocytotic release from glia, increased L-type Ca2+ channels expression could 
contribute to the activation of the release of excitatory gliotransmitters or modulators 
such as glutamate (Montana et al 2006) and D-serine (Mothet et al 2005). There is 
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some other evidence supporting that L-type Ca2+ channels may contribute to astrocytic 
[Ca2+]i oscillation in vivo (Parri et al 2001). Parri and colleagues found nifedipine (1 
μM) causes a marked reduction in astrocytic activity in the thalamus and the [Ca2+]i 
oscillation was virtually abolished by the non-specific Ca2+ channel blocker, Co2+ (1 
mM). In addition, the Ca2+ oscillation could be abolished by removing extracellular 
Ca2+, or using thapsigargin (1 μM), to deplete the intracellular store, suggesting the 
underlying mechanism of Ca2+ oscillation observed in astrocytes in vivo involves 
[Ca2+]i release with a possible dependence on plasma membrane L-type Ca2+ channels 
(Parri & Crunelli 2003; Parri et al 2001). 
 
Increased L-type Ca2+ channel expression has been observed during various forms 
of neural damages, including ischemia (Westenbroek et al 1998a), hypoxia (Hirenallur 
et al 2008), or chronic stress (Zhao et al 2009). The L-type Ca2+ channel regulation 
may also be involved with adaptation of neuroendocrine system during dehydration. 
Previously, an increase in the density of L-type Ca2+ currents in the acutely isolated 
MNC somata of dehydrated rats has been observed in our lab using electrophysiology 
(Zhang et al 2007). Pituicytes undergo a remarkable structural and function 
reorganization during periods in which the need for VP or OT release is high (Hussy 
2002; Rosso & Mienville 2009). The increased expression of the CaV1.2 Ca2+ 
channels in pituicytes might be part of a broader functional adaptation that involves 
changes in the MNCs themselves (Hatton 1997; Theodosis & MacVicar 1996).  
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An increase in Ca2+ influx through CaV1.2 could have other functions such as gene 
transcription. In neurons, CaV1.2 has a privileged function in the activation of the 
CREB signal pathway that triggers gene transcription and translation (Deisseroth et al 
2003). The proliferation of pituicytes has been reported in adult rats after 72h of water 
deprivaton (Murugaiyan & Salm 1995), and it is possible that the activation of CaV1.2 
signaling could occur in pituicytes, leading to an increase in expression of specific 
proteins during dehydration.  
 
In conclusion, the data obtained in this study shows that pituicytes in situ express 
CaV2.2 and CaV2.3 Ca2+ channels and that there is an increase in the expression of 
CaV1.2 during water deprivation. These data suggest that Ca2+ influx through VGCCs 
plays a role in pituicyte function and in particular during periods of high hormone 
demand. The increase in CaV1.2 may be involved in the adaptation of the 
neurohypophysis to allow a sustained facilitation of hormone release. 
 
 
 
 
 
 
  
156 
5.2 Splice variants of the CaV2.1 channels lacking the synprint site are expressed     
   in neuroendocrine cells  
5.2.1 The regulation of the synprint site in fast neurotransmission and      
     hormone release 
 
The identification of the splice variants that lack large portion of the synprint site of 
the CaV2.1 channels may help us understand some aspects of Ca2+-dependent 
exocytosis in neuroendocrine cells.  
 
First, the proteins that interact with the synprint site, such as syntaxins, SNAP, and 
synaptotagmins, are important for the spatial arrangement of the exocytotic machinery 
and the dynamics of neurotransmitter release upon Ca2+ influx (Chapman 2002; Chen 
& Scheller 2001). In typical presynaptic terminals, VGCCs and releasable SVs are 
likely to be within tens of nanometers (Meinrenken et al 2002). In neuroendocrine 
cells, the distance between the LDCVs and VGCCs is estimated to be hundreds of 
nanometers. If the physical interaction between the CaV2.1 channels and synaptic 
proteins in the LDCVs is lacking, LDCVs may be located further from Ca2+ channels 
and thus may result in lower release probabilities of the LDCVs compare to the SVs in 
neurons (McNeil & Wu 2009). 
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  Second, the CaV2.1 channel properties of mediating Ca2+ will be altered due to the 
lack of binding with syntaxin and SNAP25. Syntaxin 1A (35KDa) binds with WT 
CaV2 channels via its C-terminus at the active zone of the nerve terminals (Bennett et 
al 1992; Leveque et al 1994; Sheng et al 1994). The WT CaV2 channels bind with 
syntaxin via the synprint site (which is between amino acid residues 722 and 1036 in 
CaV2.1; and amino acid residues 773 and 859 in CaV2.2). Syntaxin has functional 
impact on the gating properties of CaV2 channels. Co-expression of syntaxin 1A with 
the CaV2.2 channels in Xenopus oocytes sharply decreases the availability of these 
channels at a neuronal resting membrane potential near -75mV. For both the CaV2.2 
and the CaV2.1 WT isoforms, overexpressing syntaxin 1A leads to a shift of the 
voltage-dependence of inactivation by -20 mV (Bezprozvanny et al 1995; 
Bezprozvanny et al 2000). This increasing inactivation is due to the stabilization of 
inactivation rather than inhibiting the expression of channels, because it can be 
reversed by strong hyperpolarization (Bezprozvanny et al 1995). The syntaxin binding 
only affects the CaV2.1 and CaV2.2 channels without changing the gating of CaV1 
channels, and thus the syntaxin regulation of CaV2 channels is channel-specific and 
may be critical for precisely control of the fast neurotransmission at neuronal 
terminals (Bezprozvanny et al 1995; Wiser et al 1996). Co-expression of syntaxin did 
not shift the voltage-dependence of inactivation in either of the deletion isoforms of 
CaV2.1 channels we identified in the rat brain (Rajapaksha et al 2008), indicating a 
lack of syntaxin regulation in these two splice variants. These results may suggest that 
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the splice variants identified in my study may result in altered channel properties of 
CaV2.1.  
 
Lack of the SNAP25 binding site of these CaV2.1 splice variants may also give rise 
to the change of channel activities. SNAP25 has been shown to bind to a motif of 
CaV2.2 between residues 781 and 789 (LRASCEALY) (Yokoyama et al 1995) and a 
highly homologous motif of CaV2.1 at residues 790-798 (LLASREALY). 
Interestingly, Snutch and colleagues have previously identified one CaV2.1 isoform 
(called rbA, rat brain class A, which is the old name of CaV2.1 channels, Snutch et al 
1990; Starr et al 1991) that has a partial deletion of the synprint site. The rbA isoform 
could only bind with SNAP25 but not syntaxin in vitro by immunoprecipitation 
(Rettig et al 1996). In addition, the voltage-dependence of inactivation of the rbA 
isoform of CaV2.1 channels is shifted by SNAP25 but not by syntaxin (Zhong et al 
1999), which is consistent with the in vitro binding results showing only the 
interaction between SNAP25 and the rbA isoform (Rettig et al 1996). SNAP25 
binding causes a -10 mV negative shift in the voltage-dependence of inactivation of 
rbA, and it can be completely restored by co-expression of syntaxin, SNAP25 and 
synaptotagmin together (Zhong et al 1999). These data suggest a possible mechanism 
of this restoration of the negative shifted inactivation of CaV2.1 channels include other 
exocytotic components that interact directly with syntaxin (Bezprozvanny et al 1995; 
Zhong et al 1999).  
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Neither of the splice variants of the CaV2.1 channels found in this thesis, namely 
CaV2.1-Δ1 and Δ2, is the same with the rbA isoform. The synprint site is completely 
absent in CaV2.1-Δ1 and is severely truncated in CaV2.1-Δ2, making it unlikely that 
these variants interact with any of those synaptic proteins mentioned above in vivo. 
The electrophysiological properties of the splice variants were further investigated in 
Dr. Zamponi’s lab at the University of Calgary. Both splice variants of CaV2.1 
resulted in a positive shift in the voltage dependence of inactivation (Figure 5.1). 
Although the CaV2.1-Δ2 isoform resulted in currents that were similar in amplitude 
and biophysical properties to the full length channel, the CaV2.1-Δ1 variant yielded 
currents that were of much smaller amplitude, and displayed a much larger positive 
shift (~40 mV) compared with the ~6 mV positive shift in CaV2.1-Δ2 (Rajapaksha et 
al 2008). 
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A. 
 
 
B. 
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Figure 5.1 Steady-state inactivation curves obtained from the WT CaV2.1 
channels and the splice variants. A. The steady-state inactivation curve of the 
CaV2.1-Δ1, CaV2.1-Δ2 and WT CaV2.1. The curve of the CaV2.1-Δ1 isoform was 
shifted toward a more depolarized voltage, whereas the CaV2.1-Δ2 isoform showed 
steady-state inactivation properties that were similar to those observed with WT 
CaV2.1. B. The bar graph illustrates half inactivation potentials determined from fits to 
individual steady-state inactivation curves. Numbers in parentheses reflect numbers of 
experiments (Electrophysiological recording was performed by Dr. Zamponi’s lab at 
the Hotchkiss Brain Institute, University of Calgary; Reproduced with permission 
from Copyright Clearance Center). 
 
The lack of synprint site of these two splice variants may also be implicated in the 
spatial arrangement between CaV2.1 channels and syntaptotagmin proteins. 
Synaptotagmins bind with the synprint site of CaV2 channels directly (Leveque et al 
1994; Leveque et al 1992; Sheng et al 1997), and have been found to express 
abundantly on both SVs of neurons and LDCVs of neuroendocrine cells (Matthew et 
al 1981). Synaptotagmin binds with Ca2+ through its two functional C2 domains 
(Chapman 2002; Sudhof 2006).  
 
Neurons have both highly synchronous release (the fast form of neurotransmitter 
release that predominates in synapses during low-frequency action-potential firing, 
Schneggenburger and Neher 2005) and slower asynchronous release (a slower form of 
release that mediates synaptic transmission in some synapses during high-frequency 
action potential trains, Sun et al 2007). Neuroendocrine and endocrine cells, in 
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contrast, release hormone in a more asynchronous fashion. Different synaptotagmins 
may serve as Ca2+ sensors to trigger synchronous and asynchronous release 
(Gustavsson & Han 2009). Synaptotagmin-1 knockout mice showed a complete 
absence of synchronous neurotransmission (Geppert et al 1994; Maximov & Sudhof 
2005). Similar to the hormone release in neuroendocrine cells, the deletion of 
synaptotagmin-1 specifically abolished the fast burst of LDCVs exocytosis in 
chromaffin cells, which suggests that the synaptotagmin-1 may be important for 
switching the slowly releasable state to a readily releasable state of the exocytotic 
machinery (Voets et al 2001). 
 
Synchronous release is determined by proper positioning of the SVs (Forsythe et al 
1998; Wadel et al 2007). Wadel and colleagues found that during short depolarization 
the slowly releasing vesicles experience [Ca2+]i lower than 10 μM (at which level a 
normal fast release will be triggered during action potentials; Bollmann & Sakmann 
2005; Bollmann et al 2000), suggesting the time-limiting process of synchronous fast 
release is the recruitment of releasable vesicles to the VGCCs. Regulation of vesicle 
positioning was proposed as a mechanism underlying the decrease of release 
probability (Wu et al 1999), which is not due to a decreased sensitivity of the Ca2+ 
sensors, but by an increased distance between releasable vesicles and VGCCs (Wadel 
et al 2007).  
 
  
163 
In addition to the role of a Ca2+ sensor, synaptotagmin proteins may be also 
important for positioning the releasable vesicle pool near the VGCCs (Gustavsson & 
Han 2009). Young and Neher found that the mutation in synaptotagmin-2 at the calyx 
of Held causes an increase of synaptic delay and a slowing of the kinetics of 
synchronous release induced by depolarization (Young & Neher 2009) These data 
suggest that the mutant synaptotagmin-2 leads to defective vesicle positioning, and 
uncoupled primed vesicles with VGCCs (McNeil & Wu 2009; Young & Neher 2009). 
In this thesis work, the lack of synaptagmin binding site in the splice variants of the 
CaV2.1 channels may shift the hormone releasing pattern in neuroendocrine cells to a 
slower and more asynchronous pattern. If the physical link between vesicles and 
VGCCs is missing or blocked, it will result in a lower accessibility of vesicles to the 
Ca2+ entry site or a removal of predocked vesicles away from VGCCs, which would 
decrease the efficiency by shifting Ca2+ dependence to higher values for triggering a 
typical synchronous synaptic transmission. This has been proven by the synprint site 
blocking experiments of CaV2.2 channels (Mochida et al 1996; Rettig et al 1997). By 
injecting competing peptides into the presynaptic cells of both sympathetic ganglion 
neuron synapses and Xenopus embryonic neuromuscular junctions in culture where 
only the CaV2.2 channels are involved with acetylcholine release, the rapid, 
synchronous transmission is inhibited, while late, asynchronous excitatory 
postsynaptic potential and paired-pulse facilitation are increased, consistent with the 
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conclusion that the vesicles are shifted from a pool primed for synchronous release to 
a pool that is not optimally positioned for synchronous release (Catterall 1999).  
 
Using a similar competing synprint site peptide that disrupts the interaction between 
synaptic proteins and CaV2.1 channels, Rettig and colleaugues observed a 25% 
reduction in synaptic transmission which corresponds to uncoupling of about 70% of 
the predocked vesicles from Ca2+ channels (Rettig et al 1997). This study suggests that 
the synprint site interaction may not be necessary for normal synaptic transmission but 
rather serves as a regulatory mechanism to shift the Ca2+-dependence to relatively 
higher values.  
 
Interestingly, the lack of synprint site regulation has been reported in the neuronal 
systems of different species. The splice variants of CaV2.2 channels lacking large 
portion of synprint site are distributed all over the human brain, including thalamus 
and cerebellum (Kaneko et al 2002). In addition, Kaneko and colleagues found the 
deletion isoforms of CaV2.2 channels showed relatively higher level of expression in 
the fetal brain than that in the adult brain (Kaneko et al 2002), suggesting the 
expression of the splice variants may change during development (Gray et al 2007). 
Other members of the CaV2 channel family such as CaV2.3 channels have been found 
to lack the synprint site as well. They are located in presynaptic nerve terminals but do 
not express the synprint site (Kamp et al 2005). In some inverbrate species, such as 
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Lymnaea stagnalis, CaV2 channels lack the synprint site yet still keep proper 
presynaptic neurotransmission (Spafford et al 2003). The synprint site deletion 
isoforms of the CaV2.1 variants we found in this thesis are not only distributed in the 
hypothalamus, but also other brain tissues such as cortex and thalamus, suggesting 
that the variants are widely distributed. Although our immunohistochemical data 
suggest that the dominant form of CaV2.1 in the MNCs lacks the synprint site, our 
approach could not differentiate the proportion of either of the splice variants at the 
MNC terminals. I therefore do not know which isoform is the predominant form of the 
CaV2.1 channels in MNCs. The exact physiological function of these splice variants is 
still not clear, but the positive shifted voltage-dependence of inactivation of channels 
suggest that the isoforms of P/Q-type channel observed in the MNCs may support 
more sustained Ca2+ entry during trains of action potentials arriving to the MNC 
terminals. 
 
5.2.2 Targeting properties of the CaV2.1 channels and splice variants 
 
The role of the synprint site in synaptic targeting is not clear. By creating 
recombinantly expressed CaV2.1 channels in which the synprint site was artificially 
deleted, Mochida and colleagues found the channel targeting to the nerve terminals of 
the superior cervical ganglion neurons (SCGNs) was significantly inhibited (Mochida 
et al 2003). The WT CaV2.1 channels were efficiently distributed in the terminal 
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structures, whereas the CaV2.1 deleted mutants (793–878) were less efficiently 
localized and another deleted mutant (864–934) could hardly be detected in nerve 
terminals of SCGNs (Mochida et al 2003). In contrast, similar splice variants of 
CaV2.2 channels that lack large portions of the synprint site (Kaneko et al 2002) can 
be properly targeted into the axons of hippocampal neurons (Szabo et al 2006). Szabo 
and colleagues found two distinct targeting features shown for the WT CaV2.2 
channels: axonal targeting and presynaptic clustering in the transfected hippocampal 
neurons. The axonal targeting of the splice variants of the CaV2.2 channels was not 
changed compared to the WT CaV2.2 channels, but their presynaptic clustering was 
significantly decreased. These data suggest that the protein-protein interactions at the 
synprint site of the CaV2.2 channels are neither necessary nor sufficient for axonal 
targeting (Szabo et al 2006), and also suggest that other mechanism(s) may be 
involved in the axonal targeting of CaV2.2. However, the inhibition of presynaptic 
clustering of the splice variants may still suggest a role of the synprint site in the 
incorporation of presynaptic CaV2.2 channels into the active zones of hippocampal 
neurons (Szabo et al 2006).   
 
Our data demonstrate that the synprint site deletion isoforms of CaV2.1 channels 
were targeted to the plasma membranes of MNC somata and terminals, suggesting the 
synprint site interaction is not necessary for targeting of CaV2.1 to the plasma 
membrane of MNCs (Rajapaksha et al 2008). The precise subcellular distributions of 
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CaV2.1 Δ1 and CaV2.1 Δ2 are still unknown in MNCs, but our data suggest that the 
targeting of CaV2.1 channels may be determined by mechanism(s) other than the 
synaptic protein interactions observed in some neurons. 
 
One possibility is that the channel targeting of the splice variants is determined by 
the interaction between the C-terminus of CaV2.1 channels and the modular adaptor 
proteins CASK and Mint1 (Maximov et al 1999). Our previous data have shown the 
expression of mRNA and protein of CASK in chromaffin cells. Interactions between 
CASK and CaV2.1 and CaV2.2 channels have been detected by 
co-immunoprecipitation (Xiaoyu Xu’s thesis). Experiments in cultured hippocampal 
neurons demonstrated that this interaction is necessary and sufficient for axonal 
targeting of CaV2.2 in hippocampal neurons (Maximov & Bezprozvanny 2002; 
Maximov et al 1999). When expressed, GFP-Mint1 and GFP-CASK clustered at 
synapses and colocalized in presynaptic locations with recombinant CaV2.2 channels. 
In contrast, the C-terminal GFP-NC3 construct disrupts the synaptic clustering of the 
recombinant CaV2.2 channels by blocking the interaction between CASK and Ca2+ 
channels (Maximov & Bezprozvanny 2002; Maximov et al 1999). Using RNA 
interference knockdown, Spafford and colleagues found that when the expression of 
CASK homolog (LCASK) is knocked down in the neurons of sea snail Lymnaea 
stagnalis, the presynaptic transmission of LCaV2 channels (which are homologs to 
CaV2.1 and CaV2.2, but lack the syprint site) was significantly decreased (Spafford et 
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al 2003). These data suggest that the inhibition of CASK to the C-terminus of CaV2 
channels is important for synaptic targeting.  
 
My results demonstrate that the CASK can regulate the CaV2.2 channel targeting to 
the plasma membrane in neuroendocrine cells. Co-expression of the blocking peptide 
GFP-NC3 results in a significantly decreased terminal distribution of CaV2.2 channels 
in differentiated PC12 cells. The clustering of CaV2.2 channels on the plasma 
membrane of undifferentiated bovine chromaffin cells was abolished as well (Xiaoyu 
Xu’s thesis, data not shown here), indicating that CASK may be important for both 
axonal targeting and anchoring at the releasing site of neuroendocrine cells.  
 
However, recent evidence raises questions about the importance of CASK in both 
targeting and anchoring Ca2+ channels. Genetic studies showed that CASK knockout 
mice suffer premature death one day after birth, but surprisingly, Ca2+-dependent 
presynaptic neurotransmission in the knockout mice was generally unchanged in 
primarily isolated neurons, except a decrease in spontaneous release events of 
GABAergic neurons (Atasoy et al 2007). Using immunocytochemistry, Khanna and 
colleagues found that the long C-terminus isoform of CaV2.2 channels is not 
colocalized with CASK and Mint1 at the specialized presynatic interface of chicken 
ciliary ganglion calyx terminal (Khanna et al 2006). These data suggest that CASK is 
not necessary to form a functional synapse as an anchoring protein for Ca2+ channels. 
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Notably, expressing an isoform of the CaV2.1 channel lacking the CASK binding site 
in hippocampal neurons showed no significant difference in their subcellular 
distribution compared to that of the WT CaV2.1 channels, which suggests that the 
CASK is not essential in synaptic targeting of CaV2.1 channels (Hu et al 2005). We 
still do not know whether the CaV2.1 and CaV2.2 channels share a similar targeting 
mechanism in terms of CASK binding or whether there are other determinant(s) that 
determine their trafficking from ER to the presynaptic site. 
 
The interaction between the α1 and their β subunits may also contribute to the 
targeting of CaV2.1 splice variants in MNCs. Ca2+ channel targeting experiments in a 
polarized epithelial cell lines suggest that association with different β subunits can be 
an important determinant of axonal targeting for CaV2.1, but not CaV2.2 (Brice & 
Dolphin 1999). Using MDCK cells, which are considered to be a model of axonal 
dendritic targeting in neurons (the basolateral targeting of channels in MDCK is 
believed to be equivalent to the somatodendritic targeting of channels in neurons; 
while the apical targeting in MDCK is equivalent to the axonal targeting of neurons; 
Dotti et al 1991; Jareb & Banker 1998), Brice and Dolphin found the targeting of 
CaV2.1 into the apical membranes of MDCK when co-expressed with the β1 or β4 
subunits (Herlitze et al 2003), whereas the CaV2.1 channels can only be targeted into 
the basolateral membranes of MDCK when co-expressed with the β2 subunit (Brice & 
Dolphin 1999). In contrast, no any specific β subunit effect on channel targeting was 
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observed for CaV2.2.   
 
The preferential interaction between the β4 subunit and the CaV2.1 channel has 
been observed in hippocampal neurons (Mich & Horne 2008; Wittemann et al 2000). 
Wittermann and colleagues found GFP-β4 colocalized with CaV2.1 channels and 
synaptic protein VAMP 2, and GFP-β4 co-expression with CaV2.1 channels 
significantly increased the excitatory post-synaptic current amplitude and paired pulse 
facilitation ratio, suggesting the role of β4 subunit in enhancing the CaV2.1 channel 
allocation into the presynaptic terminals (Wittemann et al 2000). Mich and colleagues 
further identified that the trafficking of CaV2.1 channels is highly dependent on the 
concentration of β4 subunits in the Xenopus oocytes, and the gabapentin inhibition of 
channel targeting is particularly related to only one of the isoform of β4 subunit, β4a 
(Mich & Horne 2008). Moreover, the binding of β4 might be also specialized for 
CaV2.1 channel to adopt a slow mode of single channel activity, which may be 
functionally linked to slow hormone release (Luvisetto et al 2004; Walker & De 
Waard 1998). Co-expression of β4 with the CaV2.1 channel has been found to cause 
slower inactivation and decreased current decay compared with CaV2.1 channels 
co-expressed with β1b or β3 (Brody & Yue 2000; Stea et al 1994). Therefore, the future 
studies on the β subunit regulation of the channel targeting of the CaV2.1 splice variants 
identified in my work would be of interest. 
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5.2.3 CaV2.2 channels expressed in neuroendocrine cells contain the synprint site   
     and exon 18a 
 
The II-III loop of CaV2.2 channels regulates cumulative inactivation of channels in response 
to stimulus trains (Catterall 1999; Degtiar et al 2000; Thaler et al 2004). One of the distinct 
alternative splicing cassettes found in CaV2.2 and CaV2.3 channels is the inserted exon 18a, a 
21 amino acid insertion in CaV2.2 and a 19 amino acid insertion in CaV2.3 channels between 
the exons 18 and 19 within the II-III loop of channels (Ghasemzadeh et al 1999; Gray et al 
2007; Pan & Lipscombe 2000). The exon 18a is found evolutionarily conserved in CaV2.2 
and CaV2.3 channels (Figure 5.2).  
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Figure 5.2 Exon 18a alternative splicing within the II-III loop of CaV2.2 and 
CaV2.3 Ca2+ channels. A) Alternatively spliced cassette exons, e18a, are found within 
human CaV2.2 and CaV2.3 genes. Partial gene structures, spanning e17 through e20, of 
human CaV2.1, CaV2.2, and CaV2.3 are illustrated. Exons are illustrated as gray 
(constitutive exons) or blue (alternatively spliced exons, e18a of CaV2.2 and CaV2.3) 
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boxes, and introns are depicted as lines. Sequences for CaV2.1 (PubMed Accession 
#X99897), CaV2.2 (#M94172, #AF222338), and CaV2.3 (#L27745). B) Partial 
alignments of the deduced amino acid sequence of the exon 18a (blue highlighted) in 
CaV2.2 (top) and CaV2.3 (bottom) from different species (Permission from Copyright 
Clearance Center; (Gray et al 2007) 
 
Our results are consistent with the earlier observation that both wild type CaV2.2 
e[Δ18a] and the splice variant containing exon 18a of CaV2.2 channels, CaV2.2 
e[18a+], are expressed in the rat brain. The mRNAs of CaV2.2 e[18a+] are abundant in 
peripheral ganglia, spinal cord, and caudal regions of the brain, but less prevalent in 
the neocortex, cerebellum, and hippocampus (Ghasemzadeh et al 1999; Pan & 
Lipscombe 2000). I found clear DNA bands representing the 18a splice variant in the 
SON, which has not been reported previously. Our data also show relatively abundant 
expression of CaV2.2 e[18a+] in the pituitary gland, suggesting that the 
neuroendocrine cells in the pituitary gland might have prevalent expression of CaV2.2 
e[18a+]. Thaler and colleagues found that exon 18a insertion in CaV2.2 channels 
protected the channel from inactivation (Thaler et al 2004). The CaV2.2e [18a+] is less 
sensitive to close-state inactivation compared to CaV2.2 e[Δ18a], which is inactivated 
at voltages ≈10 mV more depolarized than CaV2.2 e[Δ18a]. Close-state inactivation is 
a mechanism thought to underlie cumulative inactivation of HVA Ca2+ channels when 
stimulated by trains of action potentials waveforms (Patil et al 1998). The presence of 
CaV2.2 e[18a+] in neuroendocrine cells may provide a protective mechanism for 
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CaV2.2 channels when the demand of hormone release is high in the neuroendocrine 
cells that fire bursts like MNCs.  
 
The antibodies I used for CaV2.2 channels were unable to distinguish the CaV2.2 
e[18a+] and CaV2.2 e[Δ18a] in MNCs, but the results suggested that all isoforms of 
CaV2.2 channels I detected contained the synprint site. There were no differences in 
the immunostaining between selective and inclusive antibodies in all cells tested, 
including hippocampal neurons, MNC, PC12 cells, and melanotropes.  
 
5.2.4 Functions of CaV2.1 and CaV2.2 channels in MNCs 
 
Our data in this thesis demonstrate the synprint site alternative splicing of CaV2.1 and 
CaV2.2 channel in neuroendocrine cells. This is of special interest because it may 
provide comparable information to understand Ca2+-dependent exocytosis during 
hormone release vs presynaptic neurotransmitter release.  
 
Whether the CaV2.1 and CaV2.2 channels function the same way in neuroendocrine 
cells as they do in neurons is an important question to answer. In isolated MNC 
somata, multiple HVA Ca2+ currents could be detected by electrophysiology including 
the P/Q-, N-, L-, and R-type currents (Fisher & Bourque 1995a; Foehring & 
Armstrong 1996). Electrically stimulated VP release from MNC terminals can be 
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blocked by N-type and P/Q-type Ca2+ channel blockers, and by L-type Ca2+ channel 
blockers under certain conditions (Fisher & Bourque 2001; Jorgensen et al 1994). 
Using electrically evoked hormone release measurements, Jorgensen et al., found that 
a selective L-type channel blocker decreased the vasopressin release only at lowest 
frequency they used experimentally (6.5 Hz), suggesting the L-type channels may be 
involved in MNC terminal release only at certain firing rate.  
 
A detailed comparison between the ω-Aga-IVA sensitive currents in terminals and 
somata of MNCs showed marked differences in inactivation kinetics and sensitivity to 
toxin (Fisher & Bourque 1995a). Although the current in the somata is 
non-inactivating and highly sensitive to ω-agatoxin IVA (IC50≈3 nM), the current in 
the terminals inactivates (τ≈450 ms) and is much less sensitive to toxin (IC50≈270 nM). 
These properties support the conclusion that the current in the somata is a P-type 
current (Foehring & Armstrong 1996), while that in the terminals is more similar to 
identified Q-type currents (Randall & Tsien 1995; Sather et al 1993).  
 
We now know that P- and Q- type Ca2+ channels are not two distinct subtype of 
VGCC in terms of molecular identities, but rather that their differences may originate 
from the alternative splicing of CaV2.1 channels. For example, in the cerebellar 
granule neurons, a single amino acid insertion, valine at V421 within I-II loop of 
CaV2.1 cDNA sequence, which falls into the regular mechanism of alternative splicing 
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(with 5’ donor and 3’ acceptor sites), is implicated in slowing dramatically the 
inactivation of P-type currents (Bourinet et al 1999; Jimenez et al 2000). The synprint 
site deletion isoforms of CaV2.1 found in this thesis may provide another explanation 
of the different electrophysiological properties found in soma and terminals of MNCs. 
The possibly different distribution between the CaV2.1-Δ1 and CaV2.1-Δ2 variants on 
somata vs terminals of the MNCs could result in different rates of voltage-dependent 
inactivation. 
 
Functional studies using peptide-specific radioimmunoassay to measure the effects 
of different VGCCs blockers on K+ induced VP and OT release revealed that the 
Q-type component found in MNC terminals was specifically associated with VP but 
not OT release (Wang et al 1997). Using the same model, Wang and colleagues found 
that OT release was specifically sensitive to block of the R-type currents (Wang et al 
1999), which explained the resistance of the OT release inhibition to block of Q-type 
Ca2+ channel. In this thesis, I found that the CaV2.1 channels are preferentially 
expressed in the VP-MNCs but not OT-MNCs, which explains why the CaV2.1 
channels have a role in regulating VP but not OT release. 
 
A difference in inactivation of N-type Ca2+ channels has also been reported between 
the somata and terminals of MNCs. In the somata the N-type currents are slowly or 
non-inactivating (Fisher & Bourque 1995b), while the currents in the terminals 
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inactivate rapidly (Lemos & Nowycky 1989). It is not known whether the CaV2.2 
e[18a+] variant, which is inactivated at voltages ≈10 mV more depolarized than the 
WT CaV2.2 channels (Thaler et al 2004), contributes to the different N-type currents 
displayed in MNC somata and terminals.  
 
In conclusion, although isoforms of alternative splicing in CaV2.1 channels that are 
involved with different binding properties with syntaxin and SNAP25 (Rettig et al 
1996) have been found in rat brain using immunoblot analysis (Sakurai et al 1995; 
Sakurai et al 1996), our observations represent the first identification of splice variants 
of rat CaV2.1 that lack large portions of the II-III loop (Jurkat-Rott & Lehmann-Horn 
2004; Lipscombe et al 2002). These variants appear to be analogous to two 
alternatively spliced variants that have deletions within the synprint site in human 
CaV2.2 (Kaneko et al 2002). Using a combination of molecular, imaging and 
electrophysiological methods, we identified that the deletion of the synprint site of 
CaV2.1 may have multiple consequences including altered coupling to the synaptic 
release machinery and altered channel function. The predominance of these deletion 
variants in neuroendocrine cells suggests that they may have a role in triggering 
non-synaptic exocytotic release. The shift to more depolarized steady-state 
inactivation of CaV2.1-Δ1 may suggest an enhanced Ca2+ influx during multiple action 
potential firing of MNCs to sustain hormone release. 
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5.3 Future direction 
 
1. Our findings provide clues to address other questions related to the functional 
significance of splice variants of CaV2.1 Ca2+ channels in hormone release. Further 
investigation on the role of the splice variants in different phases of exocytosis in the 
neuroendocrine cells is expected. One way to approach this study is to measure the 
membrane expression of channels in the neuroendocrine cells that are 
transfected with fluorescently tagged isoforms of the CaV2.1 channels. The 
targeting properties of the CaV2.1 splice variants could be further identified in 
neuroendocrine cells.  Capacitance measurements or amperometry could also 
be used to study the effect(s) of synprint site deleted CaV2.1 isoform on exocytosis 
compared to that of WT CaV2.1 isoform. 
 
2. The second direction will be further investigating the distributions of different β 
subunits or the distributions of small GTP-binding proteins (RGK family) that 
regulate β subunits to see if there is any specific combination of β and CaV2.1 α1 
subunits or combination of RGK proteins and α1 subunits that will be important for 
the distribution of splice variants in the neuroendocrine cells. Co-immunoprecipitation 
can be used to test which β subunit or which small GTP-binding protein is bound with 
the CaV2.1 splice variants in vitro. Immunohistochemistry can be used to study the 
colocalization of different β subunits and the CaV2.1 splice variants.  
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3. Our finding that the CaV1.2 channels are selectively up-regulated in rat pituicytes 
after dehydration could lead to a series of experiments testing the downstream 
pathway(s) involved in the alterations of pituicytes. These experiments can be 
conducted both in vivo and in vitro using the selective L-type Ca2+ blockers in 
dehydrated rats. It would also be interesting to test whether CaV1.2 channels are 
regulated during other physiological changes related to the MNC functions such as 
lactation. Further immunohistochemical experiments aiming to measure the CaV1.2 
expression in the MNC somata and their terminals would also help to understand this 
specific regulation of L-type Ca2+ signaling.  
 
4. The study of Ca2+-dependent mechanism of gliotransmission is still in the early 
stage. The hurdles apparently include the difficulties to define a releasing site for glial 
cells, regardless of their even more irregular morphologies under normal or stimulated 
conditions in comparison to presynaptic terminals. Finding out where glial Ca2+ comes 
from and how it supports gliotransmission is an important issue because it will 
provide more integrative information describing the dynamics between neurons and 
glial cells within the central nervous and neuroendocrine system. More sensitive 
imaging (e.g. two photon microscopy) that operates at submicrometer resolution 
would allow recording of Ca2+ signals from astrocyte processes just outside the 
synapse (Kirchhoff 2010; Svoboda & Yasuda 2006).  
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6. CONCLUSIONS 
 
This thesis work mainly describes the expression and targeting of VGCCs in the 
neuroendocrine system, especially the typical neurosecretory cells in the SON of 
hypothalamus and glial cells in the neurohypophysis.  
 
Our major findings are as follows: 
 
1. Pituicytes express CaV2.2 and CaV2.3 Ca2+ channels in the neurohypophysis that 
belong to HVA VGCCs. When the rats are dehydrated, the CaV1.2 Ca2+ channels are 
selectively up-regulated in the pituicytes.  
2. Two novel splice variants of rat CaV2.1 that lack large portion of synprint site 
within the II-III loop of channel have been identified. Such deletion variants appear to 
be expressed in different regions of the brain and two types of neuroendocrine cells, 
including somata and terminals of VP-MNCs. These data suggested that synprint site 
might not be indispensible for channel targeting in the MNCs. Both deletions in 
CaV2.1 resulted in a rightward shift in the voltage dependence of inactivation (more 
depolarized direction), suggesting these variants of CaV2.1 channels may play a role 
for the process of Ca2+-dependent exocytosis of neuroendocrine cells. Our data also 
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indicate that alternative splicing of synprint site of CaV2.1 channels may be a general 
mechanism of VGCC regulation in neuroendocrine cells.  
 
3. CaV2.2 channel distribution in the plasma membranes of MNCs and other type of 
neuroendocrine cells were tested, where all detectable CaV2.2 channels contain the 
synprint site. The targeting of channels was measured by transfection and 
immunocytochemistry. Our data suggested the interaction of CASK and the 
C-terminus of CaV2.2 channels are important for the distribution of channels on the 
nerve terminals of differentiated PC12 cells. This may suggest that the targeting signal 
of the CaV2.2 channels through the interaction of CASK protein is conservative 
between neuroendocrine cells and neurons.  
 
This research provides insights into alternative splicing of the CaV2.1 and CaV2.2 
channels in the neuroendocrine cells and their significance in terms of channel activity 
and targeting. It also sheds light on VGCC expression and regulation in glial cells in 
the neurohypophysis and contributes to our understanding of the physiology of Ca2+ 
signaling in both neuronal and neuroendocrine systems.  
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Appendix  
 
Preparation of plasmid DNA by alkaline lysis with SDS: maxipreparation 
 
Day1, streak DYT-antibiotic plate with bacteria and grow in incubator at 37°C. Day 2, 
take one colony and inoculate 5 ml of Terrific Broth (antibiotic +) at 37 °C, shake 250 
rpm about 4h. Day 3, take 5ml of bacterial solution into 300 ml of TB (add antibiotic) 
and grow at 37°C, shake 250rpm about 16 h. Split 300 ml culture into 2 bottles (250 
ml), and spin cells at 5000 g (4000 rpm) for 15 min at 4°C. Remove supernatant.and 
suspend pellet with 50 ml of ice-cold 1XSTE for each bottle. Centrifuge at 4000 rpm 
for 15 min at 4 °C. Resuspend pellet into 10ml of solution I, fully mixed with pipette. 
Add 20 ml of solution II, mix well by gently inverting the bottle 3-5 times to lyses the 
cell. Sticky genomic DNA should been seen. Add 20 ml of Solution III for each bottle 
and mix well by shaking 8-10 times, massive white denatured protein should been 
seen. Store the mixture on ice for 5 min, and centrifuge at 4000rpm for 15 min at 4°C. 
Filter supernatant through 4 layers of cheesecloth into new centrifuge bottle (250 ml). 
A light yellow clear solution of about 50ml is obtained. Add about 30 ml of 
isopropanol and mix well at room temperature. (Isopropanol: filtered solution = 0.6:1), 
put at RT for 30 min. Centrifuge at 4000 rpm for 15 min at 4°C. Discard supernatant 
and rinse pellet (Plasmid DNA in it) carefully with 2 ml of 85% ethanol. Drain off the 
ethanol and air dry the pellet for 5 min. Dissolve pellet in 3 ml of T.E. Solution (pH 
8.0). Transfer DNA suspension into 15 ml cortex tube, add 4.8 ml of cold 5 M LiCl, 
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vortex thoroughly for 10 sec. Centrifuge at 1000 rpm or 9000 g for 10 min at 
4°C.Transfer supernatant to a 30 ml cortex tube and add 30 ml of isopropanol, and 
mix well (DNA suspension : Isopropanol=1:1). Centrifuge at 1000rpm for 10 min at 
4 °C. Discard supernatant and rinse pellet with 2 ml of 85% Ethanol by gently rotate 
the cortex tube. Drain off ethanol and air dry for 10 min (make sure minimally 
residual ethanol). Dissolve pellet (Plasmid DNA in it) with 500 μl of T.E. Solution 
(pH 8.0) and add 5 μl of RNase (10mg/ml) put for 30 min at RT. (Optional: at this 
point DNA solution can been stored at -20 °C). Add 400 μl of 1.6 M NaCl (with 13% 
(w/v) PEG800).Mix well and centrifuge at 12000g for 1-2 min at 4°C. Discard 
supernatants; dissolve the pellets (DNA in it) with 500 μl of T.E. (pH 8.0). 
 
Following steps are further purification of DNA. a) Extract DNA solution with 500 
μl of phenol, mix well by vortex 10 sec and spin at 5000rpm for 5 min. (white protein 
layer should be seen between aqueous layer and phenol); b) Transfer supernatant 
carefully into a new Eppendorf tube, add 500 μl of Chloroform, mix well vortex 10 
sec and spin at 5000rpm for 5 min at RT; c) Transfer top aqueous layer to a new tube. 
Repeat step a-c at least once; d) Once the clear DNA solution is obtained, add 5M 
NaCl to a final concentration to 125mM; (for example, for 400 μl of DNA solution, 
about 10 μl of 5M NaCl is added) e) Add 800 μl of 100% ethanol into 400 μl of DNA 
solution (ethanol: DNA solution =1:2), keep on ice for at least 30 min, then white 
cloudy precipitation of DNA should be seen. (the more long fibrous precipitation, the 
  
209 
better purity) f) Centrifuge at 12000g for 5 min at 4°C. g) Carefully remove the 
supernatant and rinse the pellet (Pure DNA) with 200 μl of 85% ethanol, vortex 
briefly and spin again at 12000g for 2 min at 4°C h) Discard supernatant and 
evaporate all ethanol i) Dissolve pellet with pure water or T.E. (if subclone is not 
expected); Spectrophotometer Reading: dilute sample at ratio 1:200 in ddH2O, 1OD 
λ260nm=50μg/μl. 
 
 
